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ABSTRACT 
Coronary artery disease accounts for nearly 50% of cardiovascular disease, the 
leading cause of death in the United States. The progression of atherosclerotic plaque is 
not yet fully understood. Histopathologic analysis of cadaver coronary plaques has 
suggested that certain subsets of coronary lesions, the vulnerable plaques, predispose 
patients to myocardial infarction. Prospective identification and treatment of vulnerable 
plaques has emerged as an important future goal for intravascular imaging and 
intervention. However, no single imaging modality has been shown to be capable of 
definitively identifying these lesions. 
Optical coherence tomography is a catheter-based imaging method that rapidly 
acquires three-dimensional images of coronary artery wall microstructure. While OCT 
has been documented to be capable of visualizing morphologic features associated with 
vulnerable plaques, it has not been shown to identify necrotic core or other putative 
chemicals/molecules associated with plaque progression and rupture. One solution is to 
add a secondary modality to OCT which detects molecules specific to necrotic cores. 
Vl 
While conducting bench top spectroscopy measurements, our laboratory 
discovered that the intensity of near-infrared autofluorescence (NIRAF) is associated 
with plaque types. Using benchtop spectroscopy, this dissertation research established the 
relationship between the NIRAF signal intensity and spectral shape and atherosclerosis, 
and demonstrated its potential to differentiate necrotic core plaques from other arterial 
lesions. In addition to these spectroscopy-disease correlations, this thesis describes 
research conducted to identify the chemical/molecular origin of the NIRAF signal , using 
histopathology, confocal microscopy, spectroscopy, and chemical synthesis. The results 
indicate that protein modification in necrotic core is a potential mechanism for high 
NIRAF in advanced plaques. To translate OCT-NIRAF clinically, this dissertation 
describes the design of a double clad fiber that enables catheter-based detection of both 
OCT and NIRAF and a safety study to demonstrate that NIRAF excitation does not 
damage the artery wall. A preclinical OCT-NIRAF catheter was fabricated and used to 
image human coronary arteries ex vivo. These data showed that vulnerable plaques can 
potentially be identified using intracoronary OCT-NIRAF. The sum total of results from 
this thesis reseatch demonstrate the feasibility of conducting OCT-NIRAF imaging in 
human patients for the prospective identification of vulnerable coronary plaques. 
Vll 
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1. Introduction 
Cardiovascular disease is reported to be the leading cause of death in the United 
States and the western world (Xu, Kochanek et al. 2010). More than 616,000 people die 
from heart disease each year in the United States, accounting for approximately one in 
every four deaths. In 2010, heart disease cost an estimated $316 billion, which included 
the cost of health care services, medications, and lost productivity (Benjamin, Sebelius et 
al. 2010). Coronary artery disease (CAD) accounts for approximately 52% of deaths 
attributed to cardiovascular disease (Lloyd-Jones, Adams et al. 2009). CAD is 
characterized by the development and progression of atherosclerotic plaques, commonly 
referred to as a hardening or furring of the arteries with the accumulation of chemicals, 
such as lipids, calcification and extracellular matrix remodeling (Ross 1993; Ross 1999). 
When plaques become mechanically unstable or vulnerable, external triggers, such as 
hemodynamic forces, vasoconstrictive forces and prothrombotic events may cause plaque 
disruption (Muller, Abela et al. 1994), releasing thrombogenic factors into the blood, 
which in tum trigger a clotting cascade. The thrombus further occludes blood flow, 
causing ischemia, myocardial infarction, stroke and even sudden death. The mechanism 
of plaque rupture is not well understood. Recent natural history studies (Falk, Nakano et 
al. 2013; Narula, Nakano et al. 2013; Bentzon, Otsuka et al. 2014) suggest that plaque 
microstructure, biochemical composition, biomechanical property and metabolic state are 
precursors for plaques rupture and acute coronary event. Therefore, comprehensive 
acquisition of both structural and compositional features of plaque progression may lead 
to better evaluation and treatment of coronary plaques in patients. Morphological imaging 
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tools such as intravascular ultrasound (Nasu, Tsuchikane et al. 2006; Okubo, Kawasaki et 
al. 2008), intravascular optical coherence tomography (Jang, Bouma et al. 2002; Teamey, 
Waxman et al. 2008) have been used clinically to diagnose the disease. However, they 
commonly lack molecular information. On the other hand, standalone spectroscopic 
methods (Motz, Fitzmaurice et al. 2006; Waxman, Dixon et al. 2009; Marcu 2010) have 
provided information about the chemical composition of coronary plaques. These 
modalities operate without the knowledge of anatomical location and microstructure of 
the plaque. Hence, multimodality imaging methods combining complementary imaging 
modalities are being intensively investigated to obtain this comprehensive information. 
1.1 Atherogenesis 
The anatomical structure of undiseased arterial wall consists of intact endothelium, 
intima and media, which are homogeneous as shown in Figure 1. Atherosclerosis is 
characterized by the buildup of lipid and fibrous tissue within the arterial wall, 
chronically causing thickening and hardening. The progression of atherosclerosis (Sanz 
and Fayad 2008) can be divided into several stages based on histological classification by 
the American Heart Association (AHA) (Schaar, de Korte et al. 2003) as described below. 
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Figure 1 Structure of normal artery wall. (Reprinted from H. Watkins, M. FarraH, Nat Rev 
Genet 7, 163 (2006).) 
Type I (intimal hyperplasia) is initiated by an injury to the normal endothelium 
due to various reasons, such as hypertension, smoking and obesity. As a result, 
endothelial cells, which are normally resistant to adhesion by leukocytes, give low 
density lipoprotein (LDL) access to the intima. Vascular cell adhesion molecule-1 
(VCAM-1) (Stefanadis, Diamantopoulos et al. 1999; Nissen and Yock 2001; Watkins and 
FarraH 2006) and intercellular adhesion molecule-1 (ICAM-1) (Nasu, Tsuchikane et al. 
2006) are thus stimulated, further recruiting monocytes to adhere to the endothelium, 
which infiltrate into the intima. The monocytes evolve into macrophages and begin to 
engulf oxidized lipoproteins (oxLDL). Lipid droplets, primarily cholesterol esters, 
accumulate in the cytoplasm, and the lipid-laden macrophage is then termed a "foam 
cell", due to its foamy microscopic appearance. The presence of macrophage foam cells, 
lipid droplets in the smooth muscle cells, and T lymphocytes characterizes a Type II 
lesion (Okubo, Kawasaki et al. 2008), which is also called a fatty streak. Type III is an 
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intermediate lesion where the plaque continues to accumulate foam cells and extracellular 
lipid droplets are observed. This process stimulates the proliferation and migration of 
smooth muscle cells into the lesion, which in tum produce collagen, resulting in the 
formation of a fibrous cap (Placke, Fischer et al. 2001 ). Apoptosis of macrophages 
releases the intracellular lipid and other digested debris into the extracellular space. As 
the process continues, this necrotic debris accumulates, forming a lipid pool which 
characterizing Type IV (atheroma). Type III and Type IV are mechanically stable. Type 
V (fibroatheroma) has large extracellular lipid deposition and more connective tissue than 
Type IV. It might develop into different types of advanced plaques, including multilayer 
fibroatheroma (Va), calcific (Vb) and fibrotic (Vc) plaques. Type IV and Type V lesions 
may eventually become mechanically unstable and prone to rupture. Lesions at this stage 
are classified as Type VI (complicated lesion). Along with the accumulation of 
extracellular lipid and degraded extracellular matrix, macrophages express proteolytic 
enzymes that break down the fibrous cap. This process can ultimately lead to the 
development of a lesion consisting of a lipid-rich necrotic core covered by a thin fibrous 
cap, referred to as a thin-capped fibroatheroma (Ross 1999). Figure 2 summarizes the 
physiological processes and hallmarks of each stage. 
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Figure 2 Overview of atherogenesis. (Reprinted from Sanz, J. and Z.A. Fayad. Imaging of 
atherosclerotic cardiovascular disease. Nature, 2008. 451: p. 953). 
1.2 Plaque stability 
The understanding of plaque stability provides indispensable guidance for the 
diagnosis and treatment of coronary artery disease. For example, identifying unstable 
plaques is critical for percutaneous coronary intervention to prevent plaque rupture and 
deliver drug from drug-eluting stents. Most of our information about unstable rupture 
prone plaques has been drawn from post mortem studies of coronary plaques from 
patients who have died of acute coronary syndromes (ACS) (Virmani, Burke et al. 2006). 
Luminal thrombosis occurs via three different pathological processes: plaque rupture, 
erosion, and calcified nodules, which correspond to three types of lesions: 1) thin-capped 
fibroatheroma (TCF A) (Virmani, Burke et al. 2006), comprising a macrophage-rich, thin 
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fibrous cap overlying a core of necrotic debris, 2) endothelial erosion, which lack 
functional endothelium and may contain higher concentrations of certain proteoglycans 
(Farb, Burke et al. 1996), and 3) superficial calcific nodule (Burke, Weber et al. 2001). 
The distribution of these different plaque types implicated in myocardial infarction 
ranges from approximately 55-60% for TCFAs, 30-35% for erosions, and 3-7% for 
calcific nodules (Virmani, Burke et al. 2006). Over 90% of these high-risk plaques are 
found within 5.0 em ofthe proximal main coronary arteries (Kolodgie, Burke et al. 2001; 
Virmani, Burke et al. 2002). 
TCF As are believed to be a major underlying cause for acute coronary syndromes 
(Muller, Abela et al. 1994; Naghavi, Libby et al. 2003 ; Virmani, Kolodgie et al. 2005), 
and therefore draw intensive research attention. The molecular composition of lesions can 
indicate physiological events and provide valuable information for understanding the 
pathology of TCFAs. For example, among the lipid components in TCFA and other 
atherosclerotic plaques, the role of cholesterol crystal formation has attracted much 
attention (Felton, Crook et al. 1997; Duewell, Kono et al. 201 0). In a widely 
acknowledged study by Felton, the composition of the necrotic core is hypothesized to be 
an important indicator of plaque stability (Felton, Crook et al. 1997). This study found 
that plaques with a greater ratio of free cholesterol over cholesterol ester are at greater 
risk to rupture. This hypothesis has provided a perspective to differentiate stable plaques 
(fatty streaks and intermediary preatheroma) from unstable plaques (mature fibrolipid 
plaques) by the composition of lipids (Moreno and Muller 2002). 
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1.3 Review of existing imaging modalities 
Noninvasive Invasive 
Clinical Computed tomography (CT) X-ray angiography 
Magnetic resonance Intravascular ultrasound (IVUS) 
imaging(MRI) Optical coherence tomography (OCT) 
Thermography 
Near infrared spectroscopy (NIRS) 
Color angioscopy 
Research Image-guide magnetic Raman spectroscopy 
resonance spectroscopy (MRS) Near infrared fluorescence imaging (NIRF) 
Time resolved laser induced fluorescence 
spectroscopy (TRLIFS) 
Table 1 Common imaging modalities addressing coronary atherosclerosis. 
Many techniques have been developed to investigate coronary atherosclerosis 
pathology based on a variety of physical modalities (MacNeill, Lowe et al. 2003; Honda 
and Fitzgerald 2008; Sanz and Fayad 2008). Table 1 lists the current imaging modalities 
that are briefly reviewed in this section. These techniques are broadly divided into 
noninvasive and invasive categories, depending on methods used to access the diseased 
lesion, and then further divided into clinical and research stages based on their current 
progress. Some techniques provide structural images of the plaques revealing different 
physical context, while others utilize molecular imaging to detect endogenous or 
exogenous sources. 
Computed tomography (CT) and magnetic resonance imaging (MRI) have been 
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developed as common noninvasive methods in medical radiology for decades (Fayad and 
Fuster 2001; Schroeder, Kopp et al. 2001; Larose, Yeghiazarians et al. 2005; Honda and 
Fitzgerald 2008 ; Kantor, Nagel et al. 2009). The basic principle of CT is to use an X-ray 
source to rotate around the object and take 2D X-ray images at various rotation angles. X-
ray sensors are positioned on the opposite side of the circle from the X-ray source. The 
superimposition of images is eliminated by projection algorithm like Radon Transform, 
providing better images than X-ray. Various CT-based techniques, such as coronary 
computed tomography angiography (CCTA) (Chow, Abraham et al. 2009; Kantor, Nagel 
et al. 2009; Hadamitzky, Distler et al. 2011), multi-slice computed tomography (MSCT) 
(Schroeder, Kopp et al. 2001) and electron beam CT (Taylor, Shaw et al. 2005) have 
made progress in detecting coronary stenosis, measuring calcium score and predicting 
cardiac events. As a noninvasive traditional modality, CT is used to assess coronary 
stenosis by evaluating luminal narrowing and is capable of detecting calcified plaques. 
However, the ability to detect non-calcified plaques with CT is still limited by image 
resolution and contrast. 
Magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) 
can probe the distribution of magnetic nuclei based on nuclear magnetic resonance. In 
biomedicine, the most studied nuclei are 1 H and 13C. MRl (Fay ad and Fuster 2001; 
Johnstone, Botnar et al. 2001; Yuan, Zhang et al. 2002; Johnstone, Perez et al. 2004; 
Larose, Yeghiazarians et al. 2005; Viereck, Ruberg et al. 2005) and MRS (Hamilton, 
Oppenheimer et al. 1977; Peng, Guo et al. 2000; Ruberg, Viereck et al. 2006) are 
continually improving their capability to evaluate the blood vessel wall. The combination 
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of :MRI and MRS, referred to as image-guided MRS, demonstrates the ability to measure 
cholesterol ester quantitatively in atherosclerotic plaques (Ruberg, Viereck et al. 2006). 
In terms of patient safety, :MRI uses magnetic field instead of ionizing radiation and has 
an advantage (Sanz and Fayad 2008). Although preliminary data demonstrate MRI's 
potential to evaluate the coronary artery wall, its clinical utility is restricted by the small 
diameter, the irregular shape and motion artifacts of the coronary arteries. Gadolinium-
based contrast agents (Placke, Fischer et al. 2001 ; Sosnovik, Schellenberger et al. 2005 ; 
Kantor, Nagel et al. 2009) are also being developed to improve the discrimination 
between the fibrous cap (Kramer, Cerilli et al. 2004), the lipid core, necrotic core 
(Wasserman, Smith et al. 2002), and the visualization of coronary atherosclerosis (Briley-
Saebo, Mulder et al. 2007). Using this type of contrast agent, vulnerable plaques and 
thrombus have been imaged in living rabbits by :MRI (Phinikaridou, Ruberg et al. 201 0). 
Another important MRI method is diffuse weighted imaging (DWI), which utilizes 
proton self-diffusion in the presence of magnetic field gradients (Bammer 2003). Using 
specially-designed echo sequences, DWI can detect lipid deposits in human carotid 
atherosclerotic plaques ex vivo (Qiao, Ronen et al. 2007) and may be used to evaluate 
positive vascular remodeling in living rabbits (Phinikaridou, Hua et al. 20 13). 
Invasive modalities require direct clinical intervention to gain access to the 
coronary wall through patient sedation and percutaneous catheterization. Currently, 
imaging of coronary stenosis requires the insertion of a catheter into the coronary artery 
during X-ray angiography. As the intracoronary imaging gold standard, X-ray 
angiography can measure lumen diameter, area, and flow resistance (Pulido, Angiolillo et 
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al. 2004). Thermography (Stefanadis, Diamantopoulos et al. 1999; Madjid, Toutouzas et 
al. 2007) is a technique that measures temperature heterogenity at the surface of the 
arterial wall using thermistors. The hypothesis is that heat as a result of inflammation 
increases temperature locally at the site of inflamed vulnerable plaques, but it has not 
fully been proven yet. 
Intracoronary ultrasound (IVUS) (Hiro, Leung et al. 1997; Nissen and Yock 2001; 
Nasu, Tsuchikane et al. 2006; Okubo, Kawasaki et al. 2008), is an important clinical 
imaging tool to diagnose coronary plaques. IVUS uses ultrasound to obtain structural 
images of the coronary arterial wall through a catheter. It shows the ability to detect 
calcification, but has limited capability to identify "necrotic core" and "lipid pools" in 
TCF As (Nissen and Yock 2001 ; Virmani 2011 ). Also, due to limited spatial resolution 
(typically 150 to 200 fJm), IVUS is incapable of identifying the fibrous cap thickness 
component ofTCFA (i.e., <65 fJm) (Virmani 2011). Contrast agents for IVUS (O'Malley, 
Vavuranakis et al. 2005; Cartier, Kakadiaris et al. 2007) are on the horizon, but the long 
term safety evaluation and regulatory approval process limits the clinical application. 
IVUS is often combined with other imaging and spectroscopic modalities (Brugaletta, 
Garcia-Garcia et al. 20 1I; Miyamoto, Okura et al. 20 II) to obtain additional information, 
but it is challenging to co-register different modalities and interpret the association and 
discrepancy. Virtual Histology-IVUS (VH-IVUS) is a promising method derived from 
IVUS (Nasu, Tsuchikane et al. 2006; Konig and Klauss 2007; Okubo, Kawasaki et al. 
2008). VH-IVUS utilizes spectrum analysis of IVUS radio frequency (RF) data to derive 
pathological classifications of plaque components. Coronary tissue maps can thus be 
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reconstructed from RF data. Different from conventional grayscale IVUS, VH-IVUS 
provides a color map representing the concentration of tissue components (fibrous, 
fibrofatty, necrotic core and dense calcium)(Konig and Klauss 2007). One limitation of 
VH-IVUS is that its morphological information does not necessarily correspond with 
underlying tissue structure (Frutkin, Mehta et al. 2007). 
Optical coherence tomography(OCT) (Huang, Swanson et al. 1991) is an optical 
imaging technology that utilizes an infrared light to provide high resolution (10-15j..tm) 
images of arterial walls (Yabushita, Bouma et al. 2002). Optical frequency domain 
imaging (OFDI) (Teamey, Waxman et al. 2008), also known as frequency domain OCT, 
achieves fast imaging speed by using a wavelength-swept source. Ex vivo studies with 
OCT and OFDI have demonstrated the ability to determine the presence of fibrous, lipid-
rich, and calcified plaques and reveal microstructure of these plaques (Jang, Bouma et al. 
2002; Yun, Teamey et al. 2006; Teamey, Waxman et al. 2008). OCT further visualizes 
morphological features of plaques thought to be associated with high-risk plaques in vivo, 
such as macrophages, thin fibrous caps, and lipid pools (Jang, Bouma et al. 2002; 
Yabushita, Bouma et al. 2002; Teamey, Yabushita et al. 2003; Yun, Teamey et al. 2006; 
Teamey, Waxman et al. 2008). Recently, j..tOCT has shown to provide spatial resolution 
down to 1 IJ.m (Liu, Gardecki et al. 2011). Images of ex vivo coronary arteries provide 
structural features at cellular and subcellular levels (i.e., cholesterol crystals), which are 
associated with atherogenesis, thrombosis and responses to interventional therapy. In 
general, the interpretation of OCT images requires experience, especially when 
differentiating lipid rich plaques (gradual attenuation or diffusive border) from calcified 
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plaques (abrupt attenuation or sharper border) (Virmani 2011). 
Although OCT and OFDI are widely recognized as a unique tool with better 
image resolution ( ~ 1 01-1m) than all other imaging modalities, there are challenges for 
large scale clinical application. Due to limited penetration depth (~1mm), OCT and OFDI 
often cannot visualize the center and bottom of a lipid pool. The ability to identify lipid 
relies on diffuse borders or diffusive signal decay(Brezinski 2011) as a result of heavy 
scattering in the cap. The scattering is suggested by other researchers to come from either 
calcium deposit or lipid crystals, and does not directly represent the compositional 
information of the plaque core (Brezinski 2006). Also, OCT imaging through catheters is 
subject to artifacts, namely superficial shadowing and tangential signal dropout, which 
show similar appearance to TCF As (van So est, Regar et al. 2011 ). Those factors limit the 
ability to reliably differentiate TCF As with other stable plaques with lipid pools. In fact, a 
recent consensus document has stated that it is currently unknown as to whether or not 
OCT can discriminate necrotic core lesions from other lipid-containing plaques (Tearney, 
Regar et al. 2012). 
To improve the reliability and diagnostic value of OFDI, the addition of 
molecular signatures that play a role in the progression of atherosclerosis would be a 
significant advancement in the treatment of coronary artery disease. In the field of 
biomedical optics, fluorescence spectroscopy, fluorescence imaging and vibrational 
spectroscopy were intensively investigated in the past decades to acquire molecular 
context of human atherosclerotic plaques. 
Fluorescence spectroscopy has been used to investigate atherosclerosis by 
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different groups (Laifer, O'Brien et al. 1989; Sosnovik, Schellenberger et al. 2005), 
especially within the UV and visible range (Keijzer, Richards-Kortum et al. 1989; Laifer, 
O'Brien et al. 1989; Baraga, Rava et al. 1990; Zangaro, Silveira et al. 1996; MUller, 
Georgakoudi et al. 2001 ; MUller, Wax et al. 2002). Native fluorophores in the arterial 
wall, including collagen, elastin, NADH, ceroid, mainly contribute to UV and visible 
autofluorescence. Normal and atherosclerotic aorta could be differentiated by a 
collagen/elastin ratio (Laifer, O'Brien et al. 1989). However, lipid is not highlighted 
according to the spectral shape for UV and visible autofluorescence spectroscopy, which 
makes it challenging to find direct correlation with lipid rich plaques. 
Time-resolved laser induced fluorescence spectroscopy (TRLIFS) (Marcu, 
Fishbein et al. 2001) is similar to autofluorescence spectroscopy, but investigates the 
fluorescence lifetime. Fluorophores with overlapping emission spectra can be better 
differentiated by their lifetime. The algorithm of Laguerre expansion (Marmarelis 1993; 
Maarek, Marcu et al. 2000) further decomposes the time decay into a series of 
polynomial coefficients, which are helpful to differentiate lipid rich plaques from normal 
and fibrous plaques (Marcu, Fang et al. 2005; Marcu, Jo et al. 2009). UV and visible 
autofluorescence provides an alternative way to study native composition of plaques, but 
both techniques suffer from low penetration depth (~250J.!m) and strong blood absorption. 
Their ability to directly detect lipid pool is thus limited. TRLIFS and Laguerre expansion 
methods provide valuable association with plaque composition, but no direct physical 
interpretation has been established. 
Color angioscopy is a straightforward technique to Image the interior of the 
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coronary wall by a fiber optic probe and obtain macroscopic morphology information 
about the surface of atherosclerotic plaques (White, Ramee et al. 1993). In general, this 
method shows some association between plaque color and vulnerability, mainly based on 
the colocalization of beta carotene and lipid deposits (Takano, Inami et al. 2005). The 
thickness of the fibrous cap also contributes to the variation of the plaque color(Kubo, 
Imanishi et al. 2008). The main limitation is the lack of quantitative colormetric 
methods(Ishibashi, Aziz et al. 2006). 
Color fluorescence angioscopy is a newly adapted method of color angioscopy 
with the aid of contrast agents (Uchida, Uchida et al. 2010; Uchida, Uchida et al. 2010; 
Uchida 2011). A fiber optic catheter delivers either UV or visible light on coronary 
plaques and generate autofluorescence. The back scattering autofluorescence is selected 
by band pass filters and collected by a three color CCD to form a color image of the 
coronary wall . Evans blue and P-carotene are added as contrast agents to modify tissue 
autofluorescence. The interpretation ofthe color is challenging since spectral resolution is 
comprised by the camera. The intensity of the image therefore is not truly calibrated since 
there is no information about the distance between the camera and the lumen surface. 
Another important approach to obtain molecular information is near infrared 
fluorescence imaging (NIRF). Using different exogenous fluorescent dyes, NIRF labels 
and visualizes thrombus (Jaffer, Sosnovik et al. 2006), macrophages (Jaffer, Libby et al. 
2006; Pande, Kohler et al. 2006; Calfon, Vinegoni et al. 201 0), fibrin (Jaffer, Libby et al. 
2006), and protease activities (Jaffer, Libby et al. 2006) through a fiber optic catheter in 
vivo. Background molecular imaging of arterial inflammation have been applied in rabbit 
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aortas to study the pathogenesis of acute myocardial infarction stemming from coronary 
atheromata and implanted stents (Jaffer, Calfon et al. 2011). NIRF shows great potential 
in molecular imaging of atherosclerotic plaques in vivo and combining with other 
modalities like OCT, IVUS and MRI, but is also limited by the long term regulatory 
approval process. 
Vibrational spectroscopy, including near infrared spectroscopy (NIRS) and 
Raman spectroscopy, are label free approaches that probe the vibration structures of 
molecules located in the arterial wall. NIRS measures NIR tissue diffuse reflectance and 
provides the result in the form of a chemogram (Wang, Geng et al. 2002), which assesses 
the presence of cholesterol crystals and cholesterol ester (Caplan, Waxman et al. 2006; 
Gardner, Tan et al. 2008) in lipid rich plaques. NIRS has superior ability to detect free 
cholesterol compared to IVUS and OCT (Virmani 2011), and has been demonstrated in 
vivo (Waxman, Dixon et al. 2009). Due to the broad NIR spectral features, it is 
challenging to differentiate lipid molecules. Since NIRS does not measure fibrous cap 
thickness, it cannot separate fibroatheroma from TCF As either (Virmani 2011 ). 
Raman spectroscopy relies on the inelastic scattering of incident monochromatic 
light. Molecules interact with laser light, absorb the energy of incident photons and shift 
the electrons from the ground state to a virtual state, and then emit photons with lower or 
higher energy than the incident light. The energy difference between the incident and 
emitted photons is called the Raman shift and is measured in units of cm-1• The Raman 
spectrum can then be determined by collecting and frequency resolving the inelastic 
photons, to provide information about the composition. Seminal work by Feld and 
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coworkers (Manoharan 1992; Deinum, Rodriguez et al. 1999; Hanlon 2000; Motz, 
Hunter et al. 2004; Motz, Gandhi et al. 2005; Motz, Fitzmaurice et al. 2006) established 
Raman spectroscopy as a tool for investigating atherosclerosis. These early studies 
identified the most prominent molecules in atherosclerotic plaques that contribute 
significantly to the Raman spectral intensity, such as lipid (cholesterol, cholesterol ester), 
structural protein (collagen, elastin), calcification and carotenoid (~ carotene) 
(Manoharan 1992). Ex vivo and in vivo Raman spectroscopy have been investigated in 
both fingerprint region (300-1840cm-1) and the high wavenumber region (1600-3300cm-1) 
(Deinum, Rodriguez et al. 1999; Hanlon 2000; Motz, Hunter et al. 2004; Motz, Gandhi et 
al. 2005; Motz, Fitzmaurice et al. 2006; Chau, Motz et al. 2008; Wachsmann-Hogiu, 
Weeks et al. 2009). 
Intracoronary Raman spectroscopy has a number of challenges to overcome 
before it can become a clinically viable technology. One of the major obstacles is the 
presence of extremely large tissue autofluorescence that is excited and collected 
simultaneously with the Raman signal. In several Raman ex vivo tissue studies, 
researchers have observed that the amount of tissue autofluorescence appears to be 
correlated with plaque type (Chau, Motz et al. 2008; Chau 2009). If this autofluorescence 
signal is specific to plaque types, it might be another promising tool to extract chemical 
information. More results from ex vivo Raman study will be introduced. 
1.4. Hypothesis about near infrared autofluorescence 
In the traditional UV -visible autofluorescence studies, the fluorescence spectra are 
interpreted as a linear combination of collagen, elastin, and NADH fluorophores with 
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hemoglobin absorption. Furthermore, the steady-state fluorescence signal intensity of 
intermediate and advanced aortic lesions is reported to be relatively lower than that of 
early lesions (Romer, Brennan et al. 2000; Marcu 201 0). The observation that near-
infrared autofluorescence may contain diagnostic information about plaque composition 
(Chau, Motz et al. 2008; Chau 2009; Gardecki, Chau et al. 2009) is a recent hypothesis 
being explored by our Laboratory. 
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Figure 3 Representative spectra from a necrotic core plaque. The red solid curve is the 
raw spectrum. The blue dot curve is the estimated autofluorescence background. The black 
dash curve is the extracted Raman spectrum. Data source: MGH ex vivo Raman study. 
Reference: (Chau 2009; Gardecki, Chau et al. 2009). 
Figure 3 shows an example of raw spectra of an atherosclerotic plaque obtained in 
the fingerprint region of the Raman spectra where the Raman peaks are clearly visible on 
top of the large autofluorescence background. A polynomial fitting procedure can be used 
to approximate and then subtract the autofluorescence background (blue dot trace) 
leaving the fingerprint Raman spectrum (black dash trace). 
NIRAF fluorophores have not been characterized to date and the influence of the 
UV fluorophores, collagen, elastin and NADH, is not yet clear in this wavelength. To 
date, there are several hypotheses about the source of near infrared autofluorescence 
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exhibited by atherosclerotic plaques that can be explored. 
First, erythrocyte remnants are accumulated in advanced plaques, which might 
participate in generating NIR autofluorescence. Using human cadaver coronary plaques, 
the accumulation of erythrocyte membrane within an atherosclerotic plaque was an 
indicator of plaque stabilization (Kolodgie, Gold et al. 2003). Plaques with intraplaque 
hemorrhage show cholesterol crystals with erythrocyte fragments, foam cells and iron 
deposits. Plaques at a late stage like TCFAs have more erythrocytes than pathological 
intimal thickening or fibrous cap fibroatheroma. The larger the necrotic core, the more 
erythrocytes and iron deposition. The accumulation of erythrocytes contributes not only 
to lipid deposition and macrophage infiltration, but also to hemoglobin and heme 
degradation product buildup. If this is the major source of NIR autofluorescence, it is 
also an indicator of plaque instability, and provides the ability to differentiate TCF As 
with pathological intimal thickening, fibroatheroma, lipid pool and Intimal xanthoma. 
Second, carotenoid, especially beta carotene, is often found colocalized with lipid 
deposition in the vascular wall (Papazoglou 1995; Rocha, Silveira Jr et al. 2007), due to 
its lipid-soluble property. The presence of beta carotene is reported to enhance 
autofluorescence from cholesterol and cholesterol esters (Uchida, Uchida et al. 201 0; 
Uchida, Uchida et al.). Although beta carotene, cholesterol, cholesterol ester themselves 
do not emit autofluorescence (Blankenhorn and Braunstein 1958), their mixture is 
reported to exhibit near infrared autofluorescence. More work is needed to study the 
interaction between carotenoid and lipids, and to validate the effect of differences in diet 
between patients. 
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Third, lipid pigments m the plaque, especially ceroid, also exhibit strong 
autofluorescence in the visible range (Yin 1996; van de Poll, Bakker Schut et al. 2002; 
Haka, Kramer et al. 2011). It is possible that they contribute partly to near infrared 
autofluorescence. Ceroid is a golden yellow, granular or globular, lipid pigment. It is 
insoluble in various organic solvents and water. Therefore it cannot be extracted and 
purified for chemical assay. Using NIR Raman spectroscopy (van de Poll, Bakker Schut 
et al. 2002; Haka, Kramer et al. 2011), quantitative measurement of ceroid formation 
shows the presence of lipid, LDL peroxidation products, and hemoglobin. The formation 
of ceroid is associated with different mechanisms, such as LDL peroxidation (Fenton 
reaction)(Dillard and Tappel1971; Itakura, Oya-Ito et al. 2000; Yamada 2001; De Meyer 
and Martinet 2009), the modification/oxidization of protein and carbohydrate reaction 
(Maillard reaction) (Baynes and Monnier 1989; Hunt, Bottoms et al. 1994). Ceroid is 
initially present in the cytoplasm of macrophages but later found as large extracellular 
deposits in the necrotic core (Mitchinson, Hothersall et al. 1985; Ball, Stowers et al. 1995; 
Cromheeke, Kockx et al. 1999). Reportedly, it is universally present in more advanced 
atherosclerotic plaques, whereas the presence of ceroid in the early-stage, diffuse intimal 
thickening of arteries is rare (van de Poll, Bakker Schut et al. 2002). While there is no 
quantitative correlation between ceroid distribution and plaque instability, it is a potential 
indicator of oxidative stress. 
1.5 Dissertation structure 
The scope of this dissertation is to evaluate the potential of near infrared 
autofluorescence as a tool to obtain chemical information from plaques and to assess the 
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diagnostic value of combining this chemical-based imaging modality with OFDI to 
improve diagnostic accuracy. The rest of this dissertation is structured as follows. 
Chapter 2 describes an ex vivo spectroscopy study of human cadaver aortic 
plaques using 740nm NIRAF spectroscopy. The results demonstrated a strong correlation 
between plaque progression and NIRAF signal intensity and spectral shape. The 
sensitivity and specificity demonstrates the ability ofNIRAF to differentiate necrotic core 
plaques from non-necrotic core plaques. 
Chapter 3 describes the engineering efforts to enable NIRAF detection through an 
optical fiber catheter. This chapter is the pre-requisite to translate benchtop NIRAF 
measurement to intracoronary imaging device, and determines the design for a combined 
OFDI-NIRAF clinical system. 
Chapter 4 further investigates the source of fiber autofluorescence and Raman 
background, which provides guidance to optimize preform and fiber design. Results from 
the spectroscopy studies of optical fiber and preforms provide understanding of fiber-
generated fluorescence and lead to the design of low background double clad fiber. 
Chapter 5 describes the fabrication of a pre-clinical OFDI-NIRAF catheter. Using 
this catheter, we conducted the first experiments of OFDI-NIRAF imaging of human 
coronaries in ex vivo setting. The results further validated the feasibility to conduct 
OFDI-NIRAF imaging in human patients. 
Chapter 6 describes a study to evaluate the laser exposure safety of NIRAF under 
the proposed illumination scheme. 633nm light was focused by a preclinical OFDI-
NIRAF catheter onto fresh swine aortas. Different power were tested and histology slides 
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showed no damage. This work contributed to the regulatory approval for OFDI-NIRAF 
clinical imaging on human patients. 
Chapter 7 discusses the source of NIRAF in native atherosclerotic plaques. A 
number of hypothesises based on a comprehensive literature review are tested using 
different approaches, including histological stain, chemical synthesis, confocal 
microscopy, NIRAF microspectroscopy and vibrational spectroscopy. The results suggest 
that protein modification might be the major potential contributor to NIRAF. 
Chapter 8 summarizes the dissertation work, draws the conclusion, and suggests 
future work. 
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2. Ex vivo NIRAF spectroscopy on aorta plaques 
In this section we present results using near infrared autofluorescence (NIRAF) 
spectroscopy on ex vivo human arterial plaques. This work is inspired by earlier 
observation from ex vivo Raman study performed by our laboratory at the Massachusetts 
General Hospital. The results demonstrated the valuable contrast of NIRAF in two 
aspects: signal intensity and spectral shape variation, and hence it holds promise for 
differentiation of necrotic core plaques from non-necrotic core plaques. 
2.1 Observation of NIRAF from ex vivo Raman study 
The origin of the dissertation work was developed from an observation from a 
number of NIR Raman spectroscopic studies of human atherosclerotic plaques. The 
objective of these studies was to link chemical composition as determined by NIR Raman 
spectroscopy to plaque type and was similar to other previous ex vivo arterial tissue 
studies published by the research groups ofFeld(Manoharan 1992; Deinum, Rodriguez et 
al. 1999; Hanlon 2000; Motz, Gandhi et al. 2005; Motz, Fitzmaurice et al. 2006), 
Puppels(Buschman, Marple et al. 2000; Romer, Brennan et al. 2000) and much later 
Landulfo Silveira Junior(Silveira, Sathaiah et al. 2002; Nogueira 2005). The Raman 
studies conducted in the Tearney Laboratory at MGH differed from the previous studies 
in two important aspects. First, all previous studies histologically classified the lesion as 
either normal, fibrotic, calcific or lipid-rich, while the MGH study further differentiated 
lipid into either pathological intimal thickening(PIT) or necrotic core(NC) according to 
the recently suggested classification system by Virmani(Virmani, Burke et al. 2006). The 
methods used in the MGH study used a line scan to obtain a cross section of the lesion 
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instead of a single 'representative' point from which both histology and spectroscopy 
were registered. Previous ex vivo Raman studies had a significant number of fibrous, 
calcified and normal specimens with few lipid-rich plaques, while the MGH study 
included a significant number of these lipid-containing plaques. Furthermore, the 
pathologist subclassified these plaques into PIT and NC. 
The central observation in the MGH study is that lipid-rich plaques, and in 
particular NC plaques, tend to have higher NIR-excited tissue autofluorescence than that 
of other plaque types (Gardecki, Chau et al. 2009). Evidence to support this observation 
comes directly from experimental observations that not all plaques selected for Raman 
scans can be used due to high autofluorescence, rendering the Raman features un-
analyzable by conventional least-squares spectral decomposition. Thus, grossly appearing 
lipid-rich samples were not included in the MGH dataset. Furthermore, some highly 
fluorescent specimens were able to be scanned by taking a line scan, not through the 
central region of the plaque but rather on the edge. Corresponding histology showed 
necrotic material in the lesion. 
In biomedical Raman studies, the excitation light intended to generate Raman 
scattering will also generate some tissue autofluorescence background that will be ideally 
smaller than the Raman features. The re-emitted light collected from the sample will be a 
combination of specular and diffusely scattered excitation light, tissue autofluorescence 
and Raman scattering. Since NIRAF has a much broader spectral shape than Raman, the 
Raman spectrum can be identified by its narrow peaks corresponding to specific 
molecular vibrations. Using polynomial fitting procedure (Lieber and Mahadevan-Jansen 
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2003), it is possible to separate the NIR autofluorescence from the Raman spectrum and 
then analyze the Raman spectrum. 
Like Raman scattering, which has molecular ongms, NIR-excited 
autofluorescence also has molecular origins. We propose that the different plaque types 
have different molecular species responsible for NIRAF and that the NIRAF from 
pathologically distinct plaques may be diagnostic and easier to detect due to the orders of 
magnitude higher signal than the signal generated through Raman scattering, especially in 
lipid-rich lesions. 
To examine this hypothesis, we separated NIR autofluorescence in the high 
wavenumber region (1600-3300cm-1) from samples taken from our ex vivo Raman 
dataset. The excitation wavelength was 740nm and focused onto a spot size of 200J..Lm. 
The integration time was 200ms per spectrum. Line scan was conducted on a 
representative necrotic core plaque. At each site, the spectrum was integrated. The 
correlation of autofluorescence intensity against trichrome stained histological position is 
shown in Figure 4. The left side of the trichrome-stained section appears histologically 
intact while the right has a clear necrotic core that was ruptured during gross sectioning 
(labeled with dashed line). 
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Figure 4 Comparison between autofluorescence intensity and tissue histology. The 
highlighted area is necrotic core, which is characterized by the destruction of extracellular 
matrix. The variation of autofluorescence intensity corresponds to the extent of necrosis for 
this case. Data source: MGH ex vivo Raman study. 
According to our observation, the variation of autofluorescence intensity appears 
to be strongly associated with structure. Following the phenomenon in Figure 4, we then 
examined 40 specimens with clear histological classifications designated as fibrous, PIT 
or NC plaques. Peak signal intensity is used as a standard, since all the measurements are 
under the same condition with the same laser parameters. Figure 5 shows the comparison 
of peak intensity among 40 ex vivo human cadaver plaques. Lipid rich plaques have 
stronger signal than fibrous plaque (FP). NC have even stronger NIRAF intensity than 
PIT. The above intensity comparison shows an interesting correlation between 
autofluorescence intensity and plaque types/composition, but the experimental data is 
limited in several aspects and does not provide strong evidence that plaque type can be 
diagnosed with NIRAF. 
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Figure 5 Comparison of autofluorescence intensity among FP, NC and PIT. FP- fibrous 
plaques; NC- necrotic core plaques; PIT- pathological intimal thickening. The autofluorescence 
intensities here are from 830nm excited autofluorescence spectra extracted from MGH ex vivo 
Raman dataset of human cadaver plaques. 
The first limitation is that the emission window is within high wavenumber region, 
which represents the tails of tissue fluorescence spectra rather than the major peaks in 
fingerprint region. It is therefore difficult to identify the spectral component responsible 
for lesion discrimination. 
The second limitation is due to how the plaques were selected in this study 
(Gardecki, Chau et al. 2009). To conduct Raman study, tissue with very high 
autofluorescence was avoided, therefore the tissue specimens in the comparison were 
mainly on the shoulder of plaques. Also, the line scan limited the region of interest and it 
is therefore difficult to understand the variation of NIRAF over the whole plaque. As a 
result, the histology corresponding to the line scan does not fully represent the pathology 
of the plaque. For example, the PIT with high NIRAF might be the shoulder of a large 
necrotic core plaque, while the PIT with low NIRAF might be the center of a less 
advanced plaque. 
Inspired by the observation from the ex vivo Raman study, a new spectrometer 
26 
was built to investigate NIRAF under 740nm excitation in the fingerprint region. This 
study will be described in the rest of this chapter. 
2.2 Diffuse reflectance measurement of atherosclerotic plaques 
To analyze autofluorescence features, it is important to compensate for spectral 
distortion factors resulted from the tissue structure. Biological tissue, i.e., turbid media 
exhibit two primary mechanisms for spectral distortions: absorption and scattering. When 
tissue is illuminated by UV or visible light, hemoglobin, water and beta carotene show 
strong absorption depending upon the wavelength region. Cellular components such as 
nucleus, mitochondria and cytoskeleton exhibit high scattering of incident photons. In the 
past, diffuse reflectance spectroscopy methods were developed by various groups to 
calibrate absorption and scattering and acquire intrinsic fluorescence spectrum 
independent of tissue optical property variance (Gardner, Jacques et al. 1996; Muller, 
Georgakoudi et al. 2001 ; Angheloiu, Arendt et al. 2006). To determine whether or not 
tissue optical properties affect NIRAF, we compared diffuse reflectance between necrotic 
core plaques and non-necrotic core plaques using a similar homemade spectroscopy 
system. 
The system schematic is shown in Figure 6. A broadband light source (LS-I , 360-
2500 nm, Ocean Optics, Dunedin, Florida, USA) provided white light illumination. A 
six-round-one fiber bundle probe was fabricated by a custom designed multimode fiber 
(NA 0.22, cladding diameter 110 micron, Polymicro Technologies, Phoenix, Arizona, 
USA). The center fiber guided the illumination onto the tissue. Diffuse reflectance 
photons were collected back through six collection fibers. The distal end of the probe was 
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fused together and polished at 8° angle to reject specular reflection. A thin glass layer 
was attached on top of the distal end as surface protector. The proximal ends of six 
collection fibers were aligned in a row and terminated with FC/PC connectors, as 
illustrated in Figure 6. The photons were collected and dispersed by an f/2 spectrometer 
(SP2300, Princeton Instrument, Trenton, New Jersey, USA) onto a CCD (PIXISlOO, 
Princeton Instrument, Trenton, New Jersey, USA). Six spectra were detected by the CCD, 
and their summation was recorded as the final spectrum. 
Halogen lamp 
Probe distal end 
\\VII 
w 
Emission fiber array 
~' 
Emission fiber 
Tissue 
Figure 6 Schematic of diffuse reflectance spectroscopy measurement. 
Diffuse reflectance spectra of barium sulfide powders were used as the calibration 
standards. Five lipid containing ex vivo human aortic plaques were then measured ex vivo. 
During the measurement, different tissue sites were in gentle contact with the probe. On 
each site, 20 spectra were collected; the integration time for each spectrum was 0.2 
second. After the experiment, the tissue was formalin-fixed and sliced for histology. 
H&E and Trichrome slides were read by a board certified pathologist. 
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Figure 7 Example of diffuse reflectance spectra from a ruptured plaque. Red solid triangle 
- plaque center, yellow dotted triangle- plaque shoulder, blue dashed triangle - normal aortic 
wall. 
Figure 7 shows diffuse reflectance spectra from a ruptured plaque and its 
Trichrome stained histology slide, which represented raw diffuse reflectance spectra 
divided by reference spectrum. The arrows on the trichrome slide indicated the measured 
positions: red solid triangle - plaque center, yellow dotted triangle - plaque shoulder, 
blue dashed triangle - normal tissue. According to histology, the plaque shoulder has 
intact extracellular matrix and a lipid pool, and was considered pathological intimal 
thickening (PIT); the plaque center was ruptured and showed cholesterol crystal needles, 
which was similar to necrotic core plaques. From the comparison, it was clear that the 
three different locations showed similar diffuse reflectance feature. This agrees with the 
fact that aorta tissue absorption and scattering between 700-880nm are weaker than UV 
and visible range (Gernert, Verdaasdonk et al. 1985; Keijzer, Richards-Kortum et al. 
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1989; Cheong 1990; Oraevsky, Jacques et al. 1997). Based on this limited DRS study, we 
conclude that the NIRAF spectrum is not significantly distorted by the presence of tissue 
absorption and scattering. Thus, the wavelength-dependent intensity of the NIRAF 
spectrum is due primarily to the fluorophores present in the tissue. 
2.3 Near infrared autofluorescence spectroscopy 
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Figure 8 Overview of experimental design and data processing. 
Based on the approximation described in the previous section, we conducted an ex 
vivo study using near infrared autofluorescence spectroscopy following the procedure 
shown in Figure 8, from which we updated our understanding of near infrared 
autofluorescence. In this study, 67 post-autopsy atherosclerotic plaques from 32 human 
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aortas were scanned by a custom-built autofluorescence spectrometer. During the 
measurement, the tissue was immersed in 10% phosphate buffer solution at 37°C to 
maintain moisture and temperature. After the measurement, the comers of the region of 
interest (ROI) were labeled by tissue marking dye. A photo was then taken to record the 
gross pathology. Next, the ROI was formalin fixed for 48 hours and decalcified for 4-6 
hours. Paraffin fixed tissue blocks were cut into 5 micron sections and stained with H&E 
and trichrome for histology. 
To acquire near infrared autofluorescence spectra from cadaver human aorta 
plaques, a spectroscopy system was built, shown in Figure 9. It consisted of a 740nm CW 
laser (Innovative Photonic Solution, Monmouth Junction, NJ) providing 30m W 
excitation light. For highly fluorescent plaques, the power was decreased to 3m W to 
avoid saturation of the detector. The light was directed toward the sample using a 
dichroic mirror and focused onto 165J.!m on the sample by an f/2 lens. Backscattering 
tissue autofluorescence was collected by another f/2 lens and detected by a spectrometer 
(Acton LS785, Princeton Instrument, Trenton, New Jersey). The emission spectrum 
(746nm-906nm, or 110cm-1-2476cm-1) was recorded by a CCD (PIXIS 400, Princeton 
Instrument, Trenton, New Jersey), digitized in the computer and visualized. A custom-
made program written in Labview (National Instruments, Austin, TX, USA) controlled 
the shutter, raster scan, and data acquisition. The exposure time for each spectrum was set 
to set to 1 OOms. The spectrometer and CCD were calibrated for wavelength and spectral 
responses using a Raman standard and white light spectrum. 
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Figure 9 Schematic ofNIR autofluorescence spectroscopy system. 
2.4 Experimental results 
Representative tissue spectra were collected point by point on the tissue. Each 
spectrum was integrated within the window of 765~855nm (442 cm-1 - 1818 cm-1). To 
normalize the difference of measurement conditions, the integrated signal was divided by 
excitation power on the tissue and integration time. Therefore, we were able to construct 
a normalized autofluorescence intensity mapping of the tissue, which was comparable 
between different tissue specimens. Tissue spectra, intensity map, histology and gross 
pathology were compared for different representative plaques. Examples of necrotic core 
(NC) plaque, pathological intimal thickening (PIT), fibrocalcific (CA) and intimal 
hyperplasia (IH) are presented in this section. 
The first example shown here is a necrotic core plaque depicted in Figure 10. 
Figure 10(a) shows a gross pathology photograph of the lesion. The lipid rich area 
appears orange color under room light, which might indicate the existence of~ carotene. 
Figure 1 O(b) is autofluorescence intensity map. The area and the shape of bright area 
corresponded well with the photo. Autofluorescence in the lipid rich area is significantly 
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rich area is significantly higher than the edge, where the tissue is diagnosed as normal or 
intimal hyperplasia. Using the mean value within the red circle and outside, the signal 
ratio of lipid rich tissue/normal tissue is estimated to be 8.9 times. 
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Figure 10 Photo and autofluorescence intensity map of a necrotic core plaque. (a) The blue 
dashed circle highlights the lipid core area in gross pathology. The blue dotted line labeled the 
specimen cut for histology. The dye on the comer is to mark the ROI in raster scan.(b) The 
dashed circle on the NIRAF intensity map labels the same ROI, which shows strong signal. 
To study the variation of autofluorescence intensity more accurately, we plotted 
the intensity profile against histology directly in Figure 12. The circled area on the 
histology slide is necrotic core, characterized by disruption of the normal arterial 
structure and lipid deposition. Autofluorescence reaches the peak intensity in the center 
of necrotic core. Due to heterogeneity in the distribution of the fluorophores , there are 
peaks and valleys, but autofluorescence intensity decreases along the shoulder of necrotic 
core in general. At both edges of the slide, the tissue appears normal, and 
autofluorescence intensity drops to the minimum. 
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Figure 11 NIRAF spectra from different locations along histology slide of NC. They are 
extracted from corresponding spots in Figure 12. Red solid curve - necrotic core center; green 
dash curve -necrotic core shoulder; blue dot curve - edge. The top figure contains the raw 
spectra. The bottom figure contains normalized spectra. 
Figure 12 NIRAF intensity correlation with trichrome stained histology ofNC. Necrotic core 
region is labeled by the dash circle. Three locations are picked to compare spectral shape: Square 
- plaque center; Dashed triangle- plaque shoulder; dotted circle -edge. 
Besides intensity, we also compared the spectral shape from different histological 
locations in Figure 11. The upper plot displays the raw fluorescence intensity of these 
three regions while the spectra are normalized in the long wavelength region. As 
expected from Figure 12, the NC center has the highest emission intensity followed by 
the NC shoulder then the NC edge or IH-like region. Normalization of the spectral red-
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edges reveals that the emission spectra for these three pathologies are identical from 
800nm to 900nm, but exhibits some variation between 755nm to 800nm. This suggests a 
compositional difference. 
Similarly, we present results for pathological intimal thickening (PIT), 
fibrocalcific plaque (CA) and intimal hyperplasia (IH) . For each example, the specimen 
cut for histology is labeled on either the photo or the NIRAF mapping. 
Figure 13 shows the photo and autofluorescence map of a PIT. The 
autofluorescence map in Figure 13(b) has poorer contrast than necrotic core, because the 
lipid region poorly defined as shown in the photo. From Figure 14, we find that 
autofluorescence is still correlated with the distribution of lipid pool in this plaque. Lipid 
pool area generally has higher autofluorescence than the edge. In Figure 15, a comparison 
of two spectra from different lipid pools shows similar spectral shape, while the spectrum 
at the edge has a different shape. The spectral shape variation is evident in the 755-
800nm region . 
(a) (b) 
-3 
-2 
histology 
Figure 13 Photo and autofluorescence map of a PIT. (a) gross pathology photograph, (b) 
autofluorescence map. The dash-dot line labels the position cut for histology. 
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Figure 14 Trichrome stained histology and autofluorescence intensity profile of PIT. Red 
square - center, green triangle - shoulder, blue circle- edge . 
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Figure 15 Comparison of autofluorescence spectra from 3 different locations on PIT. Red 
solid curve- center, green dash curve- shoulder, blue dot curve- edge. The top figure contains 
raw spectra. The bottom figure contains normalized spectra. 
Figure 16 shows a fibrocalcific plaque. Autofluorescence in the calcific nodule is 
higher than the rest of the tissue, and correlates well with the gross pathology. For a 
fibrocalcific plaque, OFDI can provide a sharp contrast on the calcific nodule, which acts 
as a substitute for histology. In Figure 17, we compared autofluorescence intensity profile 
and the corresponding OFDI image. Autofluorescence is higher on the calcific nodule 
than the surrounding tissue. Calcium mineralization, adjacent inflammation and lipid 
colocalization might contribute to this signal, and determine the variation. 
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Figure 16 Photo and autofluorescence map of fibrocalcific plaque. (a) gross pathology 
photograph. (b) autofluorescence intensity map. The region highlighted by red dashed rectangle is 
calcific nodule. 
Figure 17 Autofluorescence profile and OFDI image of a fibrocalcific plaque. Red square-
plaque center, green triangle - plaque shoulder, blue circle - edge. 
The last major pathological example is intimal hyperplasia, which appears as a 
thickened intimal layer. From Figure 19, the tissue appears uniform under white light, 
and the autofluorescence map has less variation than the above three plaques. The 
difference between left and right might be due to photobleaching and tissue heterogeneity. 
In Figure 18, we observe no sign of lipid or calcification in histology, and the 
autofluorescence is more homogeneous. 
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Figure 18 Autofluorescence intensity profile and histology of m. The top figure is the 
intensity profile. The bottom image is the trichrome stain. 
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Figure 19 Photo and autofluorescence map of m. (a) gross pathology photograph, (b) 
autofluorescence intensity map. The dash line labels the position cut for histology. 
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Figure 20 Comparison of the four representative plaques. (a) raw tissue spectra, (b) 
normalized spectra at the peak. Red solid curve - NC, green dashed curve - IH, blue dash-dot 
curve- PIT, black dot curve- CA. 
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From the above four examples, we find that necrotic core plaques exhibit higher 
signal intensity than PIT, CA and IH, as shown in Figure 20(a). Meanwhile, the spectral 
shape variation occurs on the blue edge of emission spectra shown in Figure 20(b ). 
2.5 Plaque classification 
To extract the common feature of autofluorescence from different types of 
plaques, all 67 datasets were combined to conduct a statistical analysis. The distribution 
of lesions into pathological diagnosis is summarized in Table 2. 
Tissue type Number 
Necrotic core 13 
Pathological intimal thickening 21 
Intima hyperplasia 9 
Fibrocalcific 10 
Fibrous 14 
Total 67 
Table 2 Summary of ex vivo plaques scanned by 740nm laser. 
With reference to histology, representative pixels of the same type of tissue were 
selected from each autofluorescence map and grouped together. In the intensity 
comparison, each category had 84 samples. The overall comparison of autofluorescence 
intensity among necrotic core (NC), pathological intimal thickness (PIT), fibrocalcific 
(CA), intimal hyperplasia (IH) and fibrous plaque (FB) are presented in Figure 21. 
Using one-way analysis of variance (ANOVA), we compared the difference 
between 5 types of plaques as shown in Figure 21. Since F is much bigger than F critical 
value, and p-value is 0.0001, the intensity is significantly different among all 5 types. The 
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trend of intensity variation is NC>PIT>CA> FB>IH, which IS m agreement with our 
observation from previous Raman studies. 
10 
2 
NC PIT CA IH FB 
Figure 21 Comparison of signal intensity between 5 types of plaques. NC- necrotic core, PIT 
-pathological intimal thickening; CA- calcific plaque; IH- intimal hyperplasia, FB -fibrous 
plaque. The errorbar represents standard deviation. 
Source ofVariation ss df MS F P-value F crit 
Between Groups 3.36E+l7 4 8.39E+16 1290.5 0.0001 6.71 
Within Groups 2.70E+16 415 6.50E+l3 
Total 3.63E+17 419 
Table 3 One way ANOVA result for mtens1ty companson. 
To further extract plaque characteristics from the spectrum and to develop a 
diagnostic algorithm, we investigated the change in spectral shape for different 
atherosclerotic plaques by principal component analysis (PCA). Similarly, representative 
spectra from the diagnosed region were selected and combined into a training set, 
including NC, PIT, CA and FB. All spectra were normalized by peak intensity and zero-
mean centered. The eigenvalue and principal components were shown in Figure 22. The 
eigenvalue in Figure 22 (a) means the first and second loadings contribute mainly to the 
variation of spectral shape. The second loading has a feature between 750 and 800nm, but 
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flat after 800nm, which is shown in Figure 22(b). 
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Figure 22 PCA results of ex vivo plaque spectra. (a) Eigenvalue of each principal component, 
(b) the 1st to 5th principal components. 
Since the first and second principal components dominate the spectral shape, we 
applied quadrant discriminant analysis (QDA) on their scores in order to observe the 
spectral shape difference on a two dimensional plane. To test this classification method, 
we adopted leave-one-out strategy because of the limited number of specimens in the 
dataset. In each loop, one data point is set as the test point, and the rest of the dataset 
serves as the training set for QDA. After all the loops, we can estimate the sensitivity and 
specificity of the classification. 
To evaluate the performance of this algorithm, we selected spectra from 128 NC 
and 332 PIT sites. Their PCA score map and the quadrant discriminant curve are shown 
in Figure 23. Their distribution can be clearly separated and the results are summarized in 
Table 4. The overall accuracy is 84.8%. Since necrotic core is often surrounded by 
pathological intimal thickening and other less advanced lipid rich plaques, a more strict 
pathology diagnosis will be helpful to decrease the confusion of classification. This result 
is encouraging and further demonstrates the potential to differentiate necrotic core 
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plaques and non-necrotic lipid rich plaques. 
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Figure 23 PCA-QDA classification of NC and PIT. This is a scatterplot of 1 •' and 2nd PCA 
scores ofNC(red triangle) and PIT(blue circle). The purple curve is the differentiation curve 
calculated by QDA method. Any sample enveloped by the purple circle is classified as NC. 
Any sample outside the purple circle is classified as PIT. 
Training set Classified as PIT Classified as NC 
PIT(332) 281 51 
NC(l28) 19 109 
Table 4 Classification results for NC and PIT. 
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Figure 24 PCA and QDA classification ofNC/PIT/CAJFB plaques. The purple trace is the 
differentiation curve for NC. Any sample inside the purple traced region is classified as NC. 
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Similarly, we added intimal hyperplasia and fibrocalcific plaques into the 
classification, as shown in Figure 24. With the presence of non-lipid containing plaques, 
the classification also shows high sensitivity as listed in Table 5. 
Training NC PIT CA FB Sensitivity 
set 
NC 102 14 8 4 79.69% 
PIT 49 264 3 16 79.52% 
CA 0 1 83 0 98.81% 
FB 2 0 0 82 97.62% 
Table 5 Classification ofNC/PIT/CA/FB. 
While the PCA/QDA method demonstrates the feasibility of differentiating 
necrotic core plaque's from non-necrotic core plaques by NIRAF spectral shape only, it 
requires a large and robust training set for practical applications. It will be therefore very 
useful to develop a straightforward method for diagnosis. 
We hence proposed a double channel method to differentiate necrotic core 
plaques from non-necrotic core plaques. In the NIRAF emission window, 765nm to 
780nm was chosen as the blue channel, and 780nm to 800nm was chosen as the red 
channel. NIRAF spectra were integrated in the two channels separately. Using the 
NIRAF spectral integration within 765-855nm window as X axis, and the blue channel 
intensity/red channel intensity ratio as Y axis, we performed linear discriminant analysis 
on the NC and PIT sites. 
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Figure 25 Double channel differentiation between NCA and PIT. The purple line is the 
differentiation curve. The samples above the purple line is classified as PIT. The samples 
below the purple line is classified as NC. · 
Training set Classified as NC Classified as PIT Parameters 
NC(128) 128 0 SE=100% 
PIT(332) 14 318 SP=95.7% 
Total (460) 142 318 Accuracy=97. 75% 
Table 6 Classification between NC/PIT by double channel method. 
Figure 25 shows the LDA differentiation results. The sensitivity, specificity and 
accuracy are higher than PCA/QDA method. While NIRAF intensity significantly 
distinguishes NC from PIT on X-axis, the blue/red ratio also shows a trend that the 
emission ofNC is red shifted. This is also a good indicator ofthe composition difference 
and provides the basis for making NIRAF a practical tool. 
In this preliminary study, we measured near infrared autofluorescence spectra 
form different types of plaques. Both spectral intensity and shape provide great potential 
to identify the stage of the plaque and its composition. Meanwhile, the fact that the 
primary spectral shape variation occurs near the excitation line shows that it may be 
possible to reveal more spectral features using a shorter excitation wavelength. These 
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results will be the foundation for the following ex vivo study and engineering effort 
towards developing NIRAF for in vivo applications. 
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Figure 26 Comparison of autofluorescence intensity excited by 633nm and 740nm. LPD-
lipid rich plaque; CA- calcific plaque; FB -fibrous plaque. The errorbar is standard 
deviation. 
Although 740nm excitation showed promising results, the optimal excitation 
wavelength needs further identification. In the ex vivo study of human aorta plaques, we 
used 633nm excitation light from Helium: Neon laser as a potential alternative to 740nm 
laser. Following the same procedure, 10 plaques were scanned, including lipid rich 
plaques, erosive plaques, calcific plaques and fibrous plaques. These plaques were 
immersed with 37°C 10% PBS during the measurement. NIRAF spectroscopy excited by 
740nm was illuminated first, and then the filtersets were switched to interrogate tissue 
with 633nm excitation. To avoid photobleaching, the excitation power of 740nm was 
3mW, and the excitation power of 633nm was 1mW. The ROI was labeled with tissue 
marking dye to provide reference for data registration. Autofluorescence intensity 
increased significantly by blue shifting excitation wavelength, as shown in Figure 26. To 
evaluate the sensitivity and specificity of 633nm excitation, PCA-QDA algorithm was 
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applied to both datasets. 160 data points were selected, including 40 lipid rich sites, 40 
calcified sites, 40 erosive sites and 40 fibrous sites. The 740nm and 633nm spectral 
classification results are shown in Figure 27 and Figure 28 . In this comparison, the 
classification was based on raw spectra without peak normalization. 
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Figure 27 PCA-QDA classification of plaques by 740nm. LPD -lipid rich plaque, ERO-
erosive plaque, CA- fibrocalcific plaque, FB -fibrous plaque. The purple trace is the 
discrirnnant curve for LPD. 
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Figure 28 PCA-QDA classification of plaques by 633nm. LPD- lipid rich plaque, ERO-
erosive plaque, CA- fibrocalcific plaque, FB - fibrous plaque. 
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From Figure 27 and Figure 28, the scatterplot of 1st and 2nd PCA scores showed 
different patterns for 4 different types of plaques. The confusion tables for both 
classification are shown in Table 7 and Table 8. For lipid rich plaques, the sensitivity of 
740nm is 100% while 633nm is 95%; for calcified plaque, the sensitivity of740nm is 70% 
while 633nm is 90%; for erosive plaque, the sensitivity of 740nm is 96.25%, while 
633nm is 90%; for fibrous plaque, the sensitivity of 740nm is 95%, while 633nm is 95%. 
The overall accuracy of 740nm is 90.3%, while the overall accuracy of 633nm is 92.5%. 
Training set LPD CA ERO FB Sensitivity 
LPD 40 0 0 0 100% 
CA 0 28 7 5 70% 
ERO 0 3 37 0 96.3% 
FB 0 2 0 38 95% 
Table 7 PCA-LDA classification by 740nm. 
Training set LPD CA ERO FB Sensitivity 
LPD 38 0 2 0 95% 
CA 1 36 3 0 90% 
ERO 4 0 36 0 90% 
FB 0 2 0 38 95% 
Table 8 PCA-LDA classtficatton by 633nm. 
In summary, 633nm excitation provides better signal intensity and similar spectral 
shape contrast, and is therefore considered an attractive alternative wavelength. 
In this chapter, near infrared autofluorescence spectroscopy measurement of 
human atherosclerotic plaques demonstrates that NIRAF signal has the potential to 
differentiate lipid rich plaques from non-lipid containing plaques. More importantly, 
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using NIRAF intensity and NIRAF spectral shape, the most clinically significant plaques, 
necrotic core plaques, can be differentiated from non-necrotic core lipid containing 
plaques, which adds unique valuable information to understand plaque progression. 
These results serve as the foundation for future clinical studies in human patients 
undergoing coronary imaging. 
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3 Feasibility of OFDI-NIRAF combination 
Similar to other invasive clinical technologies like IVUS and OFDI, NIRAF will 
need to be implemented in a catheter for application in vivo. OFDI, an optical-based 
imaging technology, has demonstrated intracoronary imaging by applying a brief non-
occlusive flush to clear the blood and obtain a clear optical path to the arterial wall. 
Having demonstrated that NIRAF has diagnostic potential, the next major 
challenge is to determine if the NIRAF signal can be detected through a fiber-based 
catheter and to optimize the SNR. 
From an engineering perspective, the prerequisite of OFDI-NIRAF imaging in 
human patients is to achieve high tissue/background ratio and SNR. The key optical 
element for enabling intracoronary OFDI-NIRAF is a double clad fiber with low 
background and high transmission efficiency. 
In this chapter, the efforts to compare double clad fiber background and to 
increase NIRAF SNR will be discussed, which lead to a design and material selection 
that optimize the throughput, collection efficiency and background noise level to obtain 
the highest possible SNR. The results serve as the basis to fabricate the ideal NIRAF 
catheter with the appropriate form factor to function in a coronary artery. 
3.1 Engineering basis to combine NIRAF with OFDI 
As a prototype, our lab has recently developed a multimodality OFDI system with 
near infrared fluorescence imaging(NIRF) (Y oo, Kim et al. 2011 ). This system acquires 
coregistered OFDI images and NIRF images through a rotary junction and a fiber 
catheter based on custom designed double clad fiber (DC-SMF-28T, Boston University, 
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Boston, MA, USA). 
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Figure 29 Multimodal OFDI with NIRF concept. (a) shows the system configuration, optic 
path and catheter geometry. (b) shows OFDI image of a fibroatheroma in a rabbit iliac aorta in 
vivo. The diffusive region in the OFDI image is lipid pool, which corresponds to the red region on 
the NIRF image(Distribution ofCy-7 dye for cysteine). (Quoted from: Yoo, H., J. W. Kim, eta!. 
(2011). "Intra-arterial catheter for simultaneous microstructural and molecular imaging in vivo." 
Nat Med 17(12): 1680-1684). 
The schematic and results are shown in Figure 29. The optical path, catheter 
design, detection scheme and mechanical control are shown in Figure 29(a). Using this 
system, OFDI images and NIRF images of atherosclerotic plaques in a living rabbit aorta 
treated with exogenous fluorescent dyes were obtained and coregistered in Figure 29(b), 
providing information for both plaque structure and inflammatory activities. OFDI-NIRF 
is fundamentally different from OFDI-NIRAF in the following respects: 
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1. OFDI-NIRF utilizes exogenous fluorophores to label different biomolecular 
targets on the plaque, while OFDI-NIRAF is label free, which avoids the issue with agent 
incubation, toxicity and clearance, significantly simplifying regulatory approval and 
imaging procedure. 
2. OFDI-NIRF has much lower requirement for fiber background than OFDI-
NIRAF, since the exogenous fluorophores can provide strong signal due to high quantum 
yield. 
Using the standard OFDI-NIRF catheter made of custom designed double clad 
fiber (DC-SMF-28T, Boston University, Boston, MA), we compared the typical signal-
to-noise ratio of NIRF and NIRAF. The excitation wavelength is 750nm. The power is 
20m W on the plaque. For NIRF, a rabbit coronary labeled with Prosense fluorescence 
dye (Perkin Elmer, Waltham, MA, USA) was scanned. The fluorescence signal detected 
by OFDI-NIRF catheter across the plaque is shown in Figure 30 as circumferential view. 
The mean fiber background is 1.1 V, while the plaque signal is up to 1.8V. The 
tissue/background ratio is 1.6. The standard deviation of the signal is ~0.02V, therefore 
the SNR is 80(linear scale) or 38dB (log scale). 
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Figure 30 NIRF signal of a rabbit coronary plaque from OFDI-NIRF catheter.The rabbit 
plaque was incubated with Prosense fluorescent dye before the imaging procedure. The peaks 
from l.SV to 2. 7V were from the plaque. The flat baseline around 1 V was the fiber background. 
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Figure 31 NIRAF signal on a human aorta plaque detected by OFDI-NIRF catheter. The 
same catheter in Figure 30 was used for this experiment. The black rectangle labels the fiber 
background. The yellow curcle labels NIRAF signal from the plaque. 
For comparison, the same catheter was placed near the surface of an ex vivo 
human aorta plaque and collected NIRAF signal. The plaque was confirmed by histology 
as a necrotic core plaque. Figure 31 shows the fiber background and plaque signal during 
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a manually controlled linear pullback. The x-axis of the image is the time lapse of this 
experiment and the unit is s. They-axis is a voltage read from the fluorescence detection 
PMT. The mean fiber background is 1.44V, while the plaque signal is no more than 
0.14V. The standard deviation ofthe signal is 0.05V. The tissue/background ratio is <0.1 , 
and the SNR is 2.8(linear scale) or 8.9dB (log scale). From the waveform, it is clear that 
the NIRAF signal is very close to the noise floor, which may make it very difficult to 
detect. This noise floor mainly comes from the shot noise due to the fiber background. 
Although seemingly similar to OFDI-NIRF, this result illustrates that OFDI-
NIRAF detection requires fundamental modifications to the detection scheme, including 
both optical fiber and imaging system design. 
3.2 Double clad fiber 
One optical fiber design that is adaptable to the present OFDI imaging and 
catheter platform, is a double clad fiber (DCF). The DCF is reported to have several 
benefits for non-coherent optical spectroscopy (Wang, Choi et a!. 2007), miniaturized 
optical endoscopy (Yelin, Bouma et al. 2004; Fu, Gan et al. 2005; Lemire-Renaud, 
Rivard et al. 201 0), such as high collection efficiency, low speckle reflection and 
increased depth of field. Figure 32 illustrates the three-layer structure of a typical DCF. 
The core usually has 8-10 Jlm diameter and low NA (i.e., 0.1) for single mode guidance. 
The inner cladding has a larger diameter (1 00~ 120J.!m) and larger NA (0.22~0.46) for 
multimode guidance. A low index polymer coating envelopes the inner cladding to match 
refractive index and provides the high NA of the inner cladding. To reduce the bending 
loss, a low index trench is usually designed between the core and the inner cladding 
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(Bouwmans, Pureur et al. 2007). Since it is feasible to guide single mode fluorescence 
excitation light and OFDI in the core and collect fluorescent signal in the large area 
cladding, this kind of fiber is also beneficial for multimodal imaging (Ryu, Choi et al. 
2008). 
In our evaluation to date, we have tested three different DCFs for NIRAF 
spectroscopy. These are a custom-designed DCF (DC-SMF-28T, Boston University, 
Boston, MA), Nufern DCF (FUD3236, Nufern, East Granby, CT), and Nufern DCF with 
a thin outer cladding (SM-91105/125, Nufern, East Granby, CT). To distinguish between 
the two Nufern DCFs, we refer to the latter as the Nufern TCF, although the outer 
cladding is mainly to protect the inner cladding instead of guiding light. 
3.3 DCF background testing 
As Figure 31 illustrates, the presence of fiber background degrades the sensitivity 
of the NIRAF system. Though fiber background can be measured and subtracted from the 
total signal, a large background offset invades the dynamic range of the detector and most 
importantly contributes excess noise. 
The objective of fiber testing is to determine the optimal excitation and collection 
configuration to minimize fiber background, bending loss and maximize collection 
efficiency. The geometry of DCF fiber and the experimental system is shown in Figure 
32. Two single mode laser sources were used, 740nm from a Ti: Sapphire laser and 
633nm from Helium: Neon laser. When testing the fiber, both core excitation and 
cladding excitation were applied. The length of each fiber was 1 meter. The main 
parameters we tested in the experiments include: a) fiber background, b) collection 
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efficiency and c) bending loss. 
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Figure 32 Fiber testing system schematic. BP - bandpass filter; LP - long pass filter; DM -
dichroic mirror. BU DCF and Nufem DCF FUD 3236 have similar geometry. Nufem TCF has 
another thin glass cladding between low index coating and inner cladding. 
3.2.1 Fiber background 
Excitation light from 633nm and 740nm sources were coupled into the core and 
the cladding respectively, and the back scattering fiber background was collected into the 
spectrometer. Figure 33 (a) and (b) shows the spectra excited at 633nm. Nufem DCF has 
the minimum background, while the BU DCF and Nufem TCF exhibit high fiber 
background generated from the polymer coating and doping. Figure 33 (c) and (d) show 
normalized fiber background excited at 740nm. As a comparison, we also tested a single 
mode fiber (SMF-28; Thorlabs) at 740nm. Since the single mode fiber only generates 
Raman background, and its spectrum is very similar to all three DCFs, all three DCFs are 
considered to have minimal background under 740nm excitation. Therefore, the Nufem 
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DCF is the lowest background choice because of its minimal contribution at 633nm 
excitation. 
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Figure 33 Fiber background from core/cladding by 633nm and 740nm. (a) and (b) are 
calibrated by power, length and exposure time to compare the amplitude of fiber background 
excited at 633nm. (c) and (d) are normalized by peak intensity to show the spectral shape excited 
at 7 40nm. Smf- SMF28E single mode fiber (Coming Inc., Corning, New York) . 
3.2.2 Collection efficiency 
To test the collection efficiency of the DCF fibers , we prepared a set of 
fluorescence solutions at different concentrations of indocyanine green (ICG). 740nm 
light from a Ti: Sapphire laser was coupled into a 1 meter long fiber. The distal end of the 
fiber was immersed in an ICG solution with known concentration. We excited the 
solution from the core and the cladding. ICG fluorescence signal from the fiber was 
collected, filtered, calibrated and integrated from 780nm to 800nm (near ICG emission 
peak). The calibration plots are shown in Figure 34. The collection efficiency of Nufem 
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TCF is slightly better than the Nufern DCF, and both are significantly better than the BU 
DCF. For all fibers , excitation through the cladding resulted in superior collection 
efficiency compared to core excitation. As an example, Figure 35 shows the comparison 
between cladding excitation and core excitation when collecting ICG fluorescence by the 
Nufern DCF cladding. The cladding excitation resulted in ~ 17% higher signal level. 
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Figure 34 Comparison of collected ICG fluorescence signal. (a) ICG signal collected by the 
cladding ofthree DCFs when excited through the core; (b) ICG signal collected by the cladding 
of three DCFs when excited through the cladding. 
20 40 60 80 100 
Relative concentration 
Figure 35 Comparison between cladding and core excitation using Nufern DCF. Blue 
triangle- ICG signal collected by Nufem DCF when excited through the cladding, Red circle 
- ICG signal collected by Nufem DCF when excited through the core. 
3.2.3 Bending loss 
During catheterization, the OFDI-NIRAF catheter will be introduced via either 
femoral or bracheal access, and will be transverse various arteries ultimately. Once in the 
57 
coronary artery, the OFDI-NIRAF catheter will undergo a number of significant bends, 
which may result in increased fiber fluorescence or loss of fluorescence signal. To 
characterize the expected bending losses, we wrapped the fiber in one complete 
revolution around a 25 mm diameter post to simulate the expected tortuosity and repeated 
the fluorescence collection efficiency experiments. The comparison is shown in Figure 36. 
For example, Figure 36(a) compares the ICG signal from the BU DCF when we coupled 
740nm laser into the cladding and illuminated the ICG solution under straight and 25mm 
bending condition, while Figure 36(b) shows the results when we excited the ICG 
solution through the BU DCF core. Figure 36(c) and (d) show the results for Nufern DCF. 
Figure 36(e) and (f) show the results for Nufern TCF. For Nufern DCF and BU DCF, 
there are minor differences between bent and straight fibers. But for Nufern TCF, the 
bending loss is significantly worse. 
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Figure 36 Comparison of collection efficiency between straight and bending fiber. (a) 
extracted ICG signal collected by BU DCF excited from the cladding, (b) extracted ICG signal 
collected by BU DCF excited from the core, (c) extracted ICG signal collected by Nufem DCF 
excited from the cladding, (d) extracted ICG signal collected by Nufem DCF excited from the 
core, (e) extracted ICG signal collected by Nufem TCF excited from the cladding, (f) extracted 
ICG signal collected by Nufern TCF excited from the core. For each case, the measurement was 
done on the straight fiber and bended fiber( 1 inch diameter). A stock ICG solution was diluted to 
make 5 different relative concentrations. 
Considering both collection efficiency and bending loss, we conclude that the 
Nufern DCF has the optimal performance for both 633nm and 740nm excitation and that 
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excitation through the cladding will result in better collection efficiency. This result 
relaxes the conditions for coupling the excitation light into a multimode fiber instead of a 
single mode core. 
3.4 NIRAF detection through DCF 
For in vivo applications, choice of the optimal NIRAF wavelength is a key 
parameter that needs to balance the maximum tissue autofluorescence with the minimum 
fiber background. As a general rule of thumb, blue-shifting the excitation will lead to 
increased fluorescence in both tissue and fiber. To address the optimum wavelength, we 
investigated the tissue-to-fiber ratio (TFR) at two readily available wavelengths in the 
laboratory. The sources were a low powered He:Ne at 633nm and a high powered diode 
laser at 740 nm. Intermediate wavelength sources were not available, and more 
importantly, good filter sets having high ODs with sharp cutoffs similar to those used for 
Raman were also not readily available in the wavelength region. 
Using the ex vivo benchtop datasets in Figure 26, we estimated tissue/fiber ratio 
from 633nm and 740nm. Both tissue spectra and fiber spectra were calibrated by power, 
exposure time and attenuation (to avoid detector saturation). To avoid the fiber Raman 
peak in the fingerprint region (< lOOOcm-1) , we integrated the spectra from lOOOcm-1 to 
2600cm-1 (651 ~760nm for 633nm excitation, and 799~916nm for 740nm excitation). The 
result is shown in Figure 38. The tissue/fiber ratio from 633nm is significantly higher 
than 740nm excitation. Therefore, using 633nm excitation through the cladding ofNufern 
DCF will be the optimal design for catheter design. 
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Figure 37 Tissue autofluorescence spectra from DCF with ball lens. CA-- fibrocalcific 
plaque, NC- necrotic core. 
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Figure 38 Tissue/fiber ratio for both 633nm and 740nm excitation. LPD -lipid rich plaque, 
CA - fibrocalcific plaque, FB - fibrous plaque. The errorbar is standard deviation. 
To test the Nufern DCF fiber as a potential optical core, we fused a forward-
looking ball lens to the distal end of 2-m long segment, which is similar to the OFDI 
cardiology catheter. The NA of the ball lens is ~0.3 , and its focal length is ~0.5mm. 
We placed this probe near the blood vessel wall and measured several human 
cadaver aortic plaques using 633nm excitation in Figure 37. Although there is a strong 
fused silica Raman spectrum present in the collected data, excluding the region between 
640 and 680nm, we can observe the existence of tissue autofluorescence between 680nm 
and 750nm. Lipid rich plaques generate much higher signal intensity than calcific plaques 
and fatty streaks, which is consistent with ex vivo results under 7 40nm excitation. 
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Based on these results, it is feasible to obtain a tissue autofluorescence spectrum 
from a double clad fiber catheter. An intracoronary OFDI-NIRAF catheter based on 
Nufern DCF was designed and manufactured for ex vivo coronary imaging. The details of 
this study will be described in Chapter 5. 
For OFDI-NIRAF, the challenge is to acquire NIRAF signal simultaneously with 
OFDI, which operates at an A-line rate of 100 kHz. In the previous feasibility study, the 
measurements were acquired by a high sensitivity spectrometer and CCD with an 
acquisition time of 100 ms per spectrum. To test the signal level at 100kHz, the detector 
was replaced by a PMT (H-5784, Hamamatsu, Japan). A 2m long Nufern DCF probe was 
made with forward-looking ball lens. 633nm excitation light was focused onto a piece of 
ex vivo human aorta plaque with 3m W excitation power. The plaque was ~2mm away 
from the ball lens surface, which is the maximum anticipated distance between a clinical 
catheter and human coronary wall. The collected emission signal was transmitted through 
a long pass filter and integrated by the PMT from 675nm to 820nm. The sampling rate of 
the PMT was set as 100kHz, which equals the clinical OFDI A-line rate. The results are 
shown in Figure 39. This plaque was identified by Trichrome stain as a necrotic core. In 
Figure 39(a), the photo provided gross pathology and suggested a lipid rich plaque based 
on a yellow appearance (plaque) and surrounding pink region. In Figure 39(b), the raw 
NIRAF intensity map showed strong contrast between the plaque region and the 
surrounding normal region. The intensity at each pixel is an overlap of fiber background 
and tissue signal, further demonstrating the feasibility to highlight necrotic core plaque at 
a high sampling rate. 
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Figure 39 NIRAF Map through a 2m Nufern DCF probe acquired by PMT. (a) photo of the 
plaque; (b) NIRAF intensity map. The red solid circle labels the necrotic core region, which 
appears bright. The white dashed line labels where to cut histology; (c) Trichrome histology cut 
along the dash line in (b). 
In addition to NC, representative PIT and CA plaques are scanned and shown in 
Figure 40 and Figure 41. From the raw data, the PIT and calcified lesion are clearly seen. 
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Figure 40 Example ofNIRAF imaging on PIT. (a) the gross pathology photo of the plaque; (b) 
the NIRAF intensity map, where the plaque region appears bright; (c) H&E histology cut from 
the region inside the dash rectangle in (b). 
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Figure 41 Example ofNIRAF imaging on CA. (a) photo ofthe plaque; (b) the NIRAF 
intensity map. The calcified region appears bright. The dashed rectangle labels where to cut 
histology; (c) H&E histology cut within the dashed rectangle in (b). 
We conducted a small study using 5 NC, 5 PIT, 5 CA and 5 IH to confirm that the 
intensity-based diagnostic algorithm is valid under these experimental conditions. The 
fiber background was subtracted from the raw data. The signal was divided by excitation 
power as calibration. In Figure 42, one-way ANOVA shows that NC, PIT, CA and IH are 
significantly different by intensity (p<O.OOI). This result is in agreement with ex vivo 
benchtop spectroscopy measurement of plaques. 
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Figure 42 Comparison of NIRAF intensity by ball lens probe. NC- necrotic core, PIT-
pathological intimal thickening, CA- fibrocalcific plaque, ill- intimal hyperplasia. The errorbar 
is standard deviation 
Chapter 2 and Chapter 3 discussed ex vivo study on human aorta plaques by 
NIRAF spectroscopy and imaging. We demonstrated the high specificity of 740nm 
excited autofluorescence from ex vivo human aorta plaques. The fact that lipid rich 
plaques, especially necrotic core plaques, have stronger NIRAF suggests its clinical 
significance for finding advanced lipid rich plaques. The classification results are 
promising for further evaluation of plaque vulnerability. 633nm excitation was also 
applied in the ex vivo study and showed better tissue/fiber fluorescence ratio, which is 
beneficial for detection in vivo. 
We tested and identified the optimal double clad fiber for future in vivo 
application, and evaluated the tissue/fiber ratio for both 633nm and 740nm excitation. 
633nm excitation through the cladding of Nufern DCF shows the feasibility to detect 
NIRAF spectrum through a catheter, holding the promise of intracoronary imaging. 
Using a ball lens probe made ofNufern DCF, the NIRAF intensity was compared among 
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NC, PIT, CA and IH. The feasibility of conducting high speed NIRAF imaging, which 
may highlight NC plaques, is further demonstrated. These findings serve as the 
motivation to utilize NIRAF clinically. The complementary data that NIRAF may 
provide when measured in conjunction with OFDI provides a powerful rationale for 
combining these two technologies in a single catheter. 
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4 Investigation of fiber fluorescence background 
From Chapter 2 and Chapter 3, we learn that NIRAF intensity, although improved 
by 633nm excitation, is still relatively weak, on the scale of fiber silica Raman 
background. To acquire NIRAF from tissue, low fiber fluorescence background must be 
ensured. 
This requirement is to some extent similar to intracoronary Raman spectroscopy. 
Different research groups made tremendous efforts to study the factors that impact optical 
fiber background and optimize catheter design for Raman catheter (Shim, Wilson et al. 
1999; de Lima, Sathaiah et al. 2000; Utzinger and Richards-Kortum 2003; Motz, Hunter 
et al. 2004; Santos, Wolthuis et al. 2005). While these results provided valuable 
information to understand the issues associated with fiber background, the combination 
of OFDI-NIRAF requires further investigation. For example, most of the above research 
investigated near infrared excitation (>720nm) and utilized high wavenumber window to 
avoid the fiber silica Raman band, therefore providing high signal-to-noise ratio for 
Raman spectroscopy. For OFDI-NIRAF, the differences of fiber type, excitation 
wavelength and emission window brings new variables into the equation. 
In Chapter 3, FUD3236 from Nufem was chosen for OFDI-NIRAF catheter 
fabrication. However, the fiber spool purchased at different periods showed different 
background intensity levels. Figure 43 shows the fiber background spectra from the 
cladding ofNufem FUD3236 in 2011 and 2012, which are calibrated by excitation power 
and fiber length. The latter showed significantly higher background than the former. As a 
reference, the lot number for FUD3236 in 2011 includes 04-A0257-00-3F and 04-A0257-
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00-3H. The lot number for FUD3236 in 2012 includes 04-A0257-00-3J and 04-A0257-
00-3L. The fiber produced within the same year had consistent background level. This 
problem hampered our progress towards translating OFDI-NIRAF clinically. Therefore, 
it is necessary to understand the source of double clad fiber background in order to 
provide guidance to manufacturers for the appropriate fiber design. In this chapter, 
several factors impacting the fiber background are discussed and the final design is 
validated. 
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Figure 43 Fiber background from different spools of FUD3236. 
4.1 Brief review of optical fiber fabrication 
To understand the origin of fiber background, it is necessary to review how an 
optical fiber is made. For common passive optical fibers, such as multimode fiber , single 
mode fiber and double clad fiber as used for NIRAF, the first step of fabrication is to 
construct a concentric cylindrical glass preform. The preform contains multiple layers. 
68 
The core of the preform is made of fused silica doped with very small amount of chosen 
agents (Ge, B, F, etc.) to generate the refractive index pattern. There are different ways to 
generate the core of the preform, including vapor deposition, outside vapor deposition, 
vapor axial deposition and plasma deposition(Li 1985; Buck 2004; Menez and Morse 
2006). The preform for our double clad fiber is made by modified chemical vapor 
deposition. The schematic of the preform fabrication is shown in Figure 44. Oxygen gas 
is bubbled through different liquids (POCh, SiCl4, and GeC14) and then mixed with other 
gases including BCh, SiF4, SF6, Ch, etc. The gas mixture flows through the hollow core 
of a fused silica tube and is heated by multibumer torch. Chemical reaction products 
(Si02 and dopants: Ge02, B20 3, P20s, etc.) form a soot inside the hollow core, which 
sinters into the glass. The torch is driven back and forth repeatedly to slowly build up 
very pure layers pass by pass. Eventually the tube collapses into a solid glass rod, which 
is the preform. 
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Figure 44 Schematic of modified chemical vapor deposition. Reprinted from (Li 1985). 
When a preform is ready, it is placed on a drawing tower, and the tip is heated up 
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to 2000 oc. The melted preform drops due to gravity and the distal end is cooled into a 
thread-like form, further pulled by a motor spool to form the fiber. The bare glass fiber is 
coated with different polymers to provide mechanical protection, which are usually cured 
by UV light or heat. For double clad fiber, the polymer has lower refractive index than 
fused silica, which determines the NA of the cladding. 
During the fabrication of optical fiber, different factors may affect the fiber 
background: the material, the fabrication procedure of preform and the polymer coating. 
Their contributions are discussed separately in the following sections. 
4.2 Impact of preform background 
To address the impact of material and preform fabrication on fiber background, 
the background from the preform was directly measured by a homemade spectroscopy 
system shown in Figure 45. 
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Figure 45 Schematic of preform background testing system. 
A single mode fiber coupled 633nm He: Ne laser provided 7m W excitation power. 
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The light was collimated by an objective lens into a 500J.lm diameter (FWHM) beam. The 
beam was reflected by a long pass dichroic mirror into an achromatic lens and focused on 
the preform. The back scattering Rayleigh signal was blocked by the dichroic mirror and 
long pass filter, while the Stokes shift signal was collected into the spectrometer and 
recorded on the CCD. The optical parameters of the system were measured in the air. The 
focal spot diameter was 70J.tm, and the confocal parameter was 15mm. 
The measurement was based on 2D point scan. A translation stage moved the 
preform on the horizontal plane following a square grid pattern. The step size in X and Y 
direction was 0.25mm. The total scan area was 8mm by 8mm. At each point, the 
exposure time was 0.2s per spectrum and 20 spectra were acquired. 
Preform name 12-B1243 09-B0841 12-D0104 13-B1406 13-D0362 
NA 0.165 0.135 0.1 0.123 0.123 
Core 1.82 3.34 3.84 2.29 2.572 
diameter(rnrn) 
Cladding 14.00 14.06 14.09 14.25 14.77 
diameter(mm) 
Height(mm) 12.97 13.90 13.77 6.89 9.30 
Doping in the Ge Ge Ge Ge Ge 
core 
Table 9 Parameters of tested preforms from Nufern. 
5 different preforms (Nufern Inc., East Granby, CT, USA) were flat polished at 
both ends and tested, each with a Ge doped core and fused silica cladding in common 
with different NA and sizes. The fabrication procedures were very similar, except that 
two of them had pure silica deposited outside the core before fusing with the silica 
cladding. Their parameters are listed in Table 9. In this test, the preforms have not been 
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fused with pure silica jacket tube. Since the tube only exhibits silica Raman background, 
it does not change our understanding of preform background. 
Preform 13-D0362 is taken as an example to describe how to acquire 
compositional information from the 2-D spectroscopy measurement. 
First of all, to learn the source of fiber fluorescence, an algorithm was developed 
to extract fluorescence spectrum from the raw spectrum. The major challenge is to 
remove silica Raman spectrum. 
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Figure 46 Representative normalized raw spectrum on the preform and fused silica. Red 
solid curve: raw preform spectrum; Blue dashed curve: fused silica Raman. 
In the preform, fused silica is the main component (weight percentage>90%) and 
its Raman signature dominates the raw spectrum in the short emission wavelength region. 
Figure 46 shows representative normalized raw spectrum on the preform and its 
comparison with fused silica Raman spectrum. Between 640nm and 655nm the raw 
spectrum is almost identical to silica Raman signature. Between 655nm and 720nm the 
raw spectrum shows a mixture of fluorescence and silica Raman. When emission 
wavelength>720nm, both Raman and fluorescence become very weak. 
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Since silica Raman spectrum has low frequency component which is not 
distinguishable from fluorescence, the separation algorithm is based on the high 
frequency silica Raman peaks 610cm-1,807 cm-1, 1068 cm-1 and 1206 cm-1• The algorithm 
includes three steps: 
First, polynomial fitting is applied on silica Raman spectrum to estimate the low 
frequency component, which is then subtracted. High frequency Raman peaks thus 
compose a basic spectrum. Figure 4 7 shows how to estimate low frequency component 
by polynomial fitting from silica Raman spectrum. 
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Figure 47 Example of polynomial fitting to estimate low frequency components. 
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Figure 48 Estimation of silica Raman component in the raw preform spectrum. 
Second, polynomial fitting is applied on the raw preform spectrum to estimate the 
low frequency component, which is also subtracted. The high frequency residue is fitted 
by the basic spectrum. Therefore the magnitude of silica Raman in the raw preform 
spectrum is calculated. Figure 48 shows the fitted silica Raman spectra on the preform. 
Third, from the raw preform spectrum, silica Raman spectrum multiplied by the 
weight is subtracted. The result is the fluorescence from the dopant and other chemicals. 
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Figure 49 Separated fluorescence and silica Raman spectra. 
Figure 49 shows one example of separated fluorescence and silica Raman. The 
separated fluorescence spectrum was integrated over 680-760nm window to compose an 
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intensity map shown in Figure 50. Based on intensity, the map can be divided into five 
layers from inside to outside: the core with dark gray color, the bright ring, the gray 
region, the dark region and the outer edges. Since the outer edges correspond to 
unpolished coarse surface where multiple scattering and reflection happens, its signal was 
not taken into account. The core, bright ring, gray region and dark region were 
investigated. 
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Figure 50 Fluorescence intensity map of preform 13-D0362.The yellow dashed line labels the 
position to draw intensity profile across the preform. 
First, the intensity profile of the preform is plotted against the dashed line in the 
center of the preform in Figure 51. The diameters of the core, the bright ring and the gray 
region are directly measured on the figure. Sorted by intensity from high to low, the 
sequence is: bright ring> gray region>the core>the dark region. According to the 
datasheet from Nufern, the reported core diameter is 2.572mm, which is very close to our 
measurement (2.5mm); the reported pure silica cladding diameter is 14.77mm, which is 
much larger than the gray region (6.25mm). The intensity map shows that the core, the 
bright ring and the gray region mainly contribute to fiber background. 
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Figure 51 Fluorescence intensity profile across preform 13-D0362. 
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Figure 52 Raw spectra at different positions on preform 13-D0362. 
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Figure 53 Normalized raw spectra on different layers of preform 13-D0362. 
To better understand the spectral/compositional difference, we compared the raw 
spectra from the core, the bright ring, and the gray region in Figure 52. The dark region 
shows identical silica Raman spectrum, so it is used as a reference. The core spectrum is 
very similar to silica Raman from 640 to 670nm, but shows an elevated tail from 680 to 
760nm. Both the bright ring and the gray region show fluorescence over the whole 
emission window. If we normalize the spectra by the peak intensity, a clear comparison 
of spectral shape is shown in Figure 53 . The spectrum of the bright ring contains higher 
fluorescence background than the gray region, while the dark region presents pure silica 
Raman. 
77 
E 
E 
2 0 
mm 
-2 
Filwre 54 Red/blue ratio mao of oreform 13-D0362. 
0.8 
1 .5r---~----.---~---------..---.----.---, 
2.5mm 
~~--~-3L_ ____ 2~--~----o~---L-L--~--~--~ 
rrrn 
3.75mm 
Figure 55 Red/blue ratio profile of preform 13-D0362. 
To show the spectral contrast on the preform directly, the spectrum is integrated 
within two narrow channels, 645-650nm as blue channel, and 680-700nm as red channel. 
The red/blue ratio qualitatively renders the preform fluorescence background. Figure 54 
shows the red/blue map of preform 13-D0362. It has similar contrast to the intensity map. 
The red/blue ratio profile in Figure 55 also clearly differentiates the core, the bright edge, 
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the gray region and dark region. The estimated size of core agrees with the datasheet. 
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Figure 56 Refractive index profile of Preform 13-D0362. Reprinted from Nufern datasheet. 
Courtesy ofNufern Inc .. 
Figure 56 shows the refractive index profile of preform 13-D0362 along the radial 
direction. The correlation between spectroscopic measurement and actual composition of 
the preform is as follows: 
a. The core is up-doped with Ge and exhibits minimal fluorescence. 
b. The bright ring is a thin layer of pure silica deposit to better isolate core and 
cladding. The reported silica deposit thickness is 0.5mm, which is also close to 
our measurement (0.625mm). Since our step size is 0.25mm, this error is within 
the measurement tolerance. 
c. The gray region and outer black region are supposedly uniform material, which is 
pure silica glass. 
Fluorescence spectra were extracted from the raw spectra and normalized to 
further compare spectral features, as shown in Figure 57. From the comparison, we find 
that the fluorescence spectral shape in the bright ring and the gray region is almost 
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identical. This indicates that the same fluorophores are likely to exist in both regions, 
while the concentration is much higher in the bright ring. On the other hand, the 
fluorescence in the core shows an elongated tail from 670nm to 760nm, which is 
distinguishable from the features in the bright ring and gray region. Therefore the dopant 
in the core is not responsible for the fluorescence in the cladding. 
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Figure 57 Extracted fluorescence spectra across the preform with silica reference. 
With reference to specification in Table 9, the testing of preform 13-D0362 
provides the following clues towards the source of fiber background: 
1) The core of the preform has distinct fluorescence signatures indicating the 
existence of Ge, but the signal intensity is not overwhelming silica Raman intensity. 
Based on fluorescence intensity and spectral contrast, the core can be precisely mapped to 
its physical diameter. 
2) The pure silica deposit generates very bright fluorescence, which shows 
identical fluorescence spectral features to the gray region where the intensity is weaker 
than the bright ring but stronger than the core. This indicates that the same fluorophores 
exist in both layers and have a high concentration in the pure silica deposit. 
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According to the datasheet, fused silica is the only component in the pure silica 
deposit and the cladding, which suggests that the fluorophore in those layers is not 
present in the raw material but generated during the deposition process and localized in 
the trench and the inner part of the cladding. 
To investigate the impact of the pure silica deposit layer on preform background, 
another preform (09-B0841) was tested using the same method, which had no pure silica 
deposit and served as a negative control. This preform had a doped core and silica 
cladding. 
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Figure 58 Intensity map and Red/blue map ofPreform#09-B0841. (a) Intensity map over the 
preform, (b) red/blue map over the preform. The yellow dashed line labels the position to draw 
the profile. 
Figure 58(a) shows the intensity map of preeform#09-B0841 , which consists of a 
gray core, a surrounding concentric gray region and black region reaching the edge. 
Figure 58(b) shows the red/blue map, which also indicates a core, a surrounding gray 
region and a black region. The bottom right corner is unpolished and not taken into 
account. Since the red/blue map provides sharp contrast, the profile along the dashed line 
is plotted in Figure 59. The core diameter estimated by the profile is very close to the 
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actual size. 
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Figure 59 Red/blue profile of preform#09-B0841. 
Following the same approach, we tested the remaining three preforms, and 
compared the measured data with the specs, as shown in Table 10. 
Name NA Core Core diameter Gray region Thickness of Silica deposit 
diameter from red/blue diameter from bright ring thickness( mm) 
(mm) ratio(mm) red/blue(mm) (mm) 
13-81406 0.123 2.29 2.25 7 0 N/A 
13-D0362 0.123 2.572 2.5 6 0.625 0.5 
12-81243 0.165 1.82 1.75 5.5 0 N/A 
09-80841 0.135 3.34 3.25 7.5 0 N/A 
12-D0104 0.1 3.84 3.75 7 0.25 0.25 
Table 10 Comparison of preform datasheet and measurement results. 
The common features are listed as follows: 
1) For all five preforms, the estimated core size from fluorescence spectroscopy is 
very close to the actual size. 
2) Each preform has low fluorescence in the core, and the spectral shape shows a 
tail between 670 and 760nm (Figure 60), indicating that the dopant in the core is not 
responsible for the elevated fiber background. 
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3) Each preform shows a gray region with identical fluorescence spectral shape. 
The gray region is smaller than the actual silica cladding size. In Figure 61 we compared 
the extracted fluorescence spectra, which demonstrated the similarity. 
4) For preforms with the thin silica deposit, the fluorescence intensity is 
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Figure 60 Comparison of extracted fluorescence spectra at the cores of five preforms. 
significantly higher, and the ratio of fluorescence/silica Raman also increases. 
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Figure 61 Comparison of normalized extracted fluorescence spectra from 5 preforms. 
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In summary, according to the preform testing, the source of double fiber 
background in the cladding mainly exists in the border between the preform core and 
cladding during the process when the cladding is deposited outside the core. The 
cladding-core interface also presents similar fluorescence spectrum with lower intensity. 
The dopant in the preform core is responsible for the fiber background in the core of 
double clad fiber, but has lower signal intensity and unique spectral shape. 
4.3 Impact of fiber polymer jacket 
Besides the preform material, the polymer jacket is another potential source of 
fiber fluorescence background. In general, the role of the polymer jacket is to provide 
mechanical protection for the fiber. The common material of the polymer jacket includes 
acrylic, polyimide, Teflon and other organic molecules, which usually have high 
fluorescence. 
However, for double clad fiber, the polymer jacket is required to have lower 
refractive index than the inner cladding in order to guide the inner cladding' s light. At the 
interface between the inner cladding and the polymer jacket, waves within the inner 
cladding undergo total internal reflection, which minimizes the excitation photons into 
the polymer jacket. As a result, the polymer jacket should have low impact on the double 
clad fiber fluorescence background. 
To validate this hypothesis, we measured the fluorescence spectra of polymer 
jackets from three different double clad fibers : BU DCF; FUD3236 high background 
DCF and FUD3236 low background DCF. For each fiber, we stripped a piece (~lOmm) 
of polymer jacket off the fiber, cut it open and flatten it on a magnesium fluoride window. 
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The thickness of each jacket was ~63 J.lm. The area of each jacket was -700 J.lm x 1 mm. 
The jacket was measured under the same spectrometer system as Figure 45. The 
excitation power was 0.8m W. The integration time was 0.2s per spectrum. The measured 
spectra are shown in Figure 62. 
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Figure 62 Polymer jacket fluorescence background from different double clad fibers. 
According to our previous measurement, under the same condition, the 
fluorescence background sequence sorted by intensity from high to low is BU DCF> 
FUD high background spool> FUD low background spool. In Figure 62, the sequence is 
the opposite: FUD low background spool>FUD high background spool> BU DCF. This 
result shows that the double clad fiber background is not associated with the polymer 
jacket; the BU DCF exhibits the highest fiber background despite having the lowest 
measured polymer jacket fluorescence. 
Of course, for the above measurements, the assumption is that the polymer jacket 
is very well coated and the refractive index is accurately matched. If the quality of the 
coating deteriorates; it is possible that fiber background might rise due to increased 
excitation photon leakage into the coating. 
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4.4 Other factors impacting fiber background 
Besides the material properties discussed in Section 4.1-4.3, there are other 
factors that might determine the intensity of fiber background, such as excitation power, 
fiber length and core size. Several experiments were designed to address those issues. 
First of all, as is the case whenever fluorophore concentration is unknown, it is 
possible that when excitation power reaches a certain threshold, the fiber background will 
stop increasing, which provides the opportunity to increase tissue/fiber ratio and SNR. To 
test this possibility, the relation between fiber background and excitation is measured on 
a 2m Nufern FUD3236 fiber. The experimental setup is shown in Figure 63. It is very 
similar to the system in Figure 32 except that the spectrometer is replaced by a PMT. The 
excitation is 633nm He: Ne laser. The emission window is 680-800nm. The sampling rate 
of the PMT is 1 00 kHz. 
FUD3236 
Laserline filter Shutter 
Figure 63 Fiber background measurement system using a PMT. 
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In this experiment, both core excitation and cladding excitation are tested. The 
excitation power out of the fiber is shown in Table 11. Considering laser safety issue, the 
maximum power in this test is below lOmW. The cladding and core background under 
different excitation power are plotted in Figure 64. Using linear fitting, the R2 value for 
cladding excitation is 0.9483, and for core is 0.9755 . This result shows that double clad 
fiber background has a linear relationship with excitation power under the safety 
threshold ofOFDI-NIRAF. 
Structure Power(mW) 
Core 0.37 0.65 
Cladding 0.34 0.56 
Table 11 Parameters for power testing. 
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Figure 64 Fiber background vs. power. The red rectangle is the core background read by the 
PMT. The red solid curve is the linear fitting of the core background. The black triangle is the 
cladding background read by the PMT. The black solid curve is the linear fitting of the cladding 
background. 
Second, the magnitude of fiber background depends on the optical path inside the 
fiber. It is useful to understand the relation between fiber background and fiber length. 
The propagation of excitation light relies on internal reflection at the interface between 
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different materials with different refractive index. In other words, instead of a ballistic 
path, the excitation photons travel in a "zigzag" pattern depending on the NA and modes. 
Since an optical fiber can be seen as a symmetric tube, our hypothesis is that fiber 
background is proportional to fiber length. 
To validate this hypothesis, a double clad fiber (BU), a multimode fiber 
(Polymicro) and a single mode fiber (SMF-28, Corning) are tested to obtain the relation 
between fiber background and length. For each fiber, three pieces are tested, including 
lm, 2m and 3m. The experiments are done on the system in Figure 32. The fiber 
background spectrum is integrated from 640nm to 760nrn, which covers the full range of 
the detector. The 633nm excitation power is 2.8m W out of the fiber. The single mode 
fiber serves as the reference for TEMoo propagation. The multimode fiber represents the 
propagation of higher spatial modes. The double clad fiber is excited through the core as 
a further validation. 
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Figure 65 Single mode fiber background vs. length. 
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The relation between single mode fiber background and length is shown in Figure 
65. The linear fitting curve is plotted as comparison and the R2 value is 0.9882, which 
indicates good linearity. Similarly, the relation for multimode fiber and double clad fiber 
(core excitation) are shown in Figure 66 and Figure 67 respectively, with R2 value of 
0.9981 and 0.9980. These results support our hypothesis and suggest that a shorter 
catheter length may help decrease fiber background. 
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Third, although in our application the excitation light is focused in the cladding, 
small portion of incident photons still have access to the core region and illuminate the 
Ge doping. It is necessary to learn determine whether the core size would impact the fiber 
background during cladding excitation. 
To address this problem, low background FUD3236 and two other types of 
double clad fiber from Nufern were tested. The inner cladding parameter is: FUD3236 
diameter 125J..tm, NA0.46; FUD3340 diameter 125J..lm, NA 0.46; FUD3576 diameter 
129~131J..lm, NA0.46. The core parameter is: FUD3236 9.7J..lm, NA 0.12; FUD3340 6~7 
J..lm, NA 0.14; FUD3576 8.6J..lm, NA 0.1. 633nm excitation is coupled into the cladding 
and the fiber background spectra are normalized by the peak. The results are shown in 
Figure 68. 
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Figure 68 Comparison of different FUD cladding background.FUD3236 here is the low 
background FUD3236 in 2011. 
According to the measurement, background sequence sorted by intensity from 
low to high is: FUD3236 < FUD3340 < FUD3576, while core size sequence from small 
to large is: FUD3340 < FUD3576 < FUD3236, and NA sequence from low to high is: 
FUD3576 < FUD3236 < FUD3340. This means the cladding background is not positively 
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correlated with the core size or core NA. Therefore the doping in the core is unlikely to 
determine the cladding background. 
4.5 Preform optimization and final design 
In this chapter, we evaluated different factors that have impact on double clad 
fiber fluorescence background. 
As the basic material of the optical fiber, preforms were measured by 
fluorescence spectroscopy. According to the intensity comparison, the fiber background 
mainly comes from a relatively bright region of the inner cladding close to the core. The 
interface between the core and the inner cladding is even brighter. The core, although 
containing Ge02 and other dopants, shows lower background. According to the spectral 
shape comparison, the cores of five preforms show similar features demonstrating Ge02. 
The relatively bright region of the inner cladding show distinct features indicating the 
fluorophore mainly responsible for background in the double clad fiber. The outer layer 
of inner cladding mainly shows silica Raman signatures and has no fluorescence. 
Polymer jackets from three different double clad fibers were also measured. The 
results suggest that the double clad fiber background is not correlated with the polymer 
jacket background. It agrees with the hypothesis that there is minimal excitation into the 
polymer jacket when light is traveling inside the double clad fiber. 
Besides material property, the role of excitation power, fiber length, fiber 
geometry are also investigated and the results include: within the safe range of OFDI-
NIRAF, double clad fiber will not be saturated by laser excitation power; the fiber 
background has good linear relationship with fiber length; the doping in the core does not 
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determine the cladding background. 
To optimize double clad fiber design and minimize fiber background, it is 
necessary to investigate the nature of the gray region. Non-bridging oxygen hole centers 
(NBOHC) have been reported to be generated near the core-cladding interface during 
annealing (Girard, Meunier et al. 2004; Vaccaro, Cannas et al. 2013). This phenomenon 
is characterized by an absorption peak at 2eV (~620nm) and luminescence with a lifetime 
of ~30fls(Friebele, Griscom et al. 1985). 630nm absorption in optical fiber is also 
correlated to NBOHC(Hibino and Hanafusa 1986). Considering the excitation 
wavelength we are using and the location of bright ring/gray region, NBOHC is very 
likely to contribute to the fiber/preform background. Our understanding of the problem is 
as follows: 
The molecular nature of NBOHCs are dangling oxygen defects, and its pre-
cursors, strained oxygen sites, exist in silica before making the preform. NBOHCs may 
be formed through different mechanisms during preform fabrication and fiber draw 
process. Breakage of strained Si-0-Si bonds and breakage of oxygen excess sites -
peroxy linkages are common examples. These shear stresses may arise from the thermal 
history of different sections of the preform as well as stresses arising due to 
compositional differences in sections of the preform. This explains why we noticed the 
bright rings in the preform even prior to fiber draw. Additionally, the shear stress in the 
neck down region during the draw process can provide the energy to break the bonds. 
Since various regions of the preform have varying thermal expansion coefficients, some 
regions are more prone to stress-induced breakage of bonds leading to formation of the 
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NBOHCs. 
Based on this hypothesis, to further optimize fiber design for OFDI-NIRAF, two 
approaches were proposed. 
1) Decrease the amount of deposited silica 
2) Add dopants to treat NBOHCs. For example, fluorine doped glass(Vaccaro, 
Cannas et al. 20 13) is a possible alternative of pure silica glass. 
In response to these findings, Nufern produced three new preforms, which were 
tested using the same methods as described in Section 4.2. Each preform was designed to 
decrease fiber fluorescence by a different mechanism. 
The first new preform is 14-D0439. The refractive index profile is shown in 
Figure 69. It is comprised of three layers, up-doped core, down-doped trench and pure 
silica cladding. The design of the core is similar to preforml3-D0362 in Figure 56, but 
the trench design follows a gradual transition pattern. The purpose of this design is to 
avoid using pure silica coating as the trench. 
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Figure 69 Refractive index profile of 14-D0439. Reprinted from Nufem datasheet. Courtesy 
ofNufem Inc. 
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Figure 70 Maps of preform 14-D0439. (a) NIRAF intensity map; (b) Rayleigh light intensity 
map; (c) red/blue ratio map. 
The raw NIRAF intensity map, Rayleight scattering map and red/blue map( or 
fluorescence/Raman) map are shown in Figure 70. From the intensity map, it is clear that 
the core and cladding have low background, while the interface between the trench and 
the outer silica cladding has a gray ring. The average intensity ofthe gray ring is ~3500, 
94 
which is lower than the extracted bright ring in preform 13-D0362(~5000). Since both 
intensity maps are calibrated by power and exposure time, it is confirmed that the mix 
doped trench has lower background than pure silica deposit coating. Meanwhile, from the 
intensity profile and Flu/Raman ratio profile in Figure 71, it is clear that the core and the 
trench inside the interface and the outer silica cladding all have low background and low 
Flu/Raman ratio. Since there is doping in both the core and the trench, its Flu/Raman 
ratio is slightly higher than the interface. 
NIRAF 
6000 
~ 
en 4000 c 
Q) 
1:: 
LL 
;!2 
z 
-6 -4 -2 0 2 4 6 
Flu/Raman 
0 
'§ 
c 
Cll 
E 
Cll 
~ 
::J 
u::: 
0 
-6 -4 -2 0 2 4 6 
Distance (mm) 
Figure 71 Intensity profile and Flu/Raman ratio. Top image- NIRAF intensity profile 
across the preform; bottom image - Flu/Raman or red/blue ratio profile across the preform. 
The second new preform is 13-B 1384 and consists of a deposited silica core, a F-
doped trench, and an outer pure silica cladding. The purpose of this preform is: a) 
validate if silica deposition causes high background, b) test ifF-doped material has high 
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background. The refractive index profile is shown in Figure 72. The core is deposited 
silica. The trench is down doped by F. The outer cladding is pure silica tube with the 
same refractive index as the core. 
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Figure 72 Refractive index profile of 13-B1384. Reprinted from Nufem datasheet. Couresty 
ofNufem Inc. 
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Figure 73 Maps of preform 13-B1384. (a) NIRAF intensity map; (b) Rayleigh light intensity 
map; (c) red/blue ratio map. 
The raw NIRAF intensity map, Rayleigh scattering map and red/blue map( or 
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fluorescence/Raman) map are shown in Figure 73. The intensity map shows a bright core, 
a dark area surrounding the core, a gray ring along the interface and dark outer cladding. 
Due to imperfect polishing, there are hot spots on the surface which don't represent 
preform properties. The average intensity of the bright core and gray ring is - 7000 and 
- 5000. The core is significantly higher than the gray ring in both preform 13-B 1384 and 
14-D0439. The intensity profile and Flu/Raman ratio profile in Figure 74 shows a very 
good correlation. The F doped trench shows low background ( - 1 000) and low Flu/Raman 
ratio( - 0.2), which is similar to pure silica cladding in pervious preforms. From this 
preform, we learned that the silica deposition process causes more background than 
fusing the silica jacket tube with the trench, while F doping does not introduce higher 
background than pure silica cladding. 
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Figure 74 Intensity and Flu/Raman ratio profile of 13-B1384. Top image- NIRAF 
intensity profile across the preform; bottom image - Flu/Raman or red/blue ratio profile across 
the preform. 
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ofNufem Inc. 
The third new preform is 13-D0374. It has a deposited silica core and F doped 
cladding. The silica jacket tube is F320 glass instead of pure silica glass F300. Different 
from 13-B 1384, the transition between trench and jacket tube is very smooth. The 
purpose is to test if this design can reduce the background at the interface. 
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Figure 76 Maps of preform 13-D0374. (a) NIRAF intensity map; (b) Rayleigh light intensity 
map; (c) red/blue ratio map 
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The NIRAF intensity map, Rayleigh map and Red/blue ratio map are shown in 
Figure 76. On the intensity map, there is a bright core in the center and a dark cladding all 
over the preform. The Rayleigh map shows the profile of the core and the edge between 
the trench and jacket tube. However, on the red/blue map, we can only differentiate the 
core from the rest of the preform, and there is no contrast between the trench and the 
jacket tube. 
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Figure 77 Intensity and Flu/Raman ratio of 13-D0374. Top image- NIRAF intensity 
profile across the preform; bottom image- Flu/Raman ratio or red/blue ratio profile across the 
preform. 
From the intensity and Flu/Raman ratio profile in Figure 77, it is clear that the 
core has high intensity ( ~ 7200) and high Flu/Raman ratio(~ 1 ), which is similar to 13-
B 1384. The F doped trench/cladding shows low intensity(~ 1300) and low Flu/Raman 
ratio( ~0.2) . 
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According to the test results of three new preforms, it is confirmed that preform 
background mainly comes from the deposited pure silica core and the interface between 
pure silica jacket tube and the trench. The Ge doped core and F doped trench/cladding 
contribute much less to fiber background. 
By having a doped deposited trench region, we demonstrated two advantanges to 
reduce NBOHC fluorescence. First, there are lesser/minimal sites that are prone to bond-
breakage close to the core and subsequent formation of NBOHCs. Second, the doped 
deposited trench region serves as a buffer to dissipate stresses and we believe this 
phenomena leads to offsetting the stress induced during the draw process away from the 
core region. 
In summary, to fix the issue with increased fiber background of FUD3236, nine 
preforms from Nufern were tested. The main source of perform background is deposited 
silica in the core or at the interfaces (core/cladding, trench/cladding). This observation 
supports the hypothesis that NBOHCs are generated during annealing process and emit 
luminescence when excited by 633nm light. This phenomenon is common and difficult to 
eliminate, but its impact can be reduced by engineering efforts. From the preform testing, 
a promising fact suggests the solution. Ge and F doping contribute much less background 
than the deposited silica, and they actually limit the generation of NBOHCs, which are 
localized in the deposited silica region. 
Considering these results, the following suggestions are made to design low 
background double clad fiber for OFDI-NIRAF and optimize OFDI-NIRAF SNR. 
1. For cladding excitation-cladding collection scheme, since most of the excitation 
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light propagates into the cladding, it will be helpful to confine NBOHCs as close 
to the core as possible. Inspired by preform 14-D0439, the suggested solution is to 
envelope the Ge-doped core with a narrow trench, which has smooth transition 
with the outer pure silica cladding. This design will decrease the diameter of the 
interface and its overall background intensity. 
2. For core excitation-cladding collection scheme, the refractive index of each part 
of the preform will be similar to cladding excitation-cladding collection except 
that the trench should have a much bigger diameter so the interface is far from the 
core. 
Having selected preform 14-D0439 as having the most favorable characteristics, 
the final design double clad fiber was drawn and tested. The previous low background 
FUD in 2011 and high background FUD in 2012 were tested on the same system. All 
spectra were calibrated by power, length and integration time. The result is shown m 
Figure 78. 
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Figure 78 Fiber background of final DCF design. (a) Raw fiber background spectra excited 
from the cladding; (b) Raw fiber background spectra excited from the core; (c) Peak-
normalized fiber background spectra excited from the cladding; (d) Peak-normalized fiber 
background spectra excited from the core. 
When exciting through the cladding, the absolute fiber background from all three 
fibers is compared in Figure 78(a). The final design and the low background FUD in 
2011 have very similar spectra, and both are significantly lower than high background 
FUD in 2012. The three spectra are normalized by their peak intensity and shown in 
Figure 78(c). It is clear that the final design background is similar to the low background 
FUD in 2011 but even lower from 700 to 750nm, and the high background FUD in 2012 
shows elevation from 660 to 720nm due to fluorescence. 
When exciting through the core, the absolute fiber background from all three 
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fibers is compared in Figure 78(b ). The final design has lower background than the low 
background FUD in 2011 , and both are significantly lower than high background FUD in 
2012. The three spectra are normalized by their peak intensity and shown in Figure 78(d). 
It is clear that the final design background is lower than the low background FUD in 2011 , 
and the high background FUD in 2012 shows elevation from 660 to 720nm due to 
fluorescence as well. 
DCF Version Background from cladding excitation Background from core excitation 
( Counts/mJ/m) ( Counts/mJ/m) 
FUD in 2011 2.53e6 4.74e6 
FUD in 2012 5.30e6 9.58e6 
Final design 1.96e6 1.47e6 
Table 12 Comparison ofmtegrated fiber background. 
To quantify the background comparison, all spectra are integrated from 680nm to 
760nm (NIRAF emission window) and compared in Table 13. For cladding excitation, 
the final design background is ~80% of the low background FUD in 2011. For core 
excitation, the final design background is as low as 113 of the low background FUD in 
20 11 . This vi:llidates that our new design performs far better with lower background than 
the previous low background FUD used in 2011 . 
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5 OFDI-NIRAF ex vivo imaging 
This chapter describes the first experimental demonstration of OFDI-NIRAF 
imaging in human coronary arteries ex vivo. A preclinical OFDI-NIRAF catheter was 
first fabricated and installed on a prototype OFDI-NIRAF imaging system. The catheter 
was placed in ex vivo human coronary ateries and acquired 3D composite OFDI-NIRAF 
images of the coronary wall during linear pullback. The correlation between OFDI-
NIRAF images and histology slides are discussed. 
5.1 OFDI-NIRAF preclinical imaging system 
The schematic of the preclinical OFDI-NIRAF system is shown in Figure 79. The 
OFDI module comprises a 40 kHz swept source laser with a center wavelength of 
1310nm, having a bandwidth of llOnm. OFDI light is split into a sample arm and a 
reference arm in a Michelson interferometer configuration. Light in the reference arm 
reflects off a fixed reflector, while light in the sample arm is coupled into the core of a 
double clad OFDI-NIRAF catheter. Optical and mechanical coupling is provided by the 
rotary junction, which provides torque to rotate the catheter inside human coronary 
arteries while performing a linear pullback. The back scattered light is collected by the 
core of the catheter, mixed with the light from the reference arm, and guided into a 
polarization-diverse dual balanced detector. OFDI images are generated by processing 
the collected interferogram. The NIRAF module comprises a helium neon (He: Ne) laser 
(Thorlabs, New Jersey, USA) emitting 633 nm light which is combined into the inner 
cladding of the catheter by dichroic mirrors inside the rotary junction. The back scattered 
NIRAF emission is also collected by the inner cladding of the catheter and guided back 
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into the rotary junction, where the Rayleigh photons are removed by a long pass filter. 
The remaining fluorescence light is focused onto a PMT, with output signal sampled by a 
data acquisition board (PCI-6110, National Instruments, Texas, USA). The double clad 
fiber catheter is equipped with a ball lens, inserted into a stainless steel drive shaft and 
connectorized. The drive shaft is finally enveloped by a soft, transparent plastic sheath to 
protect the coronary artery endothelium from mechanical damage during imaging. During 
the experiment, the drive shaft performs a helical scan inside the sheath. 
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Figure 79 OFDI-NIRAF system schematic. He:Ne- helium neon laser (633 nm); PMT-
photo-multiplier tube; DAQ- data acquisition board; BP- band pass filter (633±1 nm; SP-
short pass filter (cut off frequency 635 nm); LP - long pass filter (cut off frequency 680 nm). 
5.2 Experimental procedure 
Five fresh human cadaver hearts were harvested from MGH autopsy service and 
National Disease Research Interchange (NDRI). The hearts were placed in University of 
Wisconsin (UW) static preservation solution, packed in ice and shipped within 24 hours 
after the harvest procedure. Three coronary arteries from each heart were dissected, 
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including right coronary artery (RCA), left circumflex artery (LCA) and left anterior 
descending artery (LAD). Before the experiment, the lumen was flushed with 10% 
phosphate buffer solution (PBS) to guarantee access of the catheter. During the 
experiment, PBS from a peripheral IV line flowed through the coronary artery to 
maintain the natural diameter and shape of the coronary lumen. Intraluminal fluid 
pressure was maintained at approximately 110 mmHg, which was considered adequate to 
maintain the natural shape and size of the lumen. 
Throughout this experiment, the optical power of OFDI light and 633nm 
excitation light measured at the distal end of the catheter was 30m W and 3m W 
respectively. The sampling rate of the NIRAF signal was 40 kHz to coincide with the 
OFDI A-line rate. Accordingly, each NIRAF sample derived from signal integrated 
during a single A-line period. The emission signal from 680 nm to 800 nm was collected 
by the PMT. Since each OFDI frame was composed of 1024 A-lines, the acquired frame 
rate was 38Hz (40kHz I 1024). The rotary junction was accordingly set to 38 rotations 
per second so each OFDI image covered one rotation. The pullback rate was set as 
5 mm/s. 
Before the experiment, OFDI and NIRAF background signal levels were acquired 
by submerging the catheter in PBS solution. The OFDI image showed the ball lens, the 
catheter sheath and reflection noise from the rotary junction. The NIRAF signal detected 
is due to the fiber autofluorescence background, since PBS generates minimal 
fluorescence. 
To start the experiment, each coronary artery was fastened onto a cork backing 
106 
and covered with a gauze pad moistened with PBS. The sheath was inserted into the 
coronary artery and the starting point was labeled with tissue marking ink. During 
imaging, the catheter performed a linear pullback while PBS from a peripheral IV line 
was continuously flushed. The length of the pullback varied between 5 mm and 10 mm 
depending on the length of the coronary artery. The ending point was also labeled with 
tissue marking ink. Heavily calcified plaques and occluded coronaries were not imaged to 
protect the catheter. 
After each scan, the coronary artery was perfused with 10% formalin at 
1 OOmmHg. Tissue was fixed with formalin flush for 20 minutes to maintain the shape 
and size ofthe coronary lumen, which facilitated the comparison between OFDI-NIRAF 
images and histology. After formalin fixation, the fixed coronary artery was sectioned 
into 5 mm specimens. Each specimen was paraffin fixed and cut into 5 11m sections for 
histology. 
5.3 Data processing 
The postprocessing of OFDI-NIRAF datasets includes several steps outlined in 
Figure 80. A phantom and a piece of ex vivo human coronary artery were used to validate 
the detailed methods. In this phantom, a plastic tube was coated with fluorescent epoxy at 
the outer surface. Linear pullback was performed inside the phantom and coronary artery. 
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OFDI NIR..AF 
Figure 80 Data processing flowchart. 
a) Background removal. The OFDI background images of PBS solution were 
averaged and subtracted from each OFDI image of the coronary artery to reduce 
OFDI noise from the preclinical rotary junction; the NIRAF background signal 
from the catheter was also averaged and subtracted from the coronary artery 
NIRAF intensity profile. 
b) Polar transformation. The original OFDI image was rectangular, which is 
difficult to interpret and correlate with histology. Polar transformation was done 
according to the illustration in Figure 81 . The image on the left is the original 
OFDI image of the plastic tube. The first gray thin strip on the left is the ball lens 
surface. The second gray stripe is the catheter sheath. The third gray strip is the 
plastic tube. To assign the angle for polar coordinates, the top row on the 
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rectangular image is set as 0°, the center row is set as 180°, and the bottom row is 
set as 360°. The column index on the rectangular image is assigned as the radial 
coordinate on the polar image. With the defined angle and radius, the rectangular 
image is transformed to a circular image. 
Rectangular 0 FDI image Circular OFDI image 
oo 
Polar tramfonna tion 
Figure 81 Illustration of polar transformation. 
c) Coronary lumen segmentation. On the circular OFDI images, the lumen surface 
was segmented by intensity information. The assumption is that the OFDI laser 
interference attenuates when penetrating into the tissue. Therefore, the lumen 
surface is brighter than the lumen and the coronary artery wall on OFDI images. 
Original 8-bit grayscale OFDI images were translated into a binary image by 
setting an intensity threshold. A Gaussian low pass filter (the standard deviation 
was 5 pixel , corresponding to 44J..Lm) was applied to attenuate noise. The 
segmented boundary was a smooth closed curve. In some instances, lipid-
containing plaques and calcified plaques showed strong attenuation at the surface, 
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which confounded the segmentation procedure. In those cases, spline 
interpolation was applied to fit the diffusive border. Figure 82 shows an example 
of coronary OFDI image and corresponding boundary image. The lumen space 
appears white, while the coronary artery wall appears black. 
Boundary segmentation 
Figure 82 Example of coronary lumen segmentation. 
d) Distance calibration. In preclinical OFDI-NIRAF imaging procedure, the 
position of the catheter inside the lumen is constantly changing during the 
pullback. The changing distance between the catheter and the lumen surface 
causes variations in both excitation efficiency and fluorescence collection 
efficiency. A calibration phantom was created to measure the distance-dependent 
fluorescence signal, which will be used to correct the native tissue fluorescence 
level in coronary artery samples. The phantom was made by uniformly mixing 
fluorescent dye and scattering particles in an agarose gel matrix. An OFDI-
NIRAF catheter then measured the phantom from different distances. The 
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correlation between fluorescence signal and catheter-phantom separation 
(measured from OFDI images following the prior procedure) was estimated to 
build a look-up table, which is plotted as the calibration curve shown in Figure 83. 
When the distance between the catheter and the coronary artery wall is estimated 
from OFDI images, the distance-dependent correction factor can be found in this 
look-up table. Then the raw NIRAF intensity at this site will be multiplied by the 
correction factor. The result is the distance corrected NIRAF intensity. 
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Figure 83 Fluorescence distance calibration curve. 
e) Image registration. The corrected NIRAF signal was rendered as a ring-shaped 
overlay on the circular OFDI image, with its angle matched to the corresponding 
OFDI A-line. Figure 84 shows the example of OFDI-NIRAF phantom image. The 
center small circle is the ball lens. The ring structure outside the ball lens is the 
sheath of the catheter. The outer, irregular, thick "tube" region is the plastic tube. 
The colorful circular ring outside the tube is the fluorescence intensity map. The 
left side of the tube was coated with highly scattering fluorescent epoxy. 
Therefore, both the OFDI signal and the NIRAF signal should be strong in this 
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regton. Indeed, both the left side of the tube interface and the fluorescence 
intensity map are bright. The phantom experiment is also used to validate the 
post-processing algorithm for tissue experiments. 
Figure 84 OFDI-NIRAF image of phantom. The concentric circular ring is the NIRAF 
intensity map. The color bar shows the scale. The grayscale image inside the NIRAF ring is 
OFDI image ofthe phantom. 
f) Collection efficiency calibration. In practice, OFDI-NIRAF catheters have 
mechanical and optical tolerances during fabrication . As a result, individual 
catheter might have slightly different collection efficiency of tissue NIRAF signal. 
To compensate for this variable, the fiber background is used as a self-containing 
standard. According to Chapter 3 and Chapter 4, the fiber background from the 
catheter is attributed to primarily silica Raman generated in the cladding. Since all 
catheters are made of the same fiber and use the cladding for excitation and 
emission, the difference in fiber background intensity is considered as an indicator 
of collection efficiency rather than material difference. Since tissue NIRAF 
photons and fiber background photons are both from the cladding, their collection 
efficiencies are identical. Therefore it is feasible to use fiber background as a self-
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containing standard. This method also calibrates excitation power, since fiber 
background has been shown to have a linear relationship with the power. 
The final NIRAF intensity was thus calculated as distance-corrected NIRAF 
intensity divided by fiber background. It was compressed as an 8-bit grayscale image. 
5.4. Results 
5.4.1 Representative OFDI-NIRAF images of different types of plaque 
A representative NIRAF dataset acquired from an ex vivo human coronary artery 
is shown in Figure 85 as a 2-D intensity map. The colormap is "red hot", where dark red 
represents low intensity and bright yellow/white represents high intensity. The horizontal 
axis is the longitudinal coordinate, and the vertical axis is the angular coordinate. The 
corresponding OFDI-NIRAF composite frames and histology are shown in Figure 86. 
Both OFDI and NIRAF images were compressed to 8 bit. 
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Figure 85 NIRAF intensity map from a human cadaver coronary artery. Dashed line-
intimal hyperplasia (IH), Dotted line- calcified plaque (CA). 
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Figure 86 OFDI-NIRAF composite images and H&E stains for IH and CA. (a) OFDI-NIRAF 
image for the dash line in Figure 85, (b) OFDI-NIRAF image for the dotted line in Figure 85; (c) 
the H&E stain corresponding to (a); (d) is the H&E stain corresponding to (b). (c) shows IH. (d) 
shows CA. 
Figure 86(a) shows an OFDI-NIRAF composite image of intimal hyperplasia (IH), 
and corresponding H&E stained slide in Figure 86(c). The image inside the bright circle 
is the OFDI image, where the tissue appears homogeneous and bright. The NIRAF signal 
is displayed as a concentric ring using a red hot color scheme, where low intensity is dark 
red, and high intensity is bright yellow/white.The color coded ring outside the bright 
circle is the NIRAF signal, which appears homogeneously dark, as expected from 
previous studies. Figure 86(b) shows an OFDI-NIRAF composite image of a calcified 
plaque, which is confirmed by H&E stain in Figure 86(d). The left side of the OFDI 
image shows intensity attenuation with a sharp border, indicative of calcification, while 
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the rest of the image shows IH. The calcified region exhibits higher intensity NIRAF 
signal than the IH regions. 
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Figure 87 Comparison between ruptured plaque and fibrocalcific plaque. (a) OFDI-
NIRAF image for a ruptured plaque; (b) OFDI-NIRAF image for a calcified plaque; (c) the 
H&E stain corresponding to (a); (d) the H&E stain corresponding to (b). 
Next, we compared a necrotic core plaque with a fibrocalcific plaque on another 
coronary artery. Figure 87(a) shows a necrotic core plaque experiencing rupture, 
confirmed by H&E stain in Figure 87(c) . The OFDI image shows strong scattering by the 
fibrous cap, and the diffusive border underneath the cap suggests a lipid rich region, but 
the OFDI image can not definitely differentiate between a NC and a PIT. The NIRAF 
signal intensity strongly suggests a NC. Further confirmation is provided by comparing 
this signal to the weak NIRAF signal of the surrounding region, which is clearly 
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diagnosed as IH by the OFDI image. This example illustrates how NIRAF can be used to 
augment OFDI image analysis. In comparison, Figure 87(b) shows a fibrocalcific plaque, 
confirmed by H&E stain in Figure 87(d). The OFDI data shows a calcium plate at the 
right of the plaque, while the NIRAF signal ring shows a moderate signal. Those results 
also agree with the intensity comparison between different types of plaques in Figure 42. 
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Figure 88 OFDI-NIRAF image and histology ofNC with thrombus .. (a) OFDI-NIRAF 
image for a necrotic core plaque, (b) the Trichrome stain. The red dotted rectangle labels 
thrombus in the coronary lumen; the yellow dash circle labels necrotic core. 
Further, registered OFDI/NIRAF and histology for a complex plaque with a large 
rupture and intraluminal thrombus is shown in Figure 88. OFDI shows the fibrous caps of 
two necrotic cores and a piece of intraluminal thrombus near the catheter, but the 
information under the fibrous cap is limited. The shape of the lumen is irregular as a 
result of stenosis. The NIRAF intensity is significantly high on the large necrotic core 
which is labeled with yellow dash circle on Trichrome stain in Figure 88(b ). On the right 
comer, there is another necrotic core deep under the intima, and its NIRAF intensity is 
lower than the bottom necrotic core. The thrombus appears diffusive on the OFDI image, 
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but shows lower NIRAF signal than both necrotic cores, which demonstrates 
compositional difference between the thrombus and necrotic cores. 
5.4.2 Comparison between different types of coronary plaques 
In this study, we imaged 15 coronary arteries in total, including 6 healthy 
coronary arteries, 8 calcified coronary arteries and 1 coronary artery with necrotic core 
and thrombus. With reference to histology, intimal hyperplasia (IH), fibrocalcific (CA), 
and necrotic core (NC) were involved, since they were the most common types of 
plaques in the datasets. 1200 data points of each subcategory were used for comparison. 
The NIRAF intensity of those data points are grouped and compared in Figure 89. The 
intensities of these subcategories are significantly different, according to one-way 
ANOVA (p < 0.01). The sequence sorted by intensity from low to high is IH < CA < NC. 
Using Student' s t-test, the intensity ofNC is significantly higher than that of non-necrotic 
plaque types such as IH and CA (p<O.OOl). The comparison between IH, CA and NC is 
in agreement with previous NIRAF spectroscopy results. 
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Figure 89 Comparison of NIRAF intensity between different types of plaques. ill - intimal 
hyperplasia, CA - fibrocalcific, NC- necrotic core plaque. The errorbar is standard deviation. 
5.5. Discussion 
This study was conducted with a preclinical OFDI system, unoptimized rotary 
junction and a preclinical OFDI-NIRAF catheter. NIRAF signal was sampled at 40 kHz 
with low excitation power (2~3 m W). This ex vivo imaging study demonstrates that the 
NIRAF signal level is acceptable and adds valuable information to improve OFDI 
diagnostics. It is encouraging to find that the NIRAF intensity level sorted from low to 
high is IH < CA < NC. This intensity contrast agrees with NIRAF spectroscopy study. 
With the introduction of NIRAF, it is more convenient and straightforward for 
OFDI to detect NC plaques. Different from interpreting diffusive border, NIRAF 
intensity provides a direct label. According to the statistics, there is potential to set up a 
threshold for NC detection. On the other hand, using NIRAF intensity alone, it will be 
difficult to differentiate CA from certain ruptured plaques which lose the necrotic core 
material and thus have lower NIRAF intensity than intact NC plaques. With the structural 
information from OFDI, it is easy to identify calcified plaques, and eliminate the 
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possibility to mistake them as NC plaques. This is another benefit of OFDI-NIRAF 
combination. 
From literature study, fibrin and ceroid are often involved with NIRAF. The 
former is a common component of thrombus, and the latter is a byproduct of lipid 
peroxidation with different proposed mechanisms of formation, such as Fenton reaction 
and Mallard reaction. For our datasets, we also did PTAH stain for fibrin , and Sudan 
Black B stain for ceroid. 
For NC, PTAH shows abundant fibrin deposition. Figure 90 shows the OFDI-
NIRAF image of the NC plaque mentioned in Figure 88 and its PTAH stain. In the NC 
region labeled by yellow dash circle, a lot of fibrin can be seen. The thrombus in the 
coronary lumen is also clearly stained as fibrin with similar contrast. From NIRAF 
intensity, however, NC is much brighter than the thrombus. This suggests that fibrin is 
not the primary element that is responsible for NIRAF. 
(a) (b) 
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Figure 90 OFDI-NIRAF image and PTAH stain of a complicated plaque. (a) OFDI-
NIRAF image of a necrotic core plaque, (b) the corresponding PT AH stain. The red dotted 
rectangle labels thrombus in the coronary lumen; the yellow dash circle labels necrotic core. 
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For Sudan Black B stain, small ceroid nodules are observed on some of necrotic 
core plaques, but almost none in ruptured plaques or thrombus. This suggests that ceroid 
is not a primary contributor to NIRAF either. Figure 91 shows an example of the ruptured 
plaque mentioned in Figure 87. While the NIRAF intensity is high at the bottom, Sudan 
Black B shows no ceroid. 
(a) (b) 
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Figure 91 OFDI-NIRAF image and Sudan Black B stain of a ruptured plaque. (a) 
OFDI-NIRAF image for a ruptured plaque, (b) the corresponding Sudan Black B stain. 
Histology shows no ceroid on this plaque. The fibrous cap on the histology was shifted left 
when cutting the section for histology. 
Indication from NIRAF spectroscopy and OFDI-NIRAF imaging suggest the 
NIRAF fluorophores are closely correlated with the formation of necrotic core. 
In this chapter, we described the engineering efforts to translate NIRAF detection 
into a catheter-based technique, and demonstrated the first OFDI-NIRAF imaging study 
in human cadaver coronary arteries ex vivo. 
Using the minimal background double clad fiber and 633nm excitation, benchtop 
measurement demonstrated the feasibility to detect aortic necrotic core plaques in a fiber 
probe. Inspired by those preliminary results, we fabricated the first preclinical OFDI-
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NIRAF catheter and imaging system. 
From the measurement of 5 hearts, our results are consistent with the assertion 
that NIRAF intensity contrast can highlight necrotic core plaques. Data provided by 
NIRAF may add valuable information to OFDI to help improve the accuracy of 
identifying necrotic core plaques. Meanwhile, calcified plaques with necrosis and 
ruptured plaques also exhibit higher NIRAF than non-necrotic core plaques. This result 
suggests the common nature of NIRAF fluorophores on those plaques. Our previous 
spectroscopy measurement together with OFDI-NIRAF datasets suggest that NIRAF is 
closely correlated with necrotic core. 
The results of this study suggest that there is potential for multimodality OFDI-
NIRAF to become a useful clinical imaging tool. 
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6 Safety evaluation of OFDI-NIRAF 
To conduct a clinical study using OFDI-NIRAF, another prerequisite IS to 
guarantee the safety of patients. Since the mechanical properties of the OFDI-NIRAF 
catheter are identical to the pre-existing OFDI catheter, which has received regulatory 
approval for use in human patients, the safety evaluation is focused on laser exposure on 
human coronary arteries, especially with respect to light from the NIRAF excitation laser. 
In this chapter, a NIRAF laser exposure study on cadaver arterial tissue using the MGH 
OFDI-NIRAF preclinical catheter ex vivo is described. This study found no evidence of 
arterial tissue damage for NIRAF excitation fluence greater than the expected clinical 
settings. 
6.1 Experimental design 
This section explains the rationale to design an experiment that simulates laser 
exposure on coronary walls ofhumann patients during clinical OFDI-NIRAF procedure. 
6.1.1 Proposed clinical setting of OFDI-NIRAF catheter 
The scenario of clinical OFDI-NIRAF imaging will be identical to current OFDI 
imaging procedure since no addition steps are required for exogenous dye injection. 
During a clinical OFDI imaging procedure, the MGH OFDI imaging catheter is placed 
into a coronary artery with the aid of a guidewire. To avoid blood absorption during the 
imaging time window, a non-occlusive purge with saline or a contrast agent is used to 
clear the blood from the proximal to distal end of the coronary. The optical window 
created by this purge lasts approximately 5 seconds. During this time, the OFDI imaging 
catheter is linearly pulled back at a rate of 10-20 mm/s along the coronary segment and is 
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rotated at a rate of 100 Hz. The typical pullback length is approximately 5-10 em, which 
is completed in less than 5 seconds. The operation of the OFDI-NIRAF catheter will 
follow the same procedure. 
The fact that current OFDI exposure is considered to be safe (Tearney, Regar et al. 
2012) provides indirect evidence for the safety ofNIRAF exposure, since the absorption 
of 633 nm light in arterial tissues is reported to be similar to that at 1310 nm (Klein, 
Puschmann et al. 1981; Cheong 1995) . However, it is necessary to conduct a study to 
experimentally confirm that 633 nm light, at laser exposures that exceed that of our 
current OFDI-NIRAF catheter, does not damage the coronary artery wall. 
6.1.2 Design of exposure parameters 
To estimate the risk of excitation laser exposure damage on the human coronary 
artery, the experimental parameters were chosen as follows: 
1) Fluence at twice the the maximum possible fluence delivered by the MGH OFDI-
NIRAF catheter in the clinical study. The power was 5 m W as the maximum 
optical power. The integration time was 1 Os, which was twice the maximum 
exposure duration of the clinical parameters of our study; 
2) Fluence at four times the the maximum possible fluence delivered by the MGH 
OFDI-NIRAF catheter in the clinical study. The power was 10 mW, which was 
twice the maximum optical power. The integration time was 10 seconds, which 
was twice the total maximum exposure duration of the clinical parameters of our 
study. 
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6.1.3 Tissue model for the test 
An ex vivo test model based on swine aorta was designed to evaluate the 
architectural disruption and cellular response to 633 run NIRAF excitation light delivered 
by the MGH OFDI-NIRAF catheter. With reference to the operational procedure for 
clinical OFDI-NIRAF in Section 6.1.1 , the fluence on the swine aorta in this test will be 
2x and 4x of the maximum possible fluence on human coronary wall during proposed 
clinical OFDI-NIRAF procedure. 
The ex vivo swine aortic model used in this study was considered equivalent to the 
in vivo human situation for two reasons: 
The first reason is that fresh excised swine aorta (less than three hours 
postmortem) is still viable and has similar optical properties to in vivo human normal 
aorta. In general, swine are an established animal species for interventional vascular 
studies. 
The second reason is that the optical absorption of human atherosclerotic plaques 
ts similar to normal human aortas . The diffuse reflectance spectroscopy method in 
Section 2.2 in Chapter 2 provided evidence to this effect. Representative diffusive 
reflectance spectra were shown in Figure 92. At 633nm, the human aortic atherosclerotic 
plaque and normal swine aorta showed similar absorption/scattering ratio (human aorta 
plaque is 0.85, normal swine aorta is 0.78, and the difference is less than 10%). Since the 
exposure on the swine aorta in the experiments were 2x to 4x greater than clinical 
scenario, the overall laser energy absorbed by the swine aorta would be greater than the 
maximum possible laser energy absorbed by human coronary plaques during clinical 
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OFDI-NIRAF imaging procedure. Thus the swine aorta model is considered adequate to 
mimic human atherosclerotic plaques when evaluating laser exposure damage. 
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Figure 92 Comparison of diffusive reflectance spectra. Red thick solid curve -DRS from 
human atherosclerotic plaque, green thin solid curve -normal human aorta, blue dot curve -
normal swine aorta. 
In this study, the impact of laser exposure on blood coagulation was not included 
because in the proposed clinical OFDI-NIRAF imaging procedure, the saline purge 
provides a clear optical window by removing blood from the coronary artery during 
imaging. 
6.1.4 Histopathology assessment of tissue damage 
In this experiment, histochemical staining with nitro blue tetrazolium chloride 
(NBTC) was applied as a guidance to assess laser-induced damage. Figure 93 illustrates 
the molecular mechanism of NBTC. The reduction of NBTC by NADH diaphorase 
provides the image contrast (Klein, Puschmann et al. 1981 ). In biological systems, 
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NADHINAD is the most important redox system and has lower redox potential than 
NBTC. When NADH is oxidized in the presence of NADH diaphorase located on 
mitochondria and other cellular structures, NADH directly transfers electrons to the 
diaphorase, which in turn, transfers them to the NBTC. NBTC is thus reduced from a 
lightly yellow-colored solution to a water-insoluble blue diformazan precipitate. If 
thermal damage from absorption of laser energy causes denature of NADH diaphorase, 
the reaction cascade will be disrupted and stop the generation of blue diformazan 
precipitate. Therefore, a blue precipitate can only be found in viable cells since 
diaphorase activity diminishes immediately after cellular death and can not reduce NBTC. 
Using this histochemical method, the contrast between blue-stained normal and non-
stained de-vitalized or damaged structures is delineated sharply, enabling detection of the 
laser damaged sites on tissue. 
Reduced 
Substrate 
Oxid ized. 
Substrate 
NAD+ 
NADH 
Formazan 
(blue ppt) 
NBTC 
Figure 93 Mechanism of NBTC stain for tissue viability. Reprinted from Virchows Arch 
393, 287-297 (1981). 
6.2 NIRAF laser exposure experiments 
In the experiments, two tissue sections were cut from an aorta obtained from a 
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swine. They were immersed in 10% PBS maintained at 37 °C. The swine aorta was 
harvested from MGH Knight Surgical Animal Laboratory in accordance with the Partners 
IACCUC protocol 12007N000041. The exposure study was conducted within a three-
hour postmortem interval. 
6.2.1 Experimental setup 
Figure 94 shows the schematic of the experimental setup. The laser source was a 
continuous wave diode laser (LDX-2205-630 HHL, RPMC Lasers, MO, USA), which 
produced a maximum power of 200 m W at wavelength of 633 nm. It was coupled into 
the cladding of the MGH OFDI-NIRAF catheter. The output energy at the ball lens was 
adjusted to the specified output power by changing a combination of the neutral density 
filters and the driving current of the laser diode. Before each tissue exposure, the power 
was examined by a power meter. The tissue was immersed in 10% PBS solution and 
maintained at 37 oc during the whole experiment. The height of the catheter was 
manually adjusted until the arterial surface reached the focal spot of 633nm light 
(~lOO!J.m in diameter). A two-dimensional translation stage (Newport Corp., Irvine, CA, 
USA) was controlled by a custom Labview program to move the catheter from one 
exposure site to the next. An electronically-controlled shutter (Vincent Associates, 
Rochester, NY, USA) in the beam path controlled the exposure time. The shutter was 
open during each exposure and then turned off to block the light when the catheter was 
traveling between exposure sites. 
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Figure 94 Experimental schematic for MGH OFDI-NIRAF catheter exposure study. 
Adapted from an unpublished report by Dr. Joseph A. Gardecki at Massachusetts General 
Hospital. (Gardecki, Chau et al. 2009) 
6.2.2 Scheme of tissue exposure 
Figure 95 illustrates the registration of exposure sites. For each tissue section, a 
total of nine sites were exposed to 0, 5, 10 m W of 633 nm light for 10 seconds delivered 
by the MGH OFDI-NIRAF catheter. The spot size on tissue was 100 ~m in diameter. 
After the exposure on the nine sites, two registration marks located at sites 1 and 11 were 
burned into the tissue with the aid of red and green tissue marking ink (Triangle 
Biomedical Sciences, NC, USA) using a longer exposure time (>30 seconds) and higher 
power (1 00 m W). The two registration sites were illuminated until burned marks were 
observed on the luminal surface. The burned marks served to maintain the tissue 
orientation during histological cutting and as a positive control for the NBTC stain. 
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Figure 95 Registration of tissue exposure sites. Each section contained 11 sites. The 
distance between two sites was 2mm. Sites 1 and 11 were labeled with different tissue 
marking ink to register the orientation and also acted as a positive control for tissue damage. 
They were exposed at 100mW for 30s. Sites 2-4 were exposed at 10 mW for 10 s (4x fluence). 
Sites 5-7 were exposed at 5 m W for 10 s (2x fluence ). Sites 8-10 acted as negative control 
with no exposure. 
After the exposures on the registration sites, the tissue was frozen in -80 oc 
freezer until histological processing. Considering the mechanism of NBTC, frozen 
sections were cut for the stain. Before histological cutting, the tissue was trimmed close 
to the registration ink marks and embedded in OCT (Optimal Cutting Temperature) 
media. Multiple histology levels were cut starting at the edge of the ink and sectioning 
through the spot at 100 llm levels. The thickness of each section was 20jlm. The sections 
were stained with NBTC using standard protocols (Borges da Costa, Boixeda et al. 2009; 
Gardecki, Chau et al. 2009). 
6.3 Evaluation of tissue damage by histopathology 
Two representative NBTC stained sections are shown in Figure 96. The 
appearance of unstained tissue and ink on the luminal surface indicates the location of 
both registration sites. Since the tissue exposure sites (2-1 0) distributed linearly between 
the registration sites, the tissue exposure sites can be precisely registered on the histology 
section. In Figure 96, no tissue damage is observed on the tissue exposure sites 2-1 0 
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located between the unstained registration sites. 
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Figure 96 NBTC-stained slides from swine aorta 1 (A) and swine aorta 2 (B).Positive 
controls were clearly visible on both ends of this section. 
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Figure 97 40x NBTC histology images from aorta 1. (a) Tissue site 3 (10 mW for 10 s) 
showed a dark blue color and indicated tissue viability after the laser exposure. (b) Negative 
control at site 9 (0 m W) also showed a dark blue stain. (c) At tissue site 1 (positive control, 
100 m W for > 30s ), a burned mark was observed and a lack of dark blue stain indicated tissue 
damage. Scale bar is given. 
High resolution NBTC histology images from several representative sites on aorta 
1 are shown in Figure 97. The first example is the site with 4x fluence. When exposed to 
1Om W for 1 Os, the arterial wall near the site appears normal with no appearance of tissue 
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damage, as shown in Figure 97(a). Tissue is considered viable according to the dark blue 
color by NBTC throughout this region. The collagen, elastic fiber, endothelial cells and 
smooth muscle cells were stained blue in this case. The last negative control site, site 9, is 
shown in Figure 97 (b), which has similar contrast to Figure 97(a). This means that 
during the whole experiment, the part of the tissue between exposure sites was viable. 
Therefore, the experimental environment and mechanical movement did not introduce 
any tissue damage. An example of tissue damage is provided on a registration mark 
(positive control). A 40x view of the damage region is shown in Figure 97(c). A brown 
burned mark is seen on the luminal surface and a large unstained region is clearly visible 
indicating that the endothelial cells and smooth muscle cells in the intima and media have 
lost viability. A disruption of collagen and elastin fibers is also observed. 
Site 1 2 3 4 5 6 7 8 9 10 11 
Power 100 10 10 10 5 5 5 0 0 0 100 
Time (s) >30 10 10 10 10 10 10 10 10 10 >30 
Aortal + - - - - - - - - - + 
Aorta2 + - - - - - - - - - + 
(+) mdtcates that damage was observed on NBTC stam. 
(-)indicates that damage was not observed on NBTC stain. 
Table 13 Evaluation oflaser exposure damage on each site. 
A summary of the results is shown in Table 13. For the aorta specimens in this 
study, no tissue damage was observed after continuous exposure for lOs under either 5 or 
lOmW 633nrn excitation at the focal spot position. This mimics the maximum possible 
NIRAF laser exposure on human patient coronary artery wall during clinical imaging 
procedure and demonstrates the safety ofNIRAF exposure on human coronary artery. 
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7 Source of NIRAF in atherosclerotic plaques 
In this chapter, the source ofNIRAF found in atherosclerotic plaques is discussed. 
Unlike UV and visible excited autofluorescence, the fluorophores ofNIRAF are not well 
established. Chapter 1 discussed several hypothesis on potential NIRAF sources. The 
goal of this chapter is to investigate potential NIRAF sources using different approaches 
shown in Figure 98. 
lwmw Illizi Chemical syuthcsis 
Potcotial product 
Understanding of NIRAF molecular sourc:e 
Figure 98 Overview of methods to identify NIRAF source. 
Spectroscopic studies of bulk tissue discussed in Chapter 2 established the 
spectral difference between NC and non-NC plaques. Its correlation with different 
histology stains provided preliminary information about the disease. Meanwhile, 
fluorescence spectra of common chemicals found in the plaques were measured as 
reference. To locate NIRAF fluorophore on the tissue, a confocal microspectroscopy 
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system was built to measure frozen tissue slides from different types of plaques. The 
NIRAF intensity and spectral contrast of frozen slides positively identified necrotic 
material as the main location of NIRAF fluorophore . Immunohistochemistry was 
compared with NIRAF confocal images to study the inflammatory activities on the 
plaque. Meanwhile, Raman. spectroscopy was used to provide molecular contrast between 
high NIRAF region and low NIRAF region on the frozen tissue slides. Besides the above 
measurements, chemical synthesis was done to investigate oxidative modified products 
that might also contribute to NIRAF. 
7.1 NIRAF of basic tissue component 
7.1.1 Necrotic core NIRAF and DRS spectra 
Since the clinical OFDI-NIRAF system uses 633nm as excitation wavelength, the 
spectral shape feature of necrotic core was studied by 633nm as well. To establish basic 
tissue NIRAF spectra, the following measurements were done. 
The "gruel" from a representative human aorta necrotic core plaque was extracted 
and homogenized as a positive control. In contrast, a piece of healthy human aorta was 
cut intact as a negative control. The thickness for both samples was > lmm and the area 
was > 2mm x 2mm. The total volume was considered adequate for sampling. 
First, 633nm NIRAF spectroscopy was performed on the gruel and normal human 
aortic wall at 37°C in PBS. The spectra in Figure 99 were normalized by excitation 
power and integration time. They were further normalized by their intensity peaks and 
shown in Figure 100. In this comparison, normalized NC spectrum is red shifted. This 
spectral shape difference indicates the intrinsic fluorophore difference. 
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Figure 99 NIRAF spectra of NC vs. normal aortic wall. 
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Figure 100 Normalized NIRAF spectra ofNC vs. normal aortic wall. 
To compare the optical property ofNC and normal artery wall , diffuse reflectance 
spectroscopy was done on both samples. The spectra were normalized over the long 
wavelength region. For normal aortic wall, the absorption spectrum below 450nm 
showed a major peak which indicates hemoglobin absorption; 550-600nm showed a 
smaller peak which might be related to hemoglobin; 600-850nm showed a smooth 
elevating profile which might be related to water absorption. For the necrotic core, 400-
500nm showed a broad absorption feature as the main molecular difference between NC 
and normal aortic wall; 500-600nm showed a valley and a peak, which might come from 
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oxyhemoglobin absorption; 600-850nm showed a similar curve to normal tissue. This 
suggests that spectral shape distortion ofNC and normal aortic wall due to absorption and 
scattering is similar in NIRAF emission window (680-850nm), and the raw tissue spectral 
shape can be approximated as intrinsic fluorescence spectral shape. 
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Figure 101 Normalized DRS spectra of NC and normal aortic wall. 
From the comparison between NC and normal aortic wall, the observations about 
the NIRAF fluorophore are listed below: 
1. The NIRAF spectrum ofNC is red shifted significantly. 
2. NC has a strong absorption feature between 400 and 500, which is absent in 
normal aortic wall tissue. 
3. NC presents stronger blood absorption peaks between 500nm and 600nm. 
7.1.2 NIRAF spectra of basic chemicals 
Considering clues from Section 7 .1.1 , it is necessary to compare the tissue NIRAF 
spectra with basic molecule species that possibly exist in the plaque. 
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First, as mam components of extracellular matrix and normal aortic wall, 
purchased collagen and elastin (Sigma Aldrich, Missouri, USA) spectra were compared 
with the normal aortic wall. The normalized spectra are shown in Figure 102. The 
spectral shape of normal aortic wall appears very similar to collagen and elastin, which 
agrees with the composition of normal aortic wall. Therefore collagen and elastin are 
considered as the major source ofNIRAF on normal aortic wall. 
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Figure 102 Normalized NIRAF spectra of structural protein and normal aortic wall. 
Second, to identify the source of NC NIRAF, different classes of molecules need 
to be considered. 
Since NC plaques are rich in lipids with possibly beta carotene colocalization, 
lipids (cholesterol, cholesteryl palmitate, cholesteryl lin oleate, cholesteryl oleate) and 
beta carotene spectra need to be measured. The normalized spectra are shown in Figure 
103. Beta carotene shows two strong Raman signatures due to resonance enhancement. 
Fluorescence spectra of lipids also clearly show their Raman signatures. They exhibit low 
fluorescence background. Since the NC NIRAF spectrum is very smooth and no Raman 
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signatures are observed, the emission from beta carotene and lipids are very likely to be 
overwhelmed by other chemicals that contribute significantly more to NIRAF. 
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Figure 103 Normalized NIRAF spectra of lipids and beta carotene. The spectrum of each 
chemical is an overlap of Raman signatures and NIRAF. Beta carotene spectrum is dominated 
by Raman spectrum. The other four chemicals show low fluorescence background, which are 
unlikely to contribute to high NIRAF seen on NC plaques. 
From DRS measurement, NC shows a strong absorption feature due to blood, 
which draws attention to hemoglobin and hemoglobin degradation products. 
Fluorescence spectra of oxyhemoglobin, methemoglobin, biliverdin and bilirubin are thus 
measured. The measurement was done on purified powders obtained from Sigma Aldrich. 
The power, integration time and thickness were identical. 
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Figure 104 NIRAF spectra of hemoglobin related chemicals. The raw spectra were 
measured using the same power and integration time. Hemoglobin and biliverdin exhibit low 
background, while bilirubin shows high background with visible Raman peaks. 
Methemoglobin background shows intermediate intensity. 
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Figure 105 Normalized spectra of hemoglobin related chemicals. 
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The raw spectra and normalized spectra are shown in Figure 104 and Figure 105. 
Bilirubin shows much stronger signal than methemoglobin, while biliverdin and 
oxyhemoglobin have lower intensity. The normalized spectra are a mixture of Raman 
signatures and fluorescence, but those Raman peaks were not observed in the NC 
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spectrum either. Among those chemicals, methemoglobin NIRAF has a relatively smooth 
spectral shape but still lacks similarity to NC spectrm. For autopsy tissue, 
deoxyhemoglobin can be oxidized into methemoglobin in air. This means 
methemoglobin can exist in the plaque. However, DRS feature of methemoglobin was 
not found on the DRS of NC. Figure 106 shows DRS of oxyhemoglobin and 
methemoglobin. They were measured in water solution with the same concentration of 
scattering particles. The spectra were normalized by the blue edge wavelength. 
Absorption peaks of methemoglobin are distinguishable from oxyhemoglobin, which is 
apparent on NC. This result suggests that methemoglobin, if any, has low concentration 
and therefore is unlikely to contribute to NC NIRAF. 
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Figure 106 DRS of oxyhemoglobin and methemoglobin. 
The intraplaque hemorrhage hypothesis claims that fibrin and fibrinogen might 
exist in atherosclerotic plaques from PIT stage to NC stage (Michel, Virmani et al. 2011). 
To validate the contribution of fibrin/fibrinogen to NIRAF, their NIRAF spectra were 
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also measured. The normalized spectra are shown in Figure 107. While fibrin appears 
very similar to collagen, fibrinogen shows red shift emission similar to NC. This makes 
fibrinogen a potential target for histological stains in the next section, which describes its 
presence in many NC and PIT plaques. 
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Figure 107 Fibrin and fibrinogen fluorescence spectra. 
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Besides the above chemicals, 633nm excited hydroxyapatite fluorescence 
spectrum was also measured, as shown in Figure 108. The fluorescence has similar 
intensity to Raman signatures, thus hydroxyapatite is unlikely to contribute to tissue 
NIRAF. 
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Figure 108 Hydroxyapatite NIRAF spectrum. 
In this section, different basic tissue components are investigated by fluorescence 
spectroscopy. Spectrum obtained from normal aorta tissue mainly shows collagen and 
elastin fluorescence. Cholesterol and beta carotene are unlikely to contribute to NIRAF 
since their Raman signatures are not present on tissue spectra. Hemoglobin related 
chemicals, including oxyhemoglobin, methemoglobin, biliverdin and bilirubin are also 
unlikely to generate NIRAF. Among the basic chemicals, fibrinogen shows similar 
spectral shape to NC and is targeted for further validation. 
7.2 NIRAF-histology correlation on bulk tissue 
The histology from tissue provides preliminary clues about the composition of the 
plaque, which will be discussed in this section. Histology slides of ex vivo human 
atherosclerotic plaques measured in studies discussed in Chapter 2, Chapter 3 and 
Chapter 5 are compared with corresponding NIRAF intensity. 
7.2.1 Overview of histology for NIRAF ex vivo study 
Histopathology is a common method widely used m hospitals to study 
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microscopic structure of cells and tissue by preferentially staining morphological 
structures so as to highlight and distinguish these key features from other structures. 
Histopathology is the gold standard by which diseases are diagnosed. 
Name ofhistology stain Applications Target Color 
H&E (Hematoxylin and Paraffin slide; frozen Nucleus Purple-Blue 
Eosin)(Avwioro 2011) slide 
Collagen, muscle and Varying 
cytoplasm orange/pink 
Erythrocytes Bright red 
Calcification Purple 
Mason' s Trichrome Paraffin slide; frozen Collagen Blue or green 
(Sheehan and Hrapchak slide 
1980) Nuclear Black 
Cytoplasm Pink or light red 
Erythrocytes Yell ow or red 
Keratin, muscle fiber Red 
Fibrin pink 
Sudan Black B (Pfuller, Paraffin slide Oxidized lipoprotein Blue-Black 
Franz et al. 1977) 
Frozen slide Triglycerides and lipids Blue-Black 
Phosphotungstic acid- Paraffin slide; frozen Muscle Blue-black to 
haematoxylin (PT AH) slide dark brown 
(Vargas, Sampson et al. 
1999) Connective tissue Pale orange-pink 
to brownish red 
Fibrin/fibrinogen Deep blue 
Elastic fiber Purple 
Perl ' s' Prussian blue Paraffin slide; frozen Iron deposit (non- Blue or purple 
(Culling, Allison et al. slide hemoglobin, etc. ferritin) 
1985) 
Table 14 Histology stains for bulk tissue measurement. 
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In NIRAF spectroscopy, 5 different types of histology stain methods were applied 
as a qualitative approach to evaluate the progression state of the plaques and composition. 
Their applications and targets are summarized in Table 14. 
H&E is one of the most common histology stains for clinical pathology, and 
serves as the gold standard for diagnosis of many diseases like cancer. It contains two 
major components, Hematoxylin and Eosin. Based on their different sensitivity to pH 
value, Hematoxylin stains the chromatin (nuclear material) within the nucleus as a deep 
purplish-blue color, while Eosin stains the cytoplasmic material as a counter stain, 
including connective tissue and collagen, and generates orange-pink color. This provides 
sharp contrast with the cell nucleus, and helps identify other entities in the tissues such as 
cell membrane, erythrocytes, calcification and fluid . For atherosclerotic plaques, H&E 
provides information on morphology and distribution of different types of cells. 
Masson's Trichrome is a tri-color protocol widely used to distinguish structural 
protein networks from cells, such as extracellular matrix, muscle, and connective tissue. 
It usually comprises of Weigert's hematoxylin for nuclei, Solution A (plasma stain) with 
red color, Solution B (phosphomolybdic acid) with yellow-green color, and Solution C 
(fiber stain) with green or blue color. The actual color depends on the recipe used. For 
atherosclerotic plaque, Masson ' s Trichrome provides information on the degradation of 
extracellular matrix, as evidence of necrotic core. 
Sudan Black B is a special lysochrome which stains neutral triglycerides and 
lipids on frozen sections and some lipoproteins on paraffin sections. It belongs to Sudan 
Staining family, which also includes Oil Red 0, Sudan III and Sudan IV. It presents high 
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sensitivity to ceroid/lipofuscin and is often used to quench ceroid/lipofuscin 
autofluorescence during fluorescence microscopy. In the NIRAF study, Sudan Black B is 
used to stain ceroid on paraffin slides. In the microspectroscopy study, it is also used to 
stain lipids on frozen slides, which will be covered in Section 7.3. 
PT AH stain is a mixture of haematoxylin and phosphotungstic acid. It has a 
similar mechanism to H&E, where phosphotungstic acid binds to tissue protein and 
provide cytoplasmic contrast like eosin. PT AH is often used to study the central nervous 
system, tumors in skeletal muscles and fibrin deposition. For atherosclerotic plaques, 
PT AH stain is mainly targeting the presence of fibrin/fibrinogen to study thrombus. 
Perl's Prussian Blue is a special stain to label the free Fe3+ ion. The solution 
contains ferrocyanide ions, in which ferric ions will precipitate to highly form water 
insoluble complexes with blue color. For atherosclerotic plaque, the potential target is 
hemosiderin. It is most commonly found in macrophages and is especially abundant in 
situations following hemorrhage. Its formation might be linked to phagocytosis of red 
blood cells and hemoglobin, indicating intraplaque hemorrhage. 
The above five types of stains were used to understand NIRAF spectroscopy 
measurement of bulk arterial tissue. H&E acquires cell distribution on the plaque, 
including endothelial cells, inflammatory cells, erythrocytes and smooth muscle cells. 
Masson ' s Trichrome evaluates the intactness of extracellular matrix and helps identify 
necrotic core. Sudan Black B, PTAH and Perl ' s Prussian Blue target ceroid, 
fibrin/fibrinogen and hemosiderin respectively. Those methods will provide important 
insights to investigate NIRAF source. 
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7.2.2 Correlation between NIRAF and histology 
In this section, the correlation between NIRAF intensity profile and histology of 
atherosclerotic plaques are discussed in details. 
The first example is a necrotic core plaque excited by 740nm diode laser. The 
intensity profile and H&E histology stain is shown in Figure 109. The region between the 
two dashed lines has significantly higher intensity than the edge of the tissue, which 
appears normal. Two triangle labeled regions correspond to the peaks on intensity profile. 
(a} 
(b) 
~6 
~4 
i3 
u2 
~5 0 
mm 
--
Figure 109 NIRAF intensity profile and H&E slide. (a) is NIRAF intensity profile, (b) is 
corresponding H&E stain. Dashed triangle - thin fibrous cap; dotted triangle- plaque 
shoulder. 
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Figure 110 Thin fibrous cap seen by H&E. 
The region of the dashed triangle is shown at a higher resolution in Figure 110. The 
thickness ofthe fibrous cap is measured on the H&E slide as less than 65 microns, which 
is a commonly accepted threshold for thin-capped fibroatheroma (Virmani, Burke et al. 
2006). Cholesterol crystal clefts with needle shape are clear seen under the thin cap. The 
region deep into the plaque also shows cholesterol crystal clefts, but the density of cells is 
very low. The histopathology suggests that the necrotic core mainly contains extracellular 
material. 
Figure 111 shows the shoulder of this plaque. On the left of the plaque, 
cholesterol crystal clefts are also present under the fibrous cap. On the right of the plaque, 
the intima shows a transition between lipid rich plaque and fibrous plaque. Although the 
lipid concentration is decreasing significantly in this region, NIRAF intensity does not 
drop correspondingly. This suggests that cholesterol crystal is not correlated with NIRAF 
in the plaques. 
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Figure 111 Shoulder of the plaque seen by H&E. 
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Figure 112 NIRAF intensity profile and Trichrome stain. (a) NIRAF intensity profile, (b) 
corresponding trichrome stain. Dashed triangle- thin fibrous cap; dotted triangle - plaque 
shoulder. 
Figure 112 shows Masson's Trichrome stain from an adjacent serial section of 
this plaque. The Trichrome stain highlights the degradation of structural proteins in the 
plaque and identifies this plaque as a necrotic core plaque. From 'higher resolution images 
of the dashed triangle and dotted triangle area in Figure 113 and Figure 114, cholesterol 
crystal clefts are also visible. Meanwhile, there are red strands under the fibrous cap, 
which might be fibrin or blood. On the shoulder of the plaque, the transition to a fibrous 
plaque is confirmed. Red blood cells are found between the necrotic core and the fibrous 
shoulder. 
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Figure 113 Trichrome stain ofthin fibrous cap. 
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Figure 114 Trichrome stain of plaque shoulder. 
Figure 115 shows Sudan Black B stain of the same plaque. There are black 
nodules near the surface ofthe plaque. Higher magnification images in Figure 116 shows 
the distribution of ceroid where NIRAF shows that the distribution of ceroid is 
underneath the thin fibrous cap with cholesterol crystals present. Furthermore, the 
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location of ceroid corresponds to the region of high NIRAF intensity. 
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Figure 115 Sudan Black B stain of the plaque. (a) NIRAF intensity profile, (b) 
corresponding Sudan Black B stain. Dashed triangle- thin fibrous cap; dotted triangle-
plaque shoulder. 
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Figure 116 Sudan Black B stain of thin fibrous cap. 
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Figure 117 shows another smaller aggregation of ceroid located on the plaque 
shoulder. Although the extracellular matrix on the fibrous region appears intact, there are 
ceroid nodules underneath the thick fibrous cap corresponding to the less intense peak in 
the NIRAF intensity profile. 
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Figure 117 Sudan Black B stain of plaque shoulder. 
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Figure 118 PTAH stain of the plaque. (a) NIRAF intensity profile, (b) corresponding PTAH 
stain. Dashed triangle - thin fibrous cap; dotted triangle- plaque shoulder. 
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Figure 118 shows PTAH stain of another adjacent serial section of the whole 
plaque. Fast red is used as the counter stain. The top surface of the plaque shows a blue 
color indicating fibrin formation due to exposure to blood in the lumen. The intima and 
media shows only the color of counter stain. The adventia also shows blue color, which 
might be a result of fibrin or fibrinogen in the vasa vasorum. Considering the limited 
optical penetration depth, its impact on NIRAF can be neglected. A high resolution image 
ofthe region labeled by the dashed triangle (Figure 119) shows that the luminal surface is 
fully covered by fibrin. Higher resolution image of the shoulder is shown in Figure 120, 
which has much less fibrin on the plaque surface and almost no fibrin on the fibrous 
shoulder. 
Figure 119 Thin fibrous cap seen by PTAH stain. 
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Figure 120 PTAH stain of plaque shoulder. 
From the necrotic core example, several observations are found. The necrotic core 
regton has higher NIRAF intensity than non-necrotic core region. Necrosis and 
cholesterol crystal are the primary morphological features of the necrotic core region 
according to H&E and Trichrome stain. While the distribution of cholesterol crystal is 
located over the entire plaque and concentrated in the center, the NIRAF intensity profile 
shows two peaks at the shoulders of the plaque, but the center is lower. This suggests that 
the NIRAF intensity is not correlated with cholesterol concentration. 
Sudan Black B reveals ceroid distribution near the plaque surface and the plaque 
shoulder, which corresponds to the two peaks on NIRAF intensity profile. In the center of 
the plaque, less ceroid is seen on the slide, while the NIRAF intensity is also lower. The 
histological presence of ceroid actually agrees with the NIRAF intensity profile. 
PT AH stain shows fibrin on the surface of the plaque where the fibrous cap is 
ruptured. This contrast is reasonable since the plaque is in contact with blood and 
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generates thrombus. On the shoulder of the plaque, no fibrin/fibrinogen is seen on 
histology. As a result, fibrin/fibrinogen does not appear to correlate with the NIRAF 
intensity profile for this lesion. 
A second example is a pathological intimal thickening plaque. The intensity 
profile across the H&E stain is shown in Figure 121. The center of the plaque has higher 
intensity than the edges. 5x magnification image in Figure 122 shows cell infiltrations on 
top of the intima, which indicates inflammatory cell activities. The thickness of the 
intima is 500J.1m~1mm. 
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Figure 121 H&E stain of a PIT. (a) NIRAF intensity profile, (b) corresponding H&E stain. 
Dashed circle - region of interest. A higher magnification image of the ROI will be provided. 
155 
Figure 122 Center of the PIT seen by H&E. 
Figure 123 shows the intensity profile across the Trichrome stain. A region of 5x 
image of the center of the PIT is shown in Figure 124. Besides cell infiltration, necrosis is 
found in the plaque. The extracellular matrix starts to degrade and the protein network 
appears disordered at certain locations. 
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Figure 123 Trichrome stain ofthe PIT. (a) is NIRAF intensity profile, (b) is corresponding 
Trichrome stain. Dashed circle - region of interest. 
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Figure 124 Center of the PIT seen by Trichrome. 
Figure 125 shows the intensity profile across Sudan Black B stain. 5x image of 
the center of the PIT is shown in Figure 126. The plaque in general appears pale, with 
very few ceroid nodules in the intima. The density of ceroid nodules appears significantly 
lower than in the necrotic core example. 
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Figure 125 Sudan Black B stain of the PIT. (a) is NIRAF intensity profile, (b) is 
corresponding Sudan Black B stain. Dashed circle- region of interest. 
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Figure 126 Center of the PIT on Sudan Black B. 
Figure 127 shows the intensity profile vs. PTAH stain. 5x image of the center of 
the PIT is shown in Figure 128. Similar to Sudan Black B stain, the plaque shows little 
PT AH stain and as a result, very little fibrin/fibrinogen. Instead of fibrin, the 5x image 
shows cell-like small blue nodules, which might be platelets. This result suggests that 
fibrin/fibrinogen is not contributing to PIT NIRAF for this lesion. 
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Figure 127 PTAH stain of the PIT. (a) is NIRAF intensity profile, (b) is corresponding 
PT AH stain. Dashed circle- PIT region. 
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Figure 128 Center of the PIT seen by PTAH. 
Finally, the presence of Iron was investigated using Prussian Blue stain. Coronary 
arteries with high NIRAF were stained, and the results did not support hemosiderin as a 
potential NIRAF fluorophore because it is observed in very few plaques. One example is 
the NC plaque in Figure 129. Prussian Blue stain showed hemosiderin approximately 
356f.lm underneath the fibrous cap. Figure 130 shows the distribution of hemosiderin 
colocalized with red blood cells. Considering blood absorption in this region and the 
depth, the contribution of hemosiderin to the detected NIRAF will be very limited. 
Therefore hemosiderin is not considered to be the NIRAF fluorophore. 
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Figure 129 Prussian blue stain of a NC plaque. The yellow square labels the region with 
hemosiderin in Figure 130 . 
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Figure 130 Prussian blue stain ofROI in Figure 129. 
.. 
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From the above histological stained examples, there are several morphological 
differences between NC and PIT. From PIT to NC, the area of necrosis, cholesterol 
crystal density, ceroid nodule density all increase significantly. Fibrin/fibrinogen 
develops where the NC is ruptured and exposed to blood, but little can be seen on a PIT. 
The activities behind those changes, including the extracellular matrix degradation, 
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apoptosis/necrosis of infiltrated cells and formation of ceroid, might be associated with 
the increase ofNIRAF. 
The correlation study between NIRAF intensity and histology on bulk tissue 
provides a morphological context with qualitative chemical contrast, but this method has 
limitations. As with all volumetric measurement, the histology slide does not represent 
the whole sampling volume. Also, there is no depth-resolved information about NIRAF 
from each layer of the plaque. To solve those problems, NIRAF microspectroscopy on 
thin tissue slides is investigated in the next section. 
7.3 NIRAF microspectroscopy 
7.3.1 Experimental design 
To further study the location ofNIRAF fluorophores on different types of plaques, 
frozen tissue slides were measured instead of bulk tissue by NIRAF microspectroscopy 
and confocal microscopy. First, high NIRAF plaques were screened by NIRAF 
spectroscopy on bulk tissue. Those plaques were embedded in optical cutting temperature 
(OCT) compound. 5 micron unstained thin serial sections were cut and loaded on thin 
glass coverslips. The first section was scanned by a custom built NIRAF 
microspectroscopy system in Figure 131. The excitation light was 633nm. The power was 
0.2mW. The lateral resolution was 10 11m when using lOx objective lens. The step size of 
the Raster scan was 1011m. The integration time at each spot was 0.2s. The second section 
was scanned using a confocal microscope (FV-1000, Olympus, Japan). Four different 
excitation/emission schemes were used (Table 15). The lateral resolution was 1.211m. The 
adjacent serial sections were stained with H&E, Trichrome and Sudan Black B. The 
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images were combined in a correlative study to understand NIRAF location. 
Collimator Dichroic M irror 
lOx Objective 
Frozen shde on covershp 
Air 
Figure 131 NIRAF Microspectroscopy system schematic. 
Histology 
Spectral shape 
Bright field 
morphology 
Confocal 
microscopy 
Figure 132 Overview of NIRAF microspectroscopy procedure. 
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Excitation wavelength Emission channel 
405nm 425~475nm 
488nm 500~545nm 
568nm 575~620nm 
635nm 655~755nm 
Table 15 Confocal microscopy settings. 
51 ex vivo human aorta plaques from 30 patients were measured m this 
experiment. The tissue was provided by MGH autopsy service. The plaques can be 
divided into different groups shown in Table 13. 
Tissue type Number 
NC 12 
PIT 24 
Fibroatheroma exposed to blood 3 
Fibrocalcific 3 
IH 9 
Table 16 Tissue type in NIRAF microspectroscopy. 
The postprocessing procedure of data includes three parts: 
1. From NIRAF microspectroscopy measurement, the 2-D NIRAF intensity map 
was generated for each frozen section. Each pixel was the integration of NIRAF 
spectrum from 680 to 760nm. 
2. Besides intensity, spectral contrast map (red/blue ratio map) is also constructed on 
each section based on the fact that NC spectrum is red shifted (Section 7.1) and 
the blue edge ofNC is almost identical to normal tissue. Therefore the situation is 
similar to the preform testing where NBOHC shows red shift relative to silica 
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Raman. Here we apply the same method to compose a red/blue map: The blue 
channel was integrated from 645nm to 650nm. The red channel was integrated 
from 680nm to 700nm. 
3. From confocal microscopy, high resolution NIRAF and bright field images (20x, 
40x, 60x) of the frozen section were obtained on the same section. We directly 
correlated NIRAF intensity with morphological features and located NIRAF 
fluorophore at subcellular level. 
7.3.2 NIRAF features from tissue slide 
The example below is a necrotic core plaque. 
(a) 
Figure 133 NIRAF intensity map ofNC section. (a) NIRAF intensity map, (b) 
corresponding Trichrome stain. 
The intensity map of the plaque is shown in Figure 133(a). By comparing to the 
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trichrome stain in Figure 133(b), we observe that the necrotic core region is brighter than 
the surrounding media, shoulder and intima. Meanwhile, there are several bright stripes 
on the image, which is due to tissue folding. 
(a) 
Figure 134 Red/blue map ofNC section. (a) red/blue map, (b) corresponding Trichrome 
From red/blue map in Figure 134(a) and trichrome stain in Figure 134(b), we 
observe that the NC region has higher red/blue ratio than the shoulder and the media. The 
region with the high intensity stripes shows no distinguished contrast, which confirms 
tissue folding. Meanwhile, there are high red/blue spots on the edge of the plaque, which 
requires higher resolution confocal images to understand the signal origin. 
Several regions with high NIRAF intensity are investigated. The first region is 
near the interface between the fibrous cap and the shoulder of the NC, where 
inflammatory cell infiltration is observed on H&E stain. Figure 135(a) shows an 
overlapped confocal image, where the gray scale represents the bright field image, and 
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red hot map shows 635nm NIRAF (red means low intensity, yellow means high intensity). 
In the circled region on Figure 135(a), cell-like nodules with bright NIRAF are found. 
The fibrous cap and extracellular matrix have low NIRAF intensity. Figure 135(b) shows 
H&E stain on the same region. Inflammatory cells are labeled. Their diameters vary from 
12 to 221J.m, which is between polymorphonuclear leukocytes and macrophages sizes. By 
comparing the two images, the inflammatory cells are considered responsible for the 
bright NIRAF nodules. 
(a) (b) 
Figure 135 Confocal image and H&E for NC. (a) is multichannel confocal image of the 
frozen slide. The grayscale image is bright field channel. The red-yellow color is the 635nm 
excited NIRAF channel. (b) is corresponding H&E stain. The red circle highlights the ROI, 
which shows inflammatory cells on histology. 
The second region is the necrotic core region with cholesterol crystal clefts. 
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Figure 136(a) shows the overlapped NIRAF and bright field confocal images. The 
cholesterol crystal clefts are the dark needle-shaped structures on the surface of the 
plaque. They has low NIRAF signal, which agrees with cholesterol basic spectrum in 
Section 7 .1. The necrotic core region under the cholesterol crystal clefts shows high 
NIRAF intensity. On H&E slide in Figure 136(b), no cell nucleus are found on the plaque. 
This suggests the high NIRAF in NC region is from the extracellular foamy material, 
which might comprise of cell debris, degraded structural protein and lipid. Sudan Black B 
stain in Figure 137 confirms lipid. The foamy material is heterogeneous and covers the 
whole NC region. 
(a) (b) 
Figure 136 Confocal image ofNC region and H&E. (a) is multichannel confocal image of 
the frozen slide. The grayscale image is bright field channel. The red-yellow color is the 
635nm excited NIRAF channel. (b) is corresponding H&E stain. 
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Figure 137 Sudan Black B stain of NC region. 
The third region is at the bottom of the NC region and close to the right edge of 
the whole plaque. In this region, high NIRAF mainly exists on ring shaped structures in 
Figure 138(a). Since the confocal image and histology slide are from adjacent sections, 
they appear similar but not identical. A good example of this ring-shaped high NIRAF 
structure is labeled with a circle. This might be neoangiogenesis and the red ring on 
Trichrome might be elastin. It also contains cholesterol crystal clefts, which shows low 
NIRAF intensity. This region appears pale on Trichrome in Figure 138(b), which 
suggests the extracellular matrix that is starting to degrade. 
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(b) Trichro me stain 
Figure 138 Confocal image of plaque bottom and Trichrome. (a) is multichannel confocal 
image of the frozen slide. The grayscale image is bright field channel. The red-yellow color is 
the 635nrn excited NIRAF channel. (b) is corresponding Trichrome stain. The red circle 
highlights the bright rings on NIRAF image and histology. 
Guided by the above confocal images, NIRAF spectra in the inflammatory cell 
rich region, foamy material from NC region, bright rings are selected and compared. As 
negative control, spectra from the media and cholesterol crystal cleft are also combined. 
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Figure 139 Raw NIRAF spectra at different sites. 
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Figure 140 Normalized NIRAF spectra at different sites. 
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Figure 139 shows a comparison of raw NIRAF spectra at different spots on the 
section. The green dashed line is from foamy material in the NC region, which has 
significantly higher intensity than the rest of sites. The thin brown line is the bright ring. 
The red line is the inflammatory cell region. They have intermediate intensity level. The 
media shows lower NIRAF. Cholesterol crystal cleft shows the lowest signal level. In 
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normalized spectra in Figure 140, we observe that the foamy material spectrum is 
significantly red shifted with reference to media, while inflammatory cells and bright 
rings are intermediate. Further, from the raw cholesterol spectrum, Raman signatures are 
separated by polynomial fitting and shown in Figure 141. Since the overall signal level is 
low, the spectrum has strong noise floor, but the CH2 bending ( 1439cm·1 ) is still visible, 
which validates cholesterol Raman. 
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Figure 141 Raman spectrum from cholesterol crystal. 
In this NC example, the foamy material is the main contributor to both NlRAF 
intensity and spectral red shift, and spreads over the whole NC. Inflammatory cells and 
the bright rings also show high signal intensity and red shifted emission. Since they are 
both discretely distributed and relatively confined, they contribute to plaque NIRAF 
locally. Cholesterol crystals in the plaque have low fluorescence and a Raman spectrum 
can be acquired, although the SNR is limited. 
To compare different plaque types, spectra from the ROI on plaque core, intima, 
media of each tissue section are selected and added into a database. For NC plaques, the 
plaque core is actually the necrotic core with foamy material. Figure 142 shows how to 
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set ROI on a NC section. For PIT, the plaque core is actually the extracellular lipid pool. 
Figure 143 shows how to set ROI on a PIT section. 
(b) 
Figure 142 ROis on NC plaque. (a) NIRAF intensity map. The yellow solid circle is NC, the 
green dotted circle is intima; the purple dashed circle is media. (b) Trichrome stain ofthis 
plaque. 
(a) 
(b) 
Figure 143 ROis on PIT. (a) shows NIRAF intensity map, the yellow solid circle is the lipid 
pool, the green dotted circle is intima; the purple dashed circle is media. (b) trichrome of this 
plaque. 
Using this method, spectra from different tissue specimens are combined for 
comparison. Five categories are built, including NC (foamy material region), PIT 
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(extracellular lipid pool), intima (from both NC and PIT), media (from both NC and PIT) 
and lli (whole tissue) as negative control. 
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Figure 144 Comparison of intensity calibrated by excitation power. The error bar is 
standard deviation. NC -necrotic core, PIT - pathological intimal thickening, IH - whole 
intimal hyperplasia. Note: intima and media data in this comparison were measured from 
intima and media of PIT and NC. 
Using one-way ANOVA, the intensity is compared in Figure 144. The intensity 
rank from high to low is NC > Media > IH :=::: PIT > Intima. Although NC is very 
heterogeneous, its intensity is significantly higher than the other four categories (p<O.Ol ). 
Media has the second highest intensity, which is probably due to densely aligned elastin 
and smooth muscle fibers. Extracellular lipid pool has similar NIRAF intensity to the 
intima and lli, which suggests that lipid deposition by itself does not contribute to 
NIRAF. 
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Figure 145 Comparison of Red/blue ratio. The eiTor bar is standard deviation. NC-
necrotic core, PIT- pathological intimal thickening, IH- whole intimal hyperplasia. Note: 
intima and media data in this comparison were measured from intima and media of PIT and 
NC. 
To investigate the effect of the spectral shape difference, the red/blue ratio is 
compared m Figure 145. The red/blue ratio rank from high to low IS 
NC>PIT>Intima::::;Media>IH. NC shows significantly stronger red shift than the other four 
categories(p<0.01). This agrees with observation from bulk tissue measurement. PIT has 
the second strongest red/blue ratio, which suggests that, as a transition between normal 
tissue and NC, PIT experiences certain chemical reactions and physiological processes 
which leads to the generation of NIRAF fluorophore. Intima and media has similar 
red/blue ratio, which agrees with the fact that they both have collagen and elastin as main 
components. IH is slightly lower than intima/media of plaques. A possible reason is that 
the inflammatory activities present in NC and PIT might modify the structural protein on 
the intima and media. 
From this experiment, we conclude that the foamy material in the NC region is 
the main reason for high NIRAF intensity on NC plaques. The extracellular lipid pool on 
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PIT has low intensity, which suggests that in bulk tissue measurement, the intermediate 
NIRAF intensity from PIT is generated by other sources such as inflammatory cells 
activities and bright rings. Intima and media mainly present collagen and elastin signal 
similar to IH. 
Since the confocal images frequently show high NIRAF intensity on disrupted 
protein fibers, the possibility that the extracellular matrix degradation is a source of 
NIRAF should be investigated. Our hypothesis is that the NIRAF fluorophore might be 
generated during protein degradation. Enzyme activity is a target to study this hypothesis, 
which is described in Section 7.4. 
7.4 Immunohistochemistry 
During the progression of atherosclerosis, the matrix metalloproteinase enzymes 
play an important role in different aspects, including extracellular matrix degradation, 
angiogenesis, smooth muscle cell migration, apoptosis, plaque rupture and healing 
(Arroyo and Iruela-Arispe 2010; Ketelhuth and Back 2011). When triggered by 
inflammatory signaling molecules, cells in atherosclerotic plaques (macrophages, smooth 
muscle cells, endothelial cells, etc.) produce gelatinases (MMP-2 and MMP-9), 
collagenase (MMP-1, MMP-8) and other types of MMPs (Deguchi, Aikawa et al. 2006). 
MMP-2 and MMP-9 expression levels are reported to be positively correlated with 
plaque rupture (Deguchi, Aikawa et al. 2006; Wallis de Vries, Hillebrands et al. 2009). 
Therefore, they are considered important potential biomarkers to study plaque burden and 
identify plaque instability. 
To understand the impact ofMMP on NIRAF, especially in NC plaques, MMP-2 
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is chosen as a representative MMP since it is very common and capable of degrading 
many types of collagen and gelatin (Ketelhuth and Back 2011 ). 
Using antibody Ab37150 (Abeam, Cambridge, MA, USA), 
immunohistochemistry stain was done on 5 f.!m thick frozen tissue sections from 30 
plaques in Section 7.3 . We used a chromogen-based method to visualize the stain. 
Ab37150 served as the primary antibody to label MMP-2. The secondary antibody was 
alkaline phosphatase fast red (APFR), which stained the primary antibody a red color. 
Hematoxylin was used as counter stain, which stained nucleus a blue color. 
The first example is the NC plaque discussed in Section 7.3 .2. Figure 146(a) is its 
confocal NIRAF intensity map. Figure 146(b) is the MMP-2 stained slide, where the 
red/pink color labels MMP-2. From this comparison, NC region and its shoulder show 
positive correlation between NIRAF intensity and MMP-2 contrast. The intima and 
media mostly show only the counter stain. 
176 
(a) 
(b) 
Figure 146 Confocal image and MMP-2 stain ofNC. (a) confocal NIRAF intensity map, 
(b) MMP-2 stain slide. The red/pink color labels MMP-2 on the plaque. Hematoxylin provides 
counterstain of cell nucleus, which provides a blue\gray background. 
The second example is a PIT. Figure 147(a) shows the confocal NIRAF intensity 
map, where the top surface ofthe plaque is brighter than the intima. Figure 147(b) shows 
trichrome stain which identifies this plaque as PIT. Figure 147(c) is the MMP-2 stain, 
where the top surface of the plaque is pink and the intima is light pink. This indicates 
MMP-2 activity near the endothelium. 
177 
(a) 
(b) 
(c) 
Figure 147 NIRAF intensity, Trichrome and MMP-2 image of PIT. (a) confocal NIRAF 
intensity map; (b) Trichrome stain; (c) MMP-2 stain slide. The red/pink color labels MMP-2 
on the plaque. Hematoxylin provides counterstain of cell nucleus, which provides a blue\gray 
background. 
From the 30 plaques in immunohistochemistry study, 11 out of 12 NCs and 14 out 
of 15 PITs exhibit positive contrast on MMP-2 stain. NCs show MMP-2 in the whole 
plaque region, while PITs show MMP-2 mostly on the edges of extracellular lipid pool. 
Two IH show no contrast on MMP-2 stain. The results suggest that MMP-2 is active on 
NCs and PITs. This provides a positive correlation between NIRAF, extracellular matrix 
degradation and inflammation. 
To study the molecular nature ofNIRAF fluorophore, more information is needed 
to analyze protein degradation product. From literature, when degradation occurs, 
collagen is cleaved by MMP into alpha polypeptide chains with varying sizes from 40Kd 
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to 150Kd (Murata, Motayama et al. 1986). Since collagen has low NIRAF intensity, these 
chains might experience modification that causes higher NIRAF. Two important 
chemical reactions related to amino acids on atherosclerotic plaques are investigated in 
the next section. 
7.5 Study of oxidative stress product 
The chemical environment of atherosclerotic plaque potentially provides 
oxidative stress in different aspects. Inflammatory cells, such as macrophages, monocytes 
and neutrophils, can release reactive oxygen species (ROS) from lysosomes during 
phageocytosis and autophagy (Kurz, Terman et al. 2008; De Meyer and Martinet 2009). 
Ferric ions can be released during hemoglobin degradation after intraplaque hemorrhage 
(Michel, Delbosc et al. 2012). As a result, lipid peroxidation and protein modification 
occur, which trigger other chemical reactions and further inflammatory responses. 
In this section, representatives of lipid peroxidation and protein modification 
products are discussed. 
7.5.1 Oxidized lipid-amino acid adduct 
4-hydroxy-2-nonenal (HNE) is reported to be a very common highly reactive lipid 
peroxidation product (Uchida 2003), mainly from oxidation of polyunsaturated omega-6 
acyl groups, such as arachidonic or linoleic groups, and of the corresponding fatty acids 
in cells. 
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Figure 148 HNE structure. 
The molecular structure ofHNE is shown in Figure 148. Because ofthe aldehyde 
group, HNE tends to form crosslink with amino acids like lysine. A lipofuscin-like 
fluorophore on atherosclerotic plaques was identified in the past as HNE and lysine 
adduct called hydroxyiminodihydropyrrole (HIDP) derivative(ltakura, Oya-lto et al. 
2000). Its structure is shown in Figure 149. 
~NH2 
N COOH 
~ ""' ~COOH 
HIDP derivative 
Figure 149 HIDP structure. Reprinted from (Itakura, Oya-Ito eta!. 2000). 
Following published protocols (Xu and Sayre 1998; Itakura, Oya-lto et al. 2000; 
Kurangi, Tilve et al. 2006; Soulere, Queneau et al. 2007), we synthesized HNE and HIDP. 
When excited by 360nm light, HIDP presents an emission peak at 430nm, which is 
typical emission feature of lipofuscin. The fluorescence spectrum confirms that HIDP 
was synthesized. 
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Figure 150 Emission of HIDP at 360nm excitation. 
However, under 633nm excitation, HIDP does not show any emission. This 
suggests that HIDP does not contribute to tissue NIRAF. 
7.5.2 Dityrosine 
Besides lipid peroxidation, oxidative stress generates another major category of 
byproducts through protein modification. In this category, dityrosine is a representative 
biomarker and shows interesting UV fluorescence feature (Malencik and Anderson 2003). 
Dityrosine is also reported to be involved with the formation of ceroid (Haka, Kramer et 
al. 20 11 ). According to the amino acid sequence, structural proteins in the human 
coronary wall, such as collagen and elastin, contain tyrosine. Tyrosine also exists in 
LDLs and certain proteins that regulate signal messaging, such as calmodulin and protein 
tyrosine phosphatases. Phagocytes can oxidize tyrosine through the Myeloperoxidase-
Hydrogen Peroxide system and synthesize dityrosine or trityrosine crosslinks (Jacob, 
Cistola et al. 1996). An immunohistochemistry study reported the existence of dityrosine 
in atherosclerotic lesions with foam cells (Kato, Wu et al. 2000; Fukuchi, Miura et al. 
2008). Elevated concentrations of dityrosine in LDLs and protein-bound dityrosine in the 
181 
lesions were found on advanced human atherosclerotic plaques (Leeuwenburgh, 
Rasmussen eta!. 1997). 
HO 0 
OH 
dityrosine 
Figure 151 Dityrosine structure. 
In this section, dityrosine was synthesized and its fluorescence features were 
studied. The molecular structure of dityrosine is shown in Figure 151 . It forms a crosslink 
at the ortho positions on the benzene rings of two tyrosine molecules. This crosslink can 
happen between tyrosine on polypeptide chains too. 
We synthesized dityrosine based on a nonenzymatic method (Tilley, Benjamin et 
a!. 2004). L-tyrosine was oxidized by potassium bromate (KBr03). The products were 
separated by high performance liquid chromatography (HPLC). The existence of 
dityrosine was validated by NMR spectroscopy. 
First, the absorption spectra of dityrosine and tyrosine in water solution were 
compared. Since the concentration of dityrosine product was unknown, the absorption 
spectra were normalized by the peak. Figure 152 shows the comparison. Tyrosine 
exhibits a major absorption peak near 280nm and the absorbance decreases very fast, 
while dityrosine absorption spectrum is clearly red shifted and shows a tail towards 
visible region. 
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Figure 152 Normalized absorption spectra of the compound. In the legend, "tyrosine" 
means tyrosine aqueous solution, "dityrosine" means the HPLC extracted compound which 
Using the HPLC extracted compound, fluorescence spectra at different excitation 
wavelength were measured using the Skinscan spectrophotometer (Horiba Inc., Japan). 
As negative control, saturated tyrosine aqueous solution was also measured. 
The first wavelength is 270nm, which is close to absorption peak of tyrosine. The 
fluorescence spectra are shown in Figure 153. The blue dash curve shows tyrosine 
spectrum, while the red solid curve shows dityrosine. Tyrosine shows high fluorescence 
intensity, while dityrosine is much weaker. From the normalized spectra in Figure 154, it 
is clear that dityrosine fluorescence at 270nm excitation is distinguishable from tyrosine 
since it has a broad emission between 350 and 500 nm. 
183 
14 f\ 
I \ 
I l 
12 : \ 
I I 
I \ 
10 ; \ 
I \ 
~ ; \ 
·c;; 8 : \ 
C: I l 
Q) I I 
c: 6 ; \ 
I I 
I \ 
' \ 4 : \ 
I \ 
I \ 
2 1 \ 
' ' ' '-. o' - ...... 
1----· Tyrosine f 
[- Dityrosine l 
300 350 400 450 500 
Wavelength 
Figure 153 Fluorescence spectra of the compound at 270nm excitation. In the legend, 
"tyrosine" means tyrosine aqueous solution, "dityrosine" means the HPLC extracted 
compound which contained dityrosine. 
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Figure 154 Normalized fluorescence spectra of the compound at 270nm excitation. In the 
legend, "tyrosine" means tyrosine aqueous solution, "dityrosine" means the HPLC extracted 
compound which contained dityrosine. 
The second wavelength is 325nm, which is further away from tyrosine absorption 
peak but still enable to excite dityrosine. The fluorescence spectra are shown in Figure 
155. Tyrosine signal is at the level of noise floor, but dityrosine still shows fluorescence 
signal. Since the concentration of dityrosine is low, the SNR is not high. 
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Figure 155 Fluorescence spectrum of the compound at 325 om excitation. In the legend, 
"tyrosine" means tyrosine aqueous solution, "dityrosine" means the HPLC extracted 
compound which contained dityrosine. 
The above measurement on water solution demonstrates the existence of 
dityrosine from UV fluorescence perspective. To compare 633nm excited fluorescence, 
both solutions are evaporated. The 633nm fluorescence spectra of tyrosine ( ~ 1 Omg, 1 mm 
thickness) and dityrosine (<1mg, <lOOflm thickness) powders are shown in Figure 156. 
The excitation power is 1m W. Dityrosine has significantly higher intensity than tyrosine. 
When integrated within 680-760nm window (emission window for clinical imaging), 
dityrosine signal is 18 times higher than tyrosine. Since such a small amount (<1mg) can 
exhibit strong NIRAF, we believe that dityrosine has the potential to generate high 
NIRAF in tissue. 
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Figure 156 NIRAF spectra of tyrosine/dityrosine. In the legend, "tyrosine" means tyrosine 
powder, "dityrosine" means the powder ofHPLC extracted compound which contained 
dityrosine. 
The normalized spectra are shown in Figure 157. Tyrosine shows fluorescence 
and Raman signatures (extracted and shown in Figure 158), while dityrosine shows a red 
shifted smooth fluorescence profile. This result suggests that dityrosine Raman peaks will 
be overwhelmed by shot noise from its fluorescence. 
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Figure 157 Normalized NIRAF spectra oftyrosine/dityrosine. 
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In this section, two major products generated by oxidative stress were synthesized 
and measured by fluorescence spectroscopy. A representative compound of lipid 
peroxidation product, HIDP, shows similar fluorescence feature to lipofuscin under UV 
excitation, but has no signal at 633nm. A representative compound of protein 
modification, dityrosine, shows both high intensity and spectral red shift at 633nm 
excitation. This indicates that protein modification during plaque progression might be 
responsible for the high NIRAF on NC plaques. 
7.5.3 Tissue oxidation experiment 
As an attempt to test the present theory about protein modification m arterial 
tissues, an experiment using fresh normal human aorta was designed to test if ex vivo 
tissue in the presence of oxidative stress will induce increased NIRAF intensity. The 
aortic wall was screened by NIRAF spectroscopy at 633nm excitation to make sure the 
NIRAF intensity and red/blue ratio are homogeneous. Then the aortic wall was cut into 
halves. The first half was incubated in oxidative solution at 37°C, which was made by 
dissolving manganese acetate III in 10% PBS until saturation. The excessive manganese 
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was filtered . The second half was incubated in 10% PBS at 37°C as a negative control. 
After 12 hours, both tissues were measured by NIRAF spectroscopy again. 
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Figure 159 NIRAF and red/blue map before experiment. (a) the intensity map of the aortic 
wall. The blue solid rectangle labels the tissue piece for negative control. The red dash 
rectangle labels the tissue piece for oxidation. (b) the red/blue ratio ofthe aortic wall. 
Figure 159 shows NIRAF map (integrated from 680 to 760nm) and red/blue map 
of the tissue before the overnight oxidation. Although the intensity is not perfectly 
homogeneous, the red/blue ratio confirms the identical composition of this tissue. 
The tissue is cut and incubated overnight. Then NIRAF spectroscopy under 
633nm is done on the two samples. The intensities are compared with the original tissue 
in Figure 160. Because of photobleaching, both control and oxidized samples have 
decreased intensity. Since the original tissue is not absolutely homogeneous, it is difficult 
to compare the intensity between control and oxidized samples. 
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Figure 160 Comparison of tissue NIRAF intensity. "Original" is the tissue before 
incubation, "control" is the sample incubated in PBS for overnight, "oxidation" is the sample 
incubated in Manganese Acetate PBS for overnight. The errorbar means standard deviation. 
Next, the red/blue ratio is compared in Figure 161. Using ANOV A, the sequence 
of red/blue ratio from high to low is oxidized>control>original, p<O.OOl. The fact that 
control sample presents a small spectral red shift suggests minor tissue degradation or 
oxidation occurs during the overnight incubation in PBS. However, the sample incubated 
in Manganese Acetate PBS solution shows significantly stronger spectral red shift. Since 
the condition to oxidize the tissue is similar to dityrosine synthesis, this suggests that 
possibly the oxidation of normal aortic wall (mainly structural proteins) happens and 
leads to the NIRAF spectral red shift. 
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Figure 161 Comparison of tissue red/blue ratio. "Original" is the tissue before incubation, 
"control" is the sample incubated in PBS for overnight, "oxidation" is the sample incubated in 
Manganese Acetate PBS for overnight. The errorbar is standard deviation . 
The result from this experiment indicates that oxidative stress can modify intact 
structural protein and change its NIRAF emission features , while the intensity change is 
not significant. This may explain the observation of the spectral red shift in PITs where 
the intensity is not distinguishable from intima or media either. 
7.6 Vibrational spectroscopy 
To study molecular information on the tissue, vibration spectroscopy is 
commonly applied in many fields such as cardiovascular and cancer research. To 
investigate NIRAF molecular source on tissue, vibrational spectroscopy has the follow ing 
potential benefits: 
1. The NIRAF fluorophore will be well preserved without chemical treatment. 
2. The wavelength of incident light is usually from NIR to IR, which does not have 
enough energy to trigger photochemical reaction or photolysis. 
3. With adequate prior information about the spectral shape of each kind of 
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molecules, vibrational spectroscopy has the potential to provide quantitative 
chemical assay. 
In this section, Raman spectroscopy was used to study the vibration signatures on 
the high NIRAF regions of plaques and compare with low NIRAF regions. 
Two approaches were taken to study Raman signature of high AF region on 
plaques. 
7.6.1 Raman spectroscopy on bulk tissue 
The first approach was bulk tissue measurement. Previously, Tearney lab 
conducted Raman spectroscopy in fingerprint region (830nm excitation) and high 
wavenumber region (740nm excitation) on ex vivo human atherosclerotic plaques. Data 
from 90 plaques were collected into a database (Chau 2009; Gardecki, Chau et al. 2009). 
Using least square method, the spectra were decomposed into a linear combination of 
basic chemicals, including cholesterol, cholesteryl linoleate, cholesteryl oleate, 
cholesteryl palmitate, glyceryl trioleate, glyceryl palmitate and protein. Since fingerprint 
region has more distinguished vibrational features than high wavenumber region, we 
mainly analyzed fingerprint Raman spectra to find clues about the structure of NIRAF 
fluorophore. 
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-I 
Raman shift (em ) Molecular structure Indication 
1082 and 1744 Unknown Adventitia 
1158 Unknown Beta carotene 
1513 C=C stretch Beta carotene 
1157 C-C stretch Beta carotene 
1008 C-H bending Beta carotene 
1524 C=C bending shifted by lipids Beta carotene 
960 3- Calcium hydroxyapatite P04 
1671 C=C stretch Cholesterol 
958,873 Sterol nucleus Cholesterol 
1439 CH2 bending Cholesterol and cholestyl oleate 
1659 C=C stretch Cholestyl oleate 
957,922,878 Sterol nucleus Cholestyl oleate 
1136 desmosine Elastin 
1104 isodesmosine Elastin 
1440 CH2 bending Glycerol trioleate 
1301 H -C= bending Glycerol trioleate 
1265 H-C= bending Glycerol trioleate 
1656 C=C stretch Glycerol trioleate 
1450 CH2 bending Protein 
1664 Amide I Protein 
1264 Amide III Protein 
1004 phenylalanine Protein 
933 C-C, proline Protein 
855 C-C, proline Protein 
Table 17 Raman peak table. The mformatwn was summanzed and repnnted from (Chau 
2009; Gardecki, Chau et aL 2009)_ 
192 
The interpretation of Raman peaks at different wavenumbers is listed in Table 17. 
The basic chemical Raman spectra are shown in Figure 162. Cholesterol, cholesteryl 
linoleate, cholesteryl oleate, cholesteryl palmitate are the main lipid components of a 
plaque. Between 1400 and 1800cm·1, they show similar Raman signatures because of 
CH2 bending and C=C stretch modes. Between 800 and 1400cm·1, sterol nucleus and 
other structures generates more Raman signatures that differentiate specific lipids. 
Glyceryl trioleate and glyceryl palmitate present H-C= bending and shifted CH2 bending 
modes. Protein shows the Amide I, Amide III, phenylalanine and proline signatures. 
800 1000 1200 1400 1600 1800 
Wavenumber( cm·1) 
- cholesterol 
----· cholesteryl linoleate 
- cholesteryl oleate 
- cholesteryl palmitate 
- - · g lyceryl trioleate 
·········glyceryl palmitate 
- protein 
Figure 162 Raman spectra of basic chemicals. All basic spectra are normalized by the peak 
and shifted on the y axis so their shape difference can be seen clearly. The first four chemicals 
cover the major lipid components in the plaque; the fifth and sixth chemicals cover the major 
fatty acids in the plaque; the seventh chemical represents structural protein. Reprinted from 
(Chau 2009; Gardecki, Chau et al. 2009). 
On each tissue site, the raw spectrum is an overlap of Raman and NIRAF. Using 
polynomial fitting, the NIRAF spectrum is estimated and subtracted. Figure 163 shows an 
example. The red solid curve is the raw spectrum on a plaque. The spectral peak near 0 
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cm-1 is the back reflected laser light and not related to Raman or NIRAF. The blue dash-
dot curve is the estimated NIRAF spectrum. The black dashed curve is the extracted 
Raman spectrum. The extracted Raman spectrum is then decomposed into the linear 
combination of the seven basic chemical spectra. The Raman coefficient of each basic 
chemical represents their proportion in the plaque. 
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----·Raman 
8000 
(/) 
...... 
c 6000 ::l 
0 
0 
4000 
2000 
0 
0 500 1000 1500 
Wavenumber( cm·1) 
Figure 163 Separation of Raman spectrum. The red solid curve is the raw spectrum. The 
blue dash-dot curve is autofluorescence spectrum estimated by polynomial fitting. The black 
dash curve is extracted Raman spectrum. Data source: MGH ex vivo Raman study. 
Figure 164 shows the accuracy of the spectral fitting. The red thick solid curve is 
extracted Raman spectrum from a plaque. The blue dash curve is the least square fitted 
Raman spectrum. The thin black curve is the fitting residue. The fitted spectrum and 
original spectrum are very similar, and the fitting residue mainly contains error due to the 
polynomial fitting and shift of Raman peaks due to chemical environment on the plaque. 
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Figure 164 Least square fitting of Raman spectrum. The red thick solid curve is the 
extracted Raman spectrum. The blue dash curve is the least square fitted Raman spectrum. 
The black thin solid curve is the fitting residue spectrum. Data source: MGH ex vivo Raman 
study. 
Using this method, we can estimate the relative concentration of lipids, protein 
and fatty acids on atherosclerotic plaques. In the ex vivo database, each plaque is 
measured by a line scan (Gardecki, Chau et al. 2009). The correlation between NIRAF 
intensity profile and Raman coefficient profile across the plaque might indicate the 
chemical difference between high AF region and low AF region on the same plaque. 
Figure 165 shows one example on a necrotic core plaque. The NIRAF intensity 
(integration of the whole 830nm excited NIRAF spectrum), Raman coefficients of lipids 
(the summation of Raman coefficients of all four lipid component) and protein are 
normalized by their peaks and plotted again trichrome stain. The red solid curve shows 
NIRAF intensity. In the center of the plaque, it is significantly higher than the edge. The 
blue dashed curve shows lipid Raman coefficient, which is also higher in the center than 
the edge. The black dot-dash curve shows protein distribution, which is lower in the 
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plaque and higher on the right edge. This agrees with the fact that the center of the plaque 
has more lipid, while the edge ofthe plaque has less lipid and more proteins in the fibrous 
cap. From this example, there is a trend that suggests that NIRAF intensity might be 
positively correlated with lipid concentration. 
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Figure 165 Comparison ofNIRAF and Raman coefficients. The red solid curve is 
normalized AF intensity profile, the blue dash curve is normalized Raman coefficients of lipid 
(the summation of four lipid componenents in the model), the black dash-dot curve is 
normalized Raman coefficients of protein. The are plotted against trichrome stain which 
shows a necrotic core as the white area. 
To study the correlation between Raman coefficients and NIRAF intensity, 7 NC 
plaques, 7 PIT plaques and 4 fibrous plaques comprise a training set. Each category 
contains 60 data points. The correlation between Raman coefficients and NIRAF 
intensity is calculated and shown in Table 18. For the whole dataset, cholesterol and 
cholesteryl oleate have higher correlation coefficients (0.429 and 0.421) than the rest 
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components. From previous measurement of NIRAF spectra on lipids, they are not 
considered NIRAF fluorophores. Therefore the correlation between Raman and NIRAF 
mainly suggests that NIRAF fluorophore often coexists with lipids on the plaque. This 
might provide a chemical context to understand the origin ofNIRAF fluorophore. 
Chemical name Whole dataset cmTelation coefficient 
Cholesterol 0.429 
Cholesteryl linoleate 0.151 
Cholesteryl oleate 0.421 
Cholesteryl palmitate 0.072 
Glyceryl trioleate 0.340 
Glyceryl palmitate -0.133 
Protein 0.002 
Table 18 Correlation between NIRAF intensity and Raman coefficient. 
7.6.2 Raman spectroscopy on frozen tissue slides 
To acquire depth-resolved chemical distribution and correlate with NIRAF 
intensity, Raman microspectroscopy is done on 100 micron thick frozen tissue sections. 
The system schematic is similar to the confocal NIRAF microspectroscopy system. The 
source is 830nm light from a Ti: Sapphire laser (Spectra-Physics, Mountain View CA, 
USA). The lateral resolution is ~ 70 f.!m. The excitation power is 90m W. The integration 
time for each spectrum is 400ms. 
Using the same method as bulk tissue measurement, the 2D NIRAF intensity map 
(whole NIRAF spectrum integration) and Raman coefficient map can be composed. 
Figure 166 shows the results from a representative necrotic core plaque. Figure 166(a) 
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shows NIRAF intensity map. The bright region on the section includes bright spots on the 
plaque (x=-3~1mm, y= -1~0 mm), tissue folding on the media (x=5~6mm, y=0~1mm), 
and smooth muscle remodeling (x= -6~3mm, y=0~1mm) . Figure 166(b) shows lipid 
distribution on the plaque region as a summation of all four lipid components. The plaque 
is well distinguished from the media and intima. Figure 166( c) shows protein distribution 
on the section. It accurately delineates the whole section. The brightness of protein 
Raman coefficients can differentiate the media and plaque region, and highlight the 
smooth muscle remodeling. Figure 167 shows the trichrome stain of this section. This 
example also suggests that NIRAF fluorophore coexists in lipid region, but the lipid 
accumulation is not responsible for NIRAF. Also, the protein Raman coefficient map 
shows good correlation with NIRAF map on the healthy intima and media, which 
confirms that protein is the main source ofNIRAF on intima and media. 
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Figure 166 NIRAF and Raman maps of frozen section. (a) shows the NIRAF intensity map 
of the plaque. (b) shows the lipid Raman coefficient map, which indicates lipid accumulation 
in the plaque. (c) shows the protein Raman coefficient map, which indicates structural protein 
distribution in the intima, plaque and media. It also shows smooth muscle remodeling in the 
media, where the map is brighter. 
Figure 167 Trichrome stain of the frozen section in Figure 166. 
From Raman spectroscopy measurement on both bulk tissue and frozen section 
measurement, we find that Raman spectroscopy is a powerful tool to study the 
distribution of lipids and protein directly on atherosclerotic plaques. These measurements 
suggest that NIRAF fluorophore exist in lipid rich region. 
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7.7 Summary 
In this chapter, we investigated the potential source of NIRAF. To this end, we 
applied a number of spectroscopic and histochemical methods to identify the most 
promising candidates that generate NIRAF in atherosclerotic plaques. Since the NIRAF 
intensity increases as the disease progresses, we have focused on potential fluorophores 
that are related to atherogenesis. 
From NIRAF spectroscopy measurement of ex vivo human plaques, two main 
spectral features distinguish NIRAF fluorophore from common chemicals on the tissue, 
namely, high intensity and spectral red shift. This provides the guidance to use NIRAF 
spectroscopy to study basic chemicals. 
Several categories of chemicals that possibly exist on plaques are tested and 
compared with tissue spectra, including structural protein, lipids, hemoglobin-related 
products, thrombotic chemicals, calcium and carotenoid (beta carotene). Collagen and 
elastin show similar fluorescence spectra to normal aorta. Fibrinogen shows an 
interesting spectral red shift. The rest of chemicals shows low fluorescence as evidenced 
by prominent Raman features in the emission spectra. 
NIRAF spectra are compared with histology m bulk tissue measurements, 
including H&E, Trichrome, Sudan Black B and PTAH. H&E and Trichrome both 
suggests that high NIRAF intensity from NC is related to necrosis and extracellular 
material. They also show intensive inflammatory cell activities on PIT. Sudan Black B 
shows ceroid nodules in NC plaques, which provides evidence for ceroid contribution. 
PT AH stain suggests that fibrin and fibrinogen, although accumulated in NC and 
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thrombus, are not responsible for NIRAF. Prussian Blue shows that very low 
concentration of hemosiderin can be seen in NC plaques, which means hemosiderin is not 
responsible for NIRAF either. 
To locate the NIRAF fluorophore, confocal microspectroscopy is done on frozen 
tissue slides under 633nm excitation. High NIRAF is found over the whole NC region on 
the edges/shoulders of PITs. The sequence of average NIRAF intensity on the tissue 
section from high to low is: NC > Media > Intima :::::: PIT (lipid pool) > normal. Here the 
media and intima are from NCs and PITs. The difference between media and intima 
suggest the different composition of structural proteins and possible protein modification. 
Since lipids do not appear to contribute to NIRAF, PIT has similar intensity to intima. 
The spectral shape contrast provides another important insight. The sequence of 
average red/blue ratio (red shift) from high to low is NC > PIT > Intima :::::: Media > 
normal. This suggests that PIT, although it does not show high average intensity, initiates 
certain chemical reactions or modifications that eventually generate NIRAF fluorophore. 
Intima and media, on the other hand, show similar spectral shape. The intensity 
difference might come from the elastin fiber density or quantum yield of collagen/elastin. 
Compared to normal tissue, they also show minor spectral red shift. This might indicate 
that these protein-rich molecules are also modified in diseased plaque. 
From confocal NIRAF microspectroscopy and microscopy measurement in the 
NC region, we also find that on NC region, degraded protein fibers show high intensity. 
This draws our attention to extracellular matrix degradation. Since MMP activity is the 
fundamental of extracellular matrix degradation, immunohistochemistry stain is done on 
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the frozen sections to target a representative MMP enzyme, MMP-2. On NC plaques, 
MMP-2 is found over the entire NC region. On PIT, however, it only exists on the 
surface near the lumen and shoulder of PITs, where bright NIRAF spots can also be seen. 
This means that MMP initiates extracellular matrix degradation on the boundary of PITs, 
and become abundant in the NC region. According to this immunostain study, one major 
difference between NC and PIT is the extent that MMP modifies the extracellular matrix. 
PIT has intact extracellular matrix, both morphologically and chemically. 
To understand the origin of NIRAF in NC regions, one important environmental 
factor is the oxidative stress that arises from different sources. Macrophages and foam 
cells release lysosomes during apoptosis, which contains reactive oxygen species. 
Neoangiogenesis and intraplaque hemorrhage provide red blood cell infiltration, which 
eventually release free ferric ions from hemoglobin. The presence of free Fe (III) ions 
and reactive oxygen species facilitates the Fenton reaction during lipid peroxidation and 
contributes to ceroid formation. 
To understand the impact of oxidative stress on NIRAF, two representative 
chemicals are synthesized and measured. The first chemical is HIDP as a common 
oxidized lipid-amino acid adduct. We showed that it has similar fluorescence feature to 
lipofuscin/ceroid under UV excitation, but is not responsible for NIRAF. The second 
chemical is dityrosine, which is a common biomarker of protein modification. NIRAF 
spectrum of dityrosine shows both high intensity and significant spectral red shift. From 
the literature (Leeuwenburgh, Rasmussen et al. 1997), its existence is confirmed in 
atherosclerotic plaques. This is the most promising molecule we tested that might be 
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responsible for high NIRAF on NC plaques. 
In addition to the NIRAF spectroscopy experiments, we also applied Raman 
spectroscopy to understand the molecular context on plaques. Although no vibration 
signature of the NIRAF fluorophore is detected, the results suggest that NIRAF 
fluorophore exists in a lipid rich environment, which agrees with the previous 
observations. 
From the above information, we have concluded that NIRAF fluorophore is 
localized in the NC region, where several events are associated with the generation of the 
NIRAF fluorophore. We hypothesize that the structural protein is cleaved by MMPs into 
small polypeptide fragments. Second, the macrophage/foam cell debris accumulate in this 
region and provide reactive oxygen species. Both of the events provide the necessary 
environment to form dityrosine crosslinks. 
In the case of PIT, although there are also macrophage/foam cell debris, the 
structural protein is still intact. Tyrosine, as a hydrophobic amino acid, might be 
enveloped by hydrophilic amino acids and less likely to be exposed to oxidative stress. 
However, the protein modification still occurs and gives rise to the spectral red shift. 
In summary, there is evidence presented in this chapter suggesting that NIRAF is 
a result of protein modification led by inflammation and oxidative stress. The formation 
of the dityrosine crosslink is a potential molecule that explains the high intensity NIRAF 
seen in NC plaques. The chemicals evaluated in this chapter are summarized in Table 19 
for future reference. 
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Molecule Hypothesis Validation NIRAF Contribution 
Collagen N/A Fluorescence Normal tissue 
spectroscopy 
Elastin N/A 
Hydroxyapatite N/A N/A 
Hemoglobin Intraplaque hemorrhage NIA 
Biliverdin NIA 
Bilirubin N/A 
Methemoglobin Fluorescence N/A 
spectroscopy, Diffuse 
reflectance 
spectroscopy 
Fibrin Histology, OFDI- N/A 
NIRAF imaging 
Fibrinogen N/A 
Beta carotene Carotenoid-lipid Fluorescence N/A 
co localization spectroscopy 
Cholesterol NIA 
Cholesteryl palmitate N/A 
Cholesteryllinoleate NIA 
Cholesteryl oleate NIA 
Ceroid Oxidative stress Histology NC, PIT 
Oxidized lipid-amino Chemical synthesis, N/A 
acid adduct fluorescence 
spectroscopy 
Tyrosine oxidation NC, PIT* 
product 
Table 19 Summary of tested chemicals. * IS from the literature (Leeuwen burgh, Rasmussen et 
al. 1997) 
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8 Conclusions 
The pathology of coronary atherosclerosis involves various physiological events 
such as inflammation, remodeling and intraplaque hemorrhage chronically. No imaging 
modality alone can provide adequate information to understand the disease. OCT/OFDI is 
a powerful clinical tool to image microscopic structural information of atherosclerotic 
plaques. It is noninvasive, high speed and label free. To overcome the challenges such as 
limited optical penetration depth and image artifacts, it is useful to combine OCT/OFDI 
with a molecular detection method. This combination not only improves the diagnostic 
accuracy of OCT/OFDI, but also provides comprehensive perspectives regarding the 
mechanisms of coronary atherosclerosis. 
Our lab has been investigating NIR Raman spectroscopy as a quantitative tool to 
detect molecular information. NIRAF is a phenomenon observed during NIR Raman 
spectroscopy measurement on atherosclerotic plaques. It is considered as the main source 
of noise background. On NC plaques, NIRAF often overwhelms Raman signal. Although 
NIRAF strongly inhibits the application of Raman, it has the potential to be a molecular 
detection modality. 
Inspired by this observation, NIRAF was measured systematically on ex vivo 
human aorta plaques using 7 40nm excitation, and the results demonstrated high 
correlation between NIRAF and NC plaques. NC shows significantly higher NIRAF 
intensity than non-NC plaques. Meanwhile, the spectral shape variation also provides 
information to differentiate NC from non-NC lipid rich plaques. 
To translate NIRAF detection into clinical study, the main engineering challenge 
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is to detect NIRAF with an optical fiber probe. The prerequisite is to find a double clad 
fiber with minimal fluorescence background. Most current commercial double clad fibers 
that we have tested for this purpose exhibit very high background. The optimal double 
clad fiber in the past was found from Nufern in 2011. When guiding the excitation light 
through the cladding, the fiber background was dominated by silica Raman. Using the 
ratio between tissue signal and fiber background as a standard, the excitation wavelength 
and emission window were further optimized. This finalized the design of NIRAF 
excitation/emission scheme on the clinical OFDI-NIRAF system. 
Based on Nufern double clad fiber, the first OFDI-NIRAF preclinical catheter was 
fabricated. Coronary arteries from five ex vivo human hearts were measured by this 
catheter. The results demonstrated the feasibility to perform OFDI-NIRAF imaging in 
human coronaries. The NIRAF intensity contrast on coronary plaques was in agreement 
with the ex vivo study of aorta plaques by 7 40nm excitation. The prototype catheter was 
also used to detect high NIRAF on calcified plaques with necrosis, which indicated 
extracellular matrix degradation as a potential contributor to NIRAF on atherosclerotic 
plaques with high NIRAF. Further, it showed low NIRAF intensity on thrombus, which 
suggested that red blood cells and fibrin did not have high NIRAF intensity. 
Encouraged by the ex vivo coronary imaging, safety evaluation of NIRAF laser 
exposure was also conducted. In this study, 10mW 633nm light was focused by a 
preclinical OFDI-NIRAF catheter onto fresh swine aortas for 10 s. The focal spot size 
was 1 00 f.lm. Histology showed no damage on the tissue. Since the power of NIRAF was 
5m W and the exposure time was much shorter due to the fast helical scan, the exposure 
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to NIRAF excitation light does not produce cellular or tissue level damage and 1s 
therefore considered safe. 
Although both preclinical OFDI-NIRAF imaging of ex vivo human hearts and the 
safety evaluation of OFDI-NIRAF showed encouraging results, the clinical study was 
delayed by the high autofluorescence background found in the double clad fiber drawn in 
2012. This Nufern double clad fiber, although with the same model number, showed 
much higher background than the earilier fiber. This high background significantly 
decreased the SNR of OFDI-NIRAF detection. 
To understand fiber background and to design a low background double clad fiber, 
multiple glass preforms from Nufern were measured. The fluorescence intensity, 
fluorescence spectral shape and Raman signatures were analyzed within each layer of the 
preforms. Good correlation was established between silica deposit and fluorescence 
background. This background showed features of NBOHC luminescence generated 
during annealing stage. With reference to the preform measurements and previous fiber 
testing results, a new preform design was proposed in collaboration with Nufern. The 
fiber background from the new design validated our understanding of fiber background 
and showed even lower background than the Nufern double clad fiber used in ex vivo 
heart imaging. This fiber provides solid foundation for the clinical OFDI-NIRAF imaging 
of human patients in 2014. 
In addition to the engineering efforts to enable OFDI-NIRAF detection, an 
important scientific topic of this dissertation is to identify the molecules in atherosclerotic 
plaques that generates NIRAF. 
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To study the molecular nature of NIRAF, different measurement methods were 
performed, including NIRAF spectroscopy on bulk tissue, confocal NIRAF 
microspectroscopy /microscopy on frozen tissue slides, regular histology, 
immunohistochemistry stain, chemical synthesis and vibrational spectroscopy. The 
results suggest that NIRAF is a result of protein modification that is caused by the 
combination of inflammation and oxidative stress. Tyrosine oxidation was identified as 
the most promising candidate that explains the high NIRAF signal in NC plaque. Its 
concentration in atherosclerotic plaques is reported to be higher than normal arterial 
tissue, especially in the LDLs isolated from the plaques (Leeuwenburgh, Rasmussen et al. 
1997). If this finding is experimentally confirmed in the plaques by future measurements, 
NIRAF will add important new information for the diagnosis of coronary disease. 
To further investigate the molecular source of NIRAF and validate the role of 
dityrosine, the main challenge is to detect dityrosine crosslinks on atherosclerotic plaques. 
Since this crosslink can be formed between proteins with tyrosine residue, the large size 
of the molecule might be a limiting factor to certain quantitative chemistry methods like 
mass spectrometry. 
Three approaches are suggested. First, immunohistochemistry stain of dityrosine 
crosslink and other tyrosine oxidation products can provide direct link between NIRAF 
and dityrosine distribution (Fukuchi, Miura et al. 2008). The correlative study using 
confocal microspectroscopy and MMP-2 immunostain in Chapter 7 provided reference 
for this approach. 
Second, a cell/tissue culture disease model may be helpful to track the correlation 
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between NIRAF and plaque progression. Tissue culture models have been commonly 
developed by different research groups to study biochemical pathways in cardiology. For 
example, Dr. James R. Stone ' s lab in MGH has a tissue culture model to elucidate the 
biochemical pathways by which low levels of hydrogen peroxide stimulate cell 
proliferation in the vessel wall, which provides information to understand the vascular 
extracellular matrix alterations during athersclerosis progression (Panchenko, Siddiquee 
et al. 201 0). In our proposed disease model, the starting material is healthy animal aorta 
in tissue culture medium. Initial damage on the tissue will trigger inflammatory cell 
activities. Macrophages, enzymes and LDLs can be added into the medium to facilitate 
plaque progression. NIRAF is monitored over time. When NIRAF feature changes, tissue 
analysis will be done. Histology and chemical assay will provide clues about NIRAF 
change and disease progression. 
The third approach is to quantify dityrosine concentration on the material 
extracted from the plaques. This approach is inspired by literature (Leeuwenburgh, 
Rasmussen et al. 1997). From the confocal microspectroscopy measurement, we can 
select frozen plaque sections and extract the material with high NIRAF intensity. LDL 
and lipids are separated from the material and analyzed respectively. The protein 
components from the residue then experience hydrolysis and become amino acids. Amino 
acids are converted to carboxylic acid esters by the addition of reagents, based on which 
heptafluorobutyryl derivatives and pentafluoropropionyl derivatives are prepared. Mass 
spectrometry analysis of the mixture gives the dityrosine concentration. 
The results of this dissertation demonstrate the scientific explanation of NIRAF 
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and engineering basis for OFDI-NIRAF imaging of in vivo human patients. As a team 
effort, the first clinical OFDI-NIRAF imaging system is completed and waiting for the 
first human patient study in Massachusetts General Hospital. 
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